Índice

• • ·Author Index

    Página :317-329

    
• • ·Notes Page

    Página :330

    

• Podium Sessions

  • ·PD-01.01 : Even in low PSA ranges (0-2.5 ng/ml/cc) the PSA density of the transition zone is a very significant adjunct to serum PSA in differentiating prostate cancer from benign disease

    Página :1

    V. Scattoni, T. Ben Addi, P. Hoffman, C.C. Schulman, P. Rigatti, F. Montorsi, A.R. Zlotta

    Esquema Esquema
  • ·PD-01.02 : The PSA era is not over for detecting prostate cancer: correlations between PSA levels and transition zone volume in 1952 men with PSA levels < 10 ng / ml who underwent 10-14 biopsies

    Página :1

    V. Scattoni, T. Ben Addi, C.C. Schulman, P. Rigatti, F. Montorsi, A.R. Zlotta

    Esquema Esquema
  • ·PD-01.03 : Is adjuvant androgen deprivation therapy a treatment of curative intent?

    Página :1-2

    N. Fleshner, T.E. Keane, C.A. Lawton, P.F. Mulders, H. Payne, S. Taneja, T. Morris

    Esquema Esquema
  • ·PD-01.04 : Phase II dose finding study of ozarelix, an LHRH antagonist, in patients with inoperable prostate cancer

    Página :2

    F.M.J. Debruyne, K. Neykov, V.D. Taskova, S. Stratev, A. Bantchev, S.S. Karanikolov, S. Chawla, G. Lenaz, M. Peukert, J. Engel

    Esquema Esquema
  • ·PD-01.05 : Analysis of body temperature changes during hot flushes in men after bilateral orchidectomy (BO) for prostate cancer

    Página :2

    N.A. Aziz, C.F. Heyns

    Esquema Esquema
  • ·PD-01.06 : PSA / PAP ratio is a significant prognostic factor in patients with stage IV prostate cancer

    Página :2-3

    T. Saito, N. Hara, Y. Kitamura, S. Komatsubara

    Esquema Esquema
  • ·PD-01.07 : ATP combination therapy enhances the cytotoxic effect of mitoxantrone in hormone refractory prostate cancer

    Página :3

    M. Shabbir, C.S. Thompson, R.J. Morgan, G. Burnstock

    Esquema Esquema
  • ·PD-01.08 : Pragmatic recommendations and directions for future work based on a meta-analysis of 1653 patients treated with intermittent hormone therapy (IHT) for adenocarcinoma of the prostate

    Página :3

    G. Shaw, J. Cuzick, L. Goldenberg, N. Spry, D. Prapotnich, S. Malone, J. Forman, M. Scholz, W. Albrecht, T. Oliver

    Esquema Esquema
  • ·PD-01.09 : The relationship between tumor volume and the number of positive cores in men undergoing multisite extended biopsy: implication for expectant management

    Página :3-4

    A. Ochiai, P. Troncoso, M. Chen, R.J. Babaian

    Esquema Esquema
  • ·PD-01.10 : Erectile dysfunction in men treated with visually directed HIFU for clinically localized prostate cancer

    Página :4

    R.O. Illing, S. Dawkins, C.W. Ogden, M. Emberton

    Esquema Esquema
  • ·PD-02.01 : The effects of one-year treatment with an isoflavone extract from red clover on prostate, liver, sexual function and quality of life in men

    Página :4

    P. Engelhardt, C. Riedl

    Esquema Esquema
  • ·PD-02.02 : The effects of alpha-blockers, finasteride and plant extracts on the need for surgical treatment among Slovakian men with benign prostatic hyperplasia: a cross-sectional study of ten years’ follow-up

    Página :4-5

    J. Svihra, A. Szalayova, D. Bushnell, L. Macko, L. Poliak, J. Luptak, J. Kliment

    Esquema Esquema
  • ·PD-02.03 : A low vitamin D level is an independent risk factor for the development of benign prostatic hyperplasia

    Página :5

    J. Hammarsten, J.-E. Damber, O. Johnell, T. Knutson, Ö. Ljunggren, C. Ohlsson, R. Peeker, U. Smith, W. Waern, D. Mellström

    Esquema Esquema
  • ·PD-02.04 : Myocardial injury during transurethral prostatectomy: identification, incidence, and risk factors

    Página :5-6

    H. Ibrahim, D. Brathwaite, Z. Hussain, R.D. Inman, M.J. Hallworth, P.W. Jones, S.W.V. Coppinger

    Esquema Esquema
  • ·PD-02.05 : Effect of dutasteride on improvement of each IPSS item in patients with symptomatic benign prostatic hyperplasia

    Página :6

    F. Desgrandchamps, S. Droupy, J. Irani, C. Saussine, A. Comenducci

    Esquema Esquema  
  • ·PD-02.06 : Impact of baseline variables on the risk of BPH/LUTS progression: results of a 2-year placebo-controlled study with alfuzosin 10mg once daily

    Página :6-7

    C. Roehrborn, ALTESS study group

    Esquema Esquema
  • ·PD-02.07 : Serum prostate-specific antigen is a predictor of the transition zone volume rather than total prostate volume in men with benign prostatic hyperplasia

    Página :7

    A.R. Zlotta, T. Ben Addi, C.C. Schulman, P. Rigatti, V. Scattoni, F. Montorsi

    Esquema Esquema
  • ·PD-02.08 : The efficacy and safety of tadalafil administered once a day for lower urinary tract symptoms (LUTS) in men with benign prostatic hyperplasia (BPH)

    Página :7-8

    C.G. Roehrborn, K.T. McVary, J.D. Kaminestsky, S.M. Auerbach, B. Wachs, J.M. Young, A. Sesler, G.D. Sides, B.S. Denes

    Esquema Esquema
  • ·PD-02.09 : Finasteride alone maintains stable urinary symptoms (ipss) in men with benign prostatic hyperplasia after 9 months of combination therapy using an alpha-blocker and finasteride

    Página :8

    M. Elhilali, C. Dupont, C. Koch, PROACT study centers

    Esquema Esquema
  • ·PD-02.10 : Day surgery transurethral resection of prostate: our initial experience

    Página :8

    W.J. Chua, M.J.B. Tibung, D. Consigliere

    Esquema Esquema
  • ·PD-02.11 : Cetrorelix pamoate, an LHRH antagonist, in the treatment of BPH: randomized, placebo-controlled multicenter study

    Página :8-9

    F.M.J. Debruyne, M. Tzvetkov, Z. Medverec, S. Altarac, M. Peukert, J. Engel

    Esquema Esquema
  • ·PD-03.01 : Peri-urethral Zuidex^™ injection: a walk-in, walkout treatment for stress urinary incontinence

    Página :9

    H.P. Marsh, N. Dunne, S.J. Foley

    Esquema Esquema
  • ·PD-03.02 : Tension-free vaginal tape and autologous rectus fascia pubovaginal sling for the treatment of stress urinary incontinence: a medium-term follow-up

    Página :9

    F. Sharifi-Aghdas, N. Mortazavi

    Esquema Esquema
  • ·PD-03.03 : Comparison of lower urinary tract symptoms (LUTS) reported in voiding diary and its agreement to urologist and nurse assessment

    Página :9-10

    J. Gajewski, J. Puthenparumpil, S. Weerasinghe

    Esquema Esquema
  • ·PD-03.04 : Value of the I-PSS in women with bladder outlet obstruction following anti-incontinence surgery

    Página :10

    T. Fourie

    Esquema Esquema
  • ·PD-03.05 : Social demographic and clinical characteristics of females having lower urinary tract symptoms (FLUTS) in northern Malaysia: preliminary results from the FLUTS cohort study

    Página :10-11

    B.Y. Low, M.L. Liong, K.H. Yuen, C. Chee, W.L. Chong, W.S. Leong, N. Karim, P.Y. Cheah

    Esquema Esquema
  • ·PD-03.06 : The effects of duloxetine on urethral function and sphincter structure

    Página :11

    S. Athanasiou, C. Chaliha, A. Digesu, M. Sotiropoulou, A. Rodolakis, S. Jeffery, A. Antsaklis

    Esquema Esquema
  • ·PD-03.07 : Kiricuta’s omentoplasty in the treatment of vesico-vaginal fistulae

    Página :11

    D.-S. Popescu, A.D. Gavris, C.C. Turcu

    Esquema Esquema
  • ·PD-03.08 : An implant for the surgical treatment of stress urinary incontinence: Remeex System (TRT)

    Página :11-12

    J. Cabrera Pérez, I. Bravo Fernández, G. Pérez, C. González Enguita

    Esquema Esquema
  • ·PD-03.09 : Long term outcome of laparoscopic promontofixation for vaginal prolapse

    Página :12

    R. Sabbagh, P.E. Bryckaert, E. Mandron, J. Piussan

    Esquema Esquema
  • ·PD-04.01 : Clinical evaluation of the Stonebreaker^™, a new pneumatic intracorporeal lithotripter

    Página :12-13

    A. Rané, P. Rao, S.V. Kandaswamy, R. Kumar, N. Gupta

    Esquema Esquema
  • ·PD-04.02 : Novel deflecting stone basket improves calyceal access

    Página :13

    M. Monga, D. Weiland, B.K. Canales, J. Landman

    Esquema Esquema
  • ·PD-04.03 : Chronic dietary potassium depletion increases urinary oxalate excretion in rats

    Página :13

    R.Z. Hossain, C. Yachantha, Y. Ogawa, K. Yamakawa, M. Morozumi, K. Sugaya, P. Tosukhowong

    Esquema Esquema
  • ·PD-04.04 : Vitamin B6 deficiency causes hypocitraturia within one week in rats

    Página :13

    Y. Ogawa, R.Z. Hossain, K. Yamakawa, M. Morozumi, S. Hokama, Y. Oshiro, A. Uchida, K. Sugaya

    Esquema Esquema
  • ·PD-04.05 : Radial dilation of nephrostomy balloons: a comparative in vitro analysis

    Página :13-14

    M. Monga, K. Hendlin

    Esquema Esquema
  • ·PD-04.06 : Beneficial effect of lime powder intake on urinary oxidative status: a promising defence towards tubular injury

    Página :14

    C. Yachantha, T. Sasivongsbhakdi, S. Chaisawasdi, R.Z. Hossain, Y. Ogawa, K. Tangsanga, P. Tosukhowong

    Esquema Esquema
  • ·PD-04.07 : Novel inhibitors of calcium oxalate crystallisation

    Página :14

    S.E. Allen, C.H. Fry, S. Choong, W.G. Robertson

    Esquema Esquema
  • ·PD-04.08 : Laparoscopic management of upper urinary tract stones: a report of 134 cases

    Página :15

    N. Simforoosh, A. Bassiri, A. Danesh, A.M. Ziaee, F. Sharifi Aghdas, A. Tabibi, H. Abdi

    Esquema Esquema
  • ·PD-03.09 : Physical characteristics of next-generation ureteral access sheaths: buckling and kinking

    Página :15

    K. Hendlin, W.K. Durfee, M. Monga

    Esquema Esquema
  • ·PD-04.10 : Virtual reality percutaneous nephrostomy simulator: stab in the dark or valuable tool?

    Página :15

    J.R. Henderson, K. Thomas, P. Dasgupta, J.M. Glass

    Esquema Esquema
  • ·PD-04.11 : In vitro testing of a novel ureteroscopic plug to control projectile stone fragments

    Página :15-16

    D.M. Albala, G. Kolb

    Esquema Esquema
  • ·PD-05.01 : Protective effect of ADI on reperfusion injury following testicular torsion

    Página :16

    C. Yoon, D. Yoon, M. Oh, Y. Shim, B. Min, D. Yoon

    Esquema Esquema
  • ·PD-05.02 : Endoscopic management of vesicoureteral reflux with dextranomer/hyaluronic acid copolymer (Deflux) with 196 ureters in 125 patients

    Página :16

    A.N. Bissada, A.S. Safwat, N.K. Bissada

    Esquema Esquema
  • ·PD-05.03 : Urodynamic risk factors against spontaneous resolution of primary vesico-ureteral reflux in male infants

    Página :16

    Y. Igawa, M. Ichino, S. Seki, Y. Iijima, O. Ishizuka, O. Nishizawa

    Esquema Esquema
  • ·PD-05.04 : Child, family and socio-economic- dependent risk factors on nocturnal enuresis

    Página :17

    H. Basar, M. Basar, M. Saygun, E. Yilmaz, A. Cakmak, D. Tuglu, E. Batislam

    Esquema Esquema
  • ·PD-05.05 : When should cryptorchid boys have surgery? A prospective randomized controlled study

    Página :17

    C. Kollin, U. Hesser, M. Ritzén, B. Karpe

    Esquema Esquema
  • ·PD-05.06 : Evaluation of relationship between adenotonsilar hypertrophy and enuresis in children

    Página :17

    M. Mohamadzadeh Rezaei, M. Aslzare

    Esquema Esquema
  • ·PD-05.07 : Outcome analysis of one-stage repair for severe hypospadias

    Página :18

    L.H.P. Braga, J.L. Pippi Salle, A.J. Lorenzo, D. Bagli, A.E. Khoury

    Esquema Esquema
  • ·PD-05.08 : Surgical anatomy of epispadias and its impact on surgical treatment

    Página :18

    M. Djordjevic, S. Perovic, V. Vukadinovic

    Esquema Esquema
  • ·PD-05.09 : Tubularized incised urethral plate versus tubularized intact urethral plate for hypospadias repair: a comparative study

    Página :18

    A. Elbakry

    Esquema Esquema
  • ·PD-05.10 : Descent of the testes and insertion of the gubernaculum: optimal time for correction of cryptorchid testes

    Página :19

    K. Kim, H. Jung

    Esquema Esquema
  • ·PD-06.01 : Retroperitoneoscopy in urology: the Binh Dan experience in 276 initial cases

    Página :19

    P.C.H. Nguyen, V.A. Nguyen, V.L. Chuyen, T.K. Nguyen, T.P. Tran

    Esquema Esquema
  • ·PD-06.02 : Initial experience with the Endoassist^® camera holding robot in laparoscopic urological surgery

    Página :19-20

    A. Rané, P. Rimington, C. Anderson

    Esquema Esquema
  • ·PD-06.03 : Laparoscopic pyeloplasty in secondary ureteropelvic junction obstruction due to failed open surgery: a comparative clinical trial

    Página :20

    A. Basiri, S. Behjati, S. Hosseini Moghaddam, F.M.A. Beigi

    Esquema Esquema
  • ·PD-06.04 : General surgeons have a role to play in urological laparoscopic training

    Página :20

    A. Engledow, P. Tozer, M. Hussain, S. Warren, G. Webster

    Esquema Esquema
  • ·PD-06.05 : Outcomes of hand-assisted laparoscopic nephrectomy in technically challenging cases

    Página :20-21

    J. Tornero, A. Prieto, P. Lopez-Cubillana, F. Escudero, G. Gómez, M. Perez-Albacete

    Esquema Esquema
  • ·PD-06.06 : The en bloc control of the renal pedicule with gastrointestinal anastomosis stapler in laparoscopic nephrectomy

    Página :21

    M. Arslan, T. Degirmenci, B. Gunlusoy, S. Minareci, K. Ýlhan, N. Nergiz, A. Ayder

    Esquema Esquema
  • ·PD-06.07 : Our laparoscopic nephrectomy experiences: transperitoneal versus retroperitoneal approach

    Página :21

    M. Arslan, T. Degirmenci, B. Gunlusoy, I. Hergul, S. Minareci, A.R. Ayder

    Esquema Esquema
  • ·PD-06.08 : Laparoscopy assisted retroperitoneal pyeloplasty and via pelvis stone removal

    Página :21-22

    S.J. Yoon, J.B. Lee, H. Jung, M.S. Lee, J.C. Yun, J.Y. Park, E.S. Lee, H. Choi

    Esquema Esquema
  • ·PD-06.09 : Comparison laparoscopic radical and laparoscopic simple nephrectomy

    Página :22

    V. Hanchanale, A. Al-Sarira, D. Gerald, J.E. McCabe, P. Javle

    Esquema Esquema
  • ·PD-06.10 : LOTUS® vs. Harmonic Scalpel: A Controlled Pilot Study of Efficacy Ergonomics and Pathological Outcome in the Porcine Model

    Página :22

    A. Henderson, E. Whitehead, M. Nora, A. Rané

    Esquema Esquema
  • ·PD-06.11 : 44 laparoscopic retroperitoneal and transperitoneal adrenalectomies: results and complications

    Página :22-23

    Z. Jablonowski, E. Miekoś, C. Zydek, L. Kutwin, M. Sosnowski, W. Różański

    Esquema Esquema
  • ·PD-06.12 : Experience of retroperitoneal laparoscopic surgery with 1560 cases at a single institution

    Página :23

    M. Li, L. Zhou, N. Li, Y. Na

    Esquema Esquema
  • ·PD-07.01 : Incidence of bladder outlet obstruction after primary treatment for prostate cancer: data from CaPSURE

    Página :23-24

    S. Elliott, M. Meng, E. Elkin, J. McAninch, J. DuChane, P. Carroll

    Esquema Esquema
  • ·PD-07.02 : Prostatic unsaturated fatty acid levels in patients with clinically localized prostate cancer and risk of biochemical recurrence following prostatectomy

    Página :24

    R.C. Flanigan, V.L. Freeman, M. Meydani

    Esquema Esquema
  • ·PD-07.03 : Comparison of site specific labeling of prostate biopsy specimens as compared to grouped labeling by side only

    Página :24

    E.R. Richter, J.T. Moncur, I.A. Sesterhenn, D.G. McLeod

    Esquema Esquema
  • ·PD-07.04 : Transurethral resection for prostate cancer (TURPC), a radical procedure: Experience with 1084 cases

    Página :24-25

    M.A. Reuter, W. Epple, G. Ungemach, A.B. Verger-Kuhnke

    Esquema Esquema
  • ·PD-07.05 : Comparing radical retropubic prostatectomy and laparoscopic radical prostatectomy at the beginning of the learning curve for both procedures. Experience from average prostate cancer volume centre in South Africa

    Página :25

    R. Mierzwinski, F. Nel, M. Conradie

    Esquema Esquema
  • ·PD-07.06 : Impact of hospital provider volume on short-term outcomes for radical urological cancer surgery in England

    Página :25-26

    V. Hanchanale, A. Al-Sarira, D. Gerald, J. McCabe, P. Javle

    Esquema Esquema
  • ·PD-07.07 : Prospective health-related quality of life assessment in an initial cohort of robotic radical prostatectomy patients

    Página :26

    D.M. Albala, T.Y. Tseng, H. Kuebler, Q.V. Cancel, P. Dahm

    Esquema Esquema
  • ·PD-07.08 : Low correlation between insignificant cancer (ICA) on prostate biopsy and radical prostatectomy (RP) specimens

    Página :26

    M. Brausi, M. Gavioli, M. Viola, G.L. Simonini, G. DeLuca, G. Verrini, G. Peracchia, B. Djavan

    Esquema Esquema
  • ·PD-07.09 : Is the low prostate specific antigen cutoff point applicable to Chinese men?

    Página :26-27

    M. Li, Y. Na

    Esquema Esquema
  • ·PD-07.10 : High intensity focused ultrasound (HIFU) for prostate cancer: Outcome 5 years, 450 patients, and sex life, AZ Middelheim, Antwerp, Belgium

    Página :27

    C. D’Hont, P. Van Erps, J. Cortvriend, M. Sorber, W. Gelders

    Esquema Esquema
  • ·PD-07.11 : Prostate specific antigen is no longer accurate for prostate cancer (PCa) diagnosis

    Página :27

    T. Ben Addi, A. Zlotta, C. Schulman

    Esquema Esquema
  • ·PD-07.12 : Vascular targeted phototherapy with Tookad for the treatment of prostate cancer after radiation therapy

    Página :27-28

    J. Trachtenberg, M. Elhilali, J. Chin

    Esquema Esquema
  • ·PD-08.01 : Partial nephrectomy is safe and efficacious for pathologic stage T2-T3b renal cell carcinoma

    Página :28

    K.M. Jacobsohn, R. Sanchez-Ortiz, S.F. Matin, P. Tamboli, L.L. Pisters, D.A. Swanson, C.G. Wood

    Esquema Esquema
  • ·PD-08.02 : High intensity focused ultrasound for the treatment of small renal tumours. Phase II trial results from Oxford

    Página :28

    T.A. Leslie, R.O. Illing, J.E. Kennedy, F. Wu, G.R. ter Haar, R.R. Phillips, A. Protheroe, D.W. Cranston

    Esquema Esquema
  • ·PD-08.03 : Ureteroscopic holmium laser ablation of upper urinary tract carcinoma

    Página :28-29

    K. Matsuoka, K. Tomiyasu, S. Suekane, M. Noguchi

    Esquema Esquema
  • ·PD-08.04 : Percutaneous radio frequency ablation in renal tumors: the Gothenburg experience

    Página :29

    D. Lyrdal, M. Andersson, J. Sternal, S. Lundstam

    Esquema Esquema
  • ·PD-08.05 : Protective effect of arginine deiminase against interleukin induced morbidity is related with plasma NO level

    Página :29

    C.Y. Yoon, D.H. Yoon, Y.J. Shim, E.H. Kim, B.H. Min, D.K. Yoon

    Esquema Esquema
  • ·PD-08.06 : Biological significance of fascin expression in clear cell renal cell carcinoma

    Página :29-30

    R. Zigeuner, N. Droschl, V. Tauber, P. Rehak, C. Langner

    Esquema Esquema
  • ·PD-08.07 : Ureteroscopic management of transitional cell carcinoma

    Página :30

    K. Thomas, J. Henderson, O. Wiseman, P. DasGupta, J. Glass, R. Tiptaft

    Esquema Esquema
  • ·PD-08.08 : VEGF, VEGF-R1 and VEGF-R2 mRNA expression profiles different between clear and papillary renal cell carcinoma. Importance for angiogenic therapies

    Página :30

    B. Ljungberg, J. Jacobsen, K. Grankvist, T. Rasmuson, G. Lindh, S. Häggström Rudolfsson

    Esquema Esquema
  • ·PD-08.09 : Tumor VEGF and microvessel density in renal cell carcinoma

    Página :30-31

    S.K. Singh, N. Bhuvanesh, R. Prasad, K. Joshi

    Esquema Esquema
  • ·PD-08.10 : Percutaneous radiofrequency ablation (PRFA) of small renal tumors under ultrasound (US) in high-risk patients: 2-year follow-up

    Página :31

    M. Brausi, M. Gavioli, G. Verrini, G. De Luca, G. Peracchia, G. Simonini, M. Viola, F. Ferrari

    Esquema Esquema
  • ·PD-09.01 : Subcostal kidney extraction: a novel approach to laparoscopic donor nephrectomy

    Página :31

    B. Radolinski, E.K. Diner, J.D. Murdock, S.R. Ghasemian

    Esquema Esquema
  • ·PD-09.02 : Right laparoscopic donor nephrectomy: the Washington Hospital Center experience

    Página :31

    B. Radolinski, E.K. Diner, J.D. Murdock, S. Ghasemian

    Esquema Esquema
  • ·PD-09.03 : Evolution of renal transplants: arterial multiplicity influence

    Página :32

    P. Nunes, B. Parada, A. Figueiredo, A. Roseiro, V. Dias, C. Bastos, F. Rolo, A. Mota

    Esquema Esquema
  • ·PD-09.04 : Laparoscopic versus open donor nephrectomy for pediatric kidney recipients: a randomized controlled trial

    Página :32

    A. Basiri, N. Simforoosh, M. Heidari, S.M.M. Hosseini Moghaddam

    Esquema Esquema
  • ·PD-09.05 : Detouring the obstructed transplant ureter

    Página :32

    J. Olsburgh, P. Tait, G. Williams

    Esquema Esquema
  • ·PD-09.06 : Third kidney transplants: surgical aspects

    Página :32-33

    A. Rodriguez Antolin, M. Blanco, F. De la Rosa, F. Villacampa, M. Pamplona, A. Andres, J.M. Morales, J.F. Aguirre, R. Diaz, M. Praga, O. Leiva

    Esquema Esquema
  • ·PD-09.07 : Single or double kidney transplant?

    Página :33

    F. De La Rosa, A. Rodriguez, M. Pamplona, F. Villacampa, J. Passas, A. Andres, M. Praga, J.F. Aguirre, R. Diaz, O. Leiva

    Esquema Esquema
  • ·PD-09.08 : Graft loss during the first year after renal transplantation

    Página :33

    B. Parada, A. Figueiredo, P. Nunes, P. Moreira, F. Rolo, A. Mota

    Esquema Esquema
  • ·PD-09.09 : Old-to-old renal transplantation program: Single center results

    Página :33-34

    A. Schlichter, T. Steiner, W. Werner, S. Jörg

    Esquema Esquema
  • ·PD-09.10 : Experience with 350 cases of laparoscopic live donor nephrectomy; development of cost-effective techniques

    Página :34

    A. Kumar, N. Gupta, A. Srivastava, D. Dubey

    Esquema Esquema
  • ·PD-09.11 : Radiocephalic fistula at elbow-A simple solution to prevent vascular steal syndrome associated with brachiocephalic fistula: review of over 300 cases

    Página :34

    A. Kumar, N. Gupta, A. Srivastava, D. Dubey, P. Raina, V.K. Vijjan, M. Jha

    Esquema Esquema
  • ·PD-10.01 : Long-term survival of inflatable penile prostheses

    Página :34-35

    S.K. Wilson, J. Delk, A. Neeb, M. Cleves

    Esquema Esquema
  • ·PD-10.02 : Seminal plasma magnesium and premature ejaculation: a case-control study

    Página :35

    M.R. Nikoobakht, G. Pourmand, M. Aloosh, M. Hasani, A. Emamzadeh, A. Mehrsai

    Esquema Esquema
  • ·PD-10.03 : A prospective assessment of chronic post-vasectomy scrotal pain

    Página :35

    T.A. Leslie, R.O. Illing, J. Guillebaud, D.W. Cranston

    Esquema Esquema
  • ·PD-10.04 : Erectile dysfunction: the expression of phosphodiesterase-5 and soluble guanylate cyclase in circulating mononuclear cells is related with erectile dysfunction aetiology

    Página :35

    R. Vela Navarrete, J. Garcia Cardoso, A. Lopez Farre, P. Mateos Caceres, L. Lapuente, S. Zamorano Leon

    Esquema Esquema
  • ·PD-10.05 : The influence of partial androgen deficiency among aging men (PADAM) on the development of metabolic syndrome

    Página :35-36

    A.V. Pechersky, V.F. Semiglazov, V.I. Mazurov, A.I. Karpischenko, V.I. Pechersky, N.N. Zibina, N.I. Davydova, V.Y. Kravtsov, S.N. Proshin, M.G. Skorobogatikh, O.B. Loran

    Esquema Esquema
  • ·PD-10.06 : Localization of increased insulin-like growth factor binding protein-3 in the diabetic rat penis; implication for erectile dysfunction

    Página :36

    J. Soh, M. Katsuyama, S. Ushijima, Y. Naya, A. Ochiai, Y. Naitoh, K. Yoneda, A. Kawauchi, C. Yabe-Nishimura, T. MIki

    Esquema Esquema
  • ·PD-10.07 : Measurement of external genitalia dimensions and their correlation to other somatometric parameters in young Iranian men

    Página :36-37

    D. Mehraban, G.H. Naderi, S.A. Tahvildar, M. Salehi, M. Amirchagmaghi

    Esquema Esquema
  • ·PD-10.08 : Effects of statin treatment on autonomic and erectile function

    Página :37

    M. Tolga Doğru, M.M. Basar, A. Simse, E. Yuvanç, M. Güneri, H. Ebinç, E. Batislam

    Esquema Esquema
  • ·PD-10.09 : Effect of serum gonadotropins and sex steroids levels on autonomic function

    Página :37

    M. Tolga Dogru, M.M. Basar, E. Yilmaz, E. Yuvanç, E. Batsilam

    Esquema Esquema
  • ·PD-10.10 : Results and complications of bilateral vasectomy performed under local anaesthesia by urology registrars at a secondary level hospital

    Página :37-38

    G. Trollip, A. Alexander, M. Fisher, A. Naidoo, P.D. Theron, C.F. Heyns

    Esquema Esquema
  • ·PD-11.01 : Diagnosis and surveillance of bladder cancer using a point-of care proteomic assay

    Página :38

    H. Grossman, M. Soloway, NMP22 Clinical Investigation Group 3

    Esquema Esquema
  • ·PD-11.02 : Cycle-dependent response to maintenance BCG in high-risk superficial bladder cancer

    Página :38

    L. Lacombe, M. Decobert, F. Harel, H. Larue, G. Steinhoff, J. Kinahan, Y. Fradet

    Esquema Esquema
  • ·PD-11.03 : uCyt+/ImmunoCyt in the detection of recurrent urothelial carcinoma: an update on 1,991 analyses

    Página :38-39

    C. Mian, K. Maier, E. Comploj, M. Lodde, L. Berner, L. Lusuardi, S. Palermo, F. Vittadello, A. Pycha

    Esquema Esquema
  • ·PD-11.04 : Neoadjuvant cisplatinum based combination chemotherapy in patients with invasive bladder cancer: a combined analysis of two Nordic studies

    Página :39

    A. Sherif, L. Holmberg, E. Rintala, O. Mestad, J. Nilsson, S. Nilsson, P.U. Malmström

    Esquema Esquema
  • ·PD-11.05 : In vivo observation of living bladder cancer cells using catheter-type contact ultra-magnifying endoscope

    Página :39

    T. Ohigashi, N. Kozakai, R. Mizuno, K. Nishimoto, A. Miyajima, K. Nakagawa, M. Murai

    Esquema Esquema
  • ·PD-11.06 : Correlation of overall survival with pre-operative delays prior to cystectomy for bladder cancer: population-based study in Quebec

    Página :39-40

    N. Fahmy, S. Jeyaganth, S. Mahmud, S. Tanguay, A. Aprikian

    Esquema Esquema
  • ·PD-11.07 : “Second–look” TURB in the diagnostic work up of high risk superficial bladder cancer

    Página :40

    R. Sanseverino, A. Campitelli, A. Barela, G. Napodano, O. Intilla, G. Miracolo, A. Perna

    Esquema Esquema
  • ·PD-11.08 : Bladder cancer outcome prediction using gene expression signatures–a large scale international validation study

    Página :40

    L. Dyrskjøt, P.-U. Malmström, K. Zieger, F. Real, N. Malats, M. Knowles, A. Caillault, F. Radvanyi, K. Wester, T. Ørntoft

    Esquema Esquema
  • ·PD-11.09 : Potential cost savings through the use of fluorescence cystoscopy in superficial bladder cancer: development of an economic model

    Página :40-41

    P.-U. Malmström, H. Hedelin

    Esquema Esquema
  • ·PD-11.10 : The use of local anesthesia with N-DO injector (Physion) for TUR of small bladder tumors (BT) and bladder mapping: preliminary results and cost-effectiveness analysis

    Página :41

    M. Brausi, M. Gavioli, G. Peracchia, G. De Luca, M. Viola, G. Simonini, G. Verrini

    Esquema Esquema
  • ·PD-11.11 : Phase II marker lesion study with intravesical instillation of Eoquin^™ in superficial bladder cancer: toxicity, marker response and follow up

    Página :41

    A.G. van der Heijden, K. Hendricksen, E.B. Cornel, H. Vergunst, T.M. de Reijke, E. van Boven, E.J. Barten, S. Chawla, G. Lenaz, J.A. Witjes

    Esquema Esquema
  • ·PD-11.12 : Prophylactic ofloxacin to improve tolerance of BCG instillations: two-year results of a prospective double blind placebo-controlled study in patients with bladder cancer

    Página :42

    R. Buckley, P. Rischmann, M. Colombel, F. Saint, B. Malavaud, D.K. Chopin, L. Nicholas

    Esquema Esquema
  • ·PD-12.01 : A retrospective analysis of the use of intravesical Botox injection for the treatment of overactive bladder in a non-specialised unit

    Página :42

    C. Blick, J.K. Kennedy, S.J. Foley

    Esquema Esquema
  • ·PD-12.02 : Treatment of overactive bladder syndrome (OAB) with botulinum toxin-A: when anticholinergic therapy fails

    Página :42

    S. Carl, H.J. Forth, S. Laschke

    Esquema Esquema
  • ·PD-12.03 : Long-term follow-up for neurogenic bladder disorders in spina bifida children treated with Dysport botulinum toxin

    Página :43

    S. Laschke, H. Gerner, S. Carl

    Esquema Esquema
  • ·PD-12.05 : Long term evaluation of chemodenervation of detrusor and External Urethral sphincter (EUS) in patients with detrusor overactivity (DO) and external urethral sphincter dyssynergia (DESD) of both neurogenic and non-neurogenic etiologies using botulinum-A toxin (BTX-A): A multi-center study

    Página :43

    I.O. Abdel Hafeez, H.M. El-Shawaf, H.S. Shaker, K. Mokhtar

    Esquema Esquema
  • ·PD-12.06 : Repeat Botox A injections are safe and efficacious in neurogenic overactive patients: results of a single center prospective trial

    Página :43-44

    P. Barboglio, R. Rivera, H. Tunuguntla, L. Cason, A.E. Gousse

    Esquema Esquema  
  • ·PD-12.07 : Validated instrument to assess pain tolerance during flexible endoscopy for intradetrusor botulinum toxin-A injection

    Página :44

    B. Cohen, R. Rivera, P.G. Barboglio, A.E. Gousse

    Esquema Esquema
  • ·PD-12.08 : Real time measurement of bladder sensation during cystometry

    Página :44-45

    J. O’Donoghue, W. Tsang, J. Moore, J. Reynard, J. Noble, A. Brading

    Esquema Esquema
  • ·PD-12.09 : Botulinum toxin A in severe neurogenic detrusor overactivity and incontinence: long-term success of repeat detrusor injections without loss of efficacy

    Página :45

    J.O. Grosse, G. Kramer, M. Stöhrer, G. Jakse

    Esquema Esquema
  • ·PD-12.10 : Botox^™ injections in idiopathic overactive bladder: long-term outcome data after repeated injections

    Página :45-46

    A. Gousse, P. Barboglio, D. Rodriguez, R. Rivera

    Esquema Esquema  
  • ·PD-12.11 : Is the success of first and repeat multifocal Botulinum Toxin A detrusor injections predictable by urodynamics in neurogenic detrusor overactivity?

    Página :46

    J.O. Grosse, G. Kramer, G. Jakse

    Esquema Esquema
  • ·PD-12.12 : Efficacy and complications of the intradetrusor injection of Dysport (Botulinum Toxin A) in patients with refractory OAB

    Página :46-47

    S. Jeffery, K. Wang, F. Lee, R. Morley, M. Fynes

    Esquema Esquema

• Moderated Poster Sessions

  • ·Comparison of prazosin with combination of prazosin and finasteride in successful spontaneous voiding for 48 hours after removal of urethral catheter in men with acute urinary retention (AUR) due to benign prostatic hyperplasia (BPH)

    Página :48

    M. Salehi, F. Poor Reza, H. Ghasemi, M. Fouladi Mehr

    Esquema Esquema
  • ·MP-01.02 : Bilateral seminal vesicles puncture unremitting instillation: an effective way to treat intractable hemospermia

    Página :48

    X.R. Zhang, Y.M. Xu, R. Chen

    Esquema Esquema
  • ·MP-01.03 : Additive effects of extracorporeal magnetic innervation and terazosin therapy for non-inflammatory chronic pelvic pain syndrome: a pilot study

    Página :48-49

    J. Paick, S. Song, J. Ku, S. Oh, S. Kim

    Esquema Esquema
  • ·MP-01.04 : Prognostic factors in Fournier gangrene

    Página :49

    H. Jeong, S. Park, S. Oh, I. Seo, J. Rim, D. Kwon, S. Kim, S. Baek

    Esquema Esquema
  • ·MP-01.05 : Genitourinary filariasis: the West African experience

    Página :49

    S. Mante, A. Seim

    Esquema Esquema
  • ·MP-01.06 : Treatment of interstitial cystitis with botulinum toxin type A

    Página :49

    S. Carl, J. Grosse, S. Laschke

    Esquema Esquema
  • ·MP-01.07 : A study of the bacterial flora of the perineum in adult male urological patients

    Página :50

    E. Kehinde, Y. Ali, F. Khodakhast, W. Jamal, V. Rotimi

    Esquema Esquema
  • ·MP-01.08 : Evaluation of a rapid test for detection of chlamydia trachomatis infection in female commercial sex workers

    Página :50

    G. Lee, Y. Byun, Y. Ryu, H. Kim

    Esquema Esquema
  • ·MP-01.09 : Antibiotics resistance pattern in urinary isolated bacteria

    Página :50

    M. Mansour Ghanai, S.A. Asgari

    Esquema Esquema
  • ·MP-01.10 : Factors influencing urinary tract infection after flexible cystoscopy: does wearing a sterile surgical gown prevent UTI after flexible cystoscopy?

    Página :50-51

    P. Chandrasekar, J. Raynard, J.S. Virdi, B.S. Potluri

    Esquema Esquema
  • ·MP-01.11 : The epidemiology and clinical characteristics of acute pediatric epididymitis in Korea

    Página :51

    C.H. Lee, D.S. Kim, Y.S. Jeon, N.K. Lee

    Esquema Esquema  
  • ·MP-01.12 : A pilot study of tamsulosin in patients with chronic pelvic pain syndrome: prospective trial

    Página :51

    C.H. Lee, D.S. Kim, Y.S. Jeon, N.K. Lee

    Esquema Esquema
  • ·MP-01.13 : Treatment of infected urachal cyst: single stage vs two stage

    Página :51-52

    K. Yoo, S. Joen, S. Lee, S. Chang, J. Kim

    Esquema Esquema
  • ·MP-01.14 : The analysis of autoinducer synthesis gene expression involved in quorum sensing mechanism with catheter associated urinary tract infection (CAUTI)

    Página :52

    J.S. Koh, H.S. Kim, K. Peck, M. Lee, H. Lee, S. Lee, J.Y. Lee

    Esquema Esquema
  • ·MP-01.15 : Epididymectomy in the management of chronic scrotal pain

    Página :52

    C. Sweeney, G. Oades

    Esquema Esquema
  • ·MP-01.16 : Diagnostic and treatment of prostatic abscess: value of transrectal ultrasonography. Our experience

    Página :52-53

    A. Sanchı́s Bonet, F. Cabrera Meirás, O. Blanco Carballo, A. Martı́n Parada, G. Duque Ruiz, A. Tejido Sánchez, A. Rodriguez Antolı́n, J. Passas Martı́nez, O. Leiva Galvis

    Esquema Esquema
  • ·MP-01.17 : Intravesical electromotive drug administration as a treatment option for females with interstitial cystitis

    Página :53

    K. Tevlin, D. Pushkar, I. Korsunskaya

    Esquema Esquema
  • ·MP-01.18 : The influence of endovesical electromotive drug therapy on sexual function of female patients suffering from interstitial cystitis

    Página :53

    K. Tevlin, D. Pushkar, I. Korsunskaya

    Esquema Esquema
  • ·MP-01.19 : Fluoxetine in the management of men with chronic prostatitis/chronic pelvic pain syndrome

    Página :53-54

    P. Xanthopoulos, P.M. Pavlopoulos, G. Xanthopoulou, P. Kakouri, S. Bouzoukas

    Esquema Esquema
  • ·MP-01.20 : Augmented floor strip dorsal onlay urethroplasty for anterior urethral strictures

    Página :54

    A. Kumar, R. Kapoor, A. Srivastava, A. Mandhani, D. Dubey

    Esquema Esquema
  • ·MP-01.21 : Dorsal onlay buccal mucosa versus penile skin flap urethroplasty for anterior urethral strictures: results from a randomized prospective trial

    Página :54

    D. Dubey, K. Rakesh, K. Anant, S. Anees

    Esquema Esquema
  • ·MP-01.22 : A single centre experience of male urethral diverticula

    Página :54

    V. Mishra, D. Allen, M. Sharma, A. Hussain, S. Shah, H. Motiwala

    Esquema Esquema
  • ·MP-01.23 : Circumcision: a ‘vaccine’ against AIDS? Changing concepts in Swaziland

    Página :54-55

    A.E. Groeneveld, D. Halperin

    Esquema Esquema
  • ·MP-01.24 : Prostatic fistula to perineum and rectum: a vexing problem

    Página :55

    V. Mishra, A. Rao, V. Hanchanale, R. Plail, O. Karim, H. Motiwala

    Esquema Esquema
  • ·MP-01.25 : The effect of terazosin on symptom recurrence in men with chronic prostatitis/chronic pelvic pain syndrome

    Página :55

    I. Cho, J. Kim, K. Lee, K. Lee, Y. Chang

    Esquema Esquema
  • ·MP-02.01 : Azoospermia and diagnostic methods

    Página :56

    S. Falahatkar, A. Hamidi, S. Tavasoli, Z. Atrkar, M. Zareian, E. Sazgari, S. Nicpoor

    Esquema Esquema
  • ·MP-02.02 : Comparison of results of bilateral testicular biopsy with conventional markers of testicular size and serum FSH in presence of testicular spermatozoa in azoospermic infertile men

    Página :56

    S. Falahatkar, A. Hamidi, Z. Atrkar Roshan, M. Zareian, E. Sazgari, G. Fadakar Soogheh

    Esquema Esquema
  • ·MP-02.03 : Effect of varicocelectomy on spermogram, fertility, premature ejaculation and abortion

    Página :56

    A. Shamsa, M. Nademi, M. Aqaee, A. Nouraee Fard

    Esquema Esquema
  • ·MP-02.04 : Comparison of the perinatal outcome in ICSI cycles with testicular or seminal spermatozoa

    Página :56-57

    M. Badalotti, C. Telöken, A. Arent, P. Telöken, F. Badalotti, D. Farinatti, R. Azambuja, J. Michelon, A. Petracco

    Esquema Esquema
  • ·MP-02.05 : Double-blind, case-control, multicenter study for therapeutic effects of panax ginseng C.A. Meyer extract in male infertility with low sperm quality

    Página :57

    H. Lee, S. Woo, H. Kim, H. Park, T. Kim, N. Youn, J. Kim, S. Chang

    Esquema Esquema
  • ·MP-02.06 : Invagination of tubular loop: A new modified technique of microsurgical vasoepididymostomy

    Página :57

    R.K. Shimpi

    Esquema Esquema
  • ·MP-02.07 : Laparoscopic varicocelectomy using bipolar cautery vs. open varicocelectomy: first randomized clinical trial

    Página :57-58

    N. Simforoosh, S. Behjati, A. Bassiri, S.A.M. Ziai, A. Danesh, A. Tabibi, F. Sharifi Aghdas, F.M.A. Beygi

    Esquema Esquema
  • ·MP-02.08 : Seminal plasma epidermal growth factor and transforming growth factor-beta levels in varicocele patients: the role of testicular autocrine function in varicocele physiopathology

    Página :58

    U. Kisa, M.M. Basar, M. Ferhat, O. Caglayan, E. Yilmaz, E. Batislam

    Esquema Esquema
  • ·MP-02.09 : Serum and seminal plasma inhibin B levels in adult and adolescent patients with varicocele and comparison of semen parameters

    Página :58

    M. Basar, U. Kisa, D. Tuglu, M. Kacmaz, H. Basar, E. Batislam

    Esquema Esquema
  • ·MP-02.10 : ICSI outcome using frozen oocytes and three different sperm sources

    Página :58-59

    C. Telöken, A. Arent, M. Badalotti, R. Azambuja, L. Okada, A. Petracco

    Esquema Esquema
  • ·MP-02.11 : Comparison of the reproductive performance of testicular sperm with ejaculated sperm from severe oligospermia

    Página :59

    C. Telöken, M. Badalotti, A. Arent, R. Azambuja, P. Telöken, L. Okada, F. Badalotti, A. Petracco

    Esquema Esquema
  • ·MP-02.12 : The comparison of infusion of sterile water with normal saline into distal vas deferens on post-vasectomy azoospermia

    Página :59

    A. Roshani, A. Kiani, M.A. Golbaghi

    Esquema Esquema
  • ·MP-02.13 : Serum inhibin-B as a prognostic factor to predict sperm retrieval in testis biopsy of patients with azoospermia

    Página :59-60

    M. Nowroozi, K. Radkhah

    Esquema Esquema
  • ·MP-02.14 : Prevalence of disease in brothers of patients with varicocele: a comparison with healthy controls

    Página :60

    F. Mohammad Ali Beigi, S. Mehrabi

    Esquema Esquema
  • ·MP-02.15 : Seminal plasma interleukin-10 levels and effect on seminal parameters

    Página :60

    S.H. Unal, M.M. Basar, O. Caǧlayan, E. Yılmaz, E. Batislam

    Esquema Esquema
  • ·MP-02.16 : Evaluation of the reactive oxygen species in peripheral and testicular vein in patients with varicocele

    Página :60-61

    M. Karalar, M. Şamlý, E. Tüzel, T. Köken, M. Demirbaş, C. Güler

    Esquema Esquema
  • ·MP-02.17 : Smoking and semen parameters in infertile men

    Página :61

    M. Hosseini, S. Zahraee, S. Hashemi, B. Kasraee

    Esquema Esquema
  • ·MP-02.18 : Comparison of systematic fine needle aspiration mapping and multiple microbiopsies of testis in evaluation of azoospermia

    Página :61

    D. Hota, S. Sasturkar

    Esquema Esquema
  • ·MP-03.01 : The correlation between spinning and erectile dysfunction

    Página :61

    G. Meyer, M. Gross, M. Mullerad, A. Kravtsov, B. Moskovitz, O. Nativ

    Esquema Esquema
  • ·MP-03.02 : Sildenafil efficacy: does food matter? Sixteen-week randomized, double blind, placebo-controlled, double-crossover study assessing effects of food and dose timing

    Página :61-62

    N. Zinner

    Esquema Esquema
  • ·MP-03.03 : Role of histamine type 2 receptor antagonist in erectile dysfunction

    Página :62

    J. Park, W.S. Cui, S.Z. Kim, Y.K. Park, K.W. Cho, J.H. Lim

    Esquema Esquema
  • ·MP-03.04 : Metabolic syndrome as an indicator of erectile dysfunction

    Página :62

    N. Park, H. Park, B. Park

    Esquema Esquema
  • ·MP-03.05 : Effects of long-term administration of tadalafil on lower urinary tract symptoms and erectile dysfunction

    Página :62-63

    J.S. Hyun, S.C. Gam, S.M. Choi, K.H. Moon

    Esquema Esquema
  • ·MP-03.06 : Mini-incision high open varicocelectomy

    Página :63

    A. Hinev, S. Paunov

    Esquema Esquema
  • ·MP-03.07 : Change in the serum testosterone level and quality of life after transdermal testosterone (Testogel) supplement therapy in late onset hypogonadism patients

    Página :63

    J.J. Kim, J.H. Bae, D.G. Moon, S.H. Kang, J. Cheon, N.S. Kim

    Esquema Esquema
  • ·MP-03.08 : Abstract Withdrawn

    Página :63

    
  • ·MP-03.09 : The COUPLE-project: pooled analysis of satisfaction with vardenafil treatment in men with erectile dysfunction and their partners

    Página :64

    W.A. Fisher, R.C. Rosen, M. Beneke, M. Homering, T. Evers, I. Eardley

    Esquema Esquema
  • ·MP-03.10 : The effect of transdermal electromotive administration (EMDA) of verapamil on the serum levels of transforming growth factor-beta (TGF-beta), metalloproteinase 1 (MMP1) and their inhibitors (TIMPs) in Peyronie’s disease

    Página :64

    A. Lekas, G. Doumanis, C. Tsalikis, S. Tsalavoutas, V. Politis, C. Mitsios, S. Koritsiadis

    Esquema Esquema
  • ·MP-03.11 : The effect of vardenafil on cell proliferation in the paraventricular nucleus and dentate gyrus of conscious rats

    Página :64-65

    K. Kim, C. Kwon, H. Park, J. Park, H. Kim, Y. Kim, H. Lee, K. Min, Y. Song, G. Sim

    Esquema Esquema
  • ·MP-03.12 : Mini-incision high open varicocelectomy versus laparoscopic varicocelectomy: a prospective comparative study with two microsurgical lymphatic sparing techniques

    Página :65

    A. Hinev, S. Paunov, V. Bojkov, M. Andonov

    Esquema Esquema
  • ·MP-03.13 : Efficacy and safety of tadalafil in men with erectile dysfunction: results of the first Middle East clinical study

    Página :65

    I. Khalaf, M. Elgallad

    Esquema Esquema
  • ·MP-03.14 : The real-life safety and efficacy of vardenafil (REALISE) study: results from South Africa

    Página :65-66

    M. Haffejee, R. Coetzee, H. Landen

    Esquema Esquema
  • ·MP-03.15 : Premature ejaculation: combined intervention

    Página :66

    A. Fernández Lozano, F. Cabello Santamarı́a, I. Sotolongo Vergo, E. Ruiz Castañe

    Esquema Esquema
  • ·MP-03.16 : How strong is the relationship between the metabolic syndrome and erectile dysfunction?

    Página :66

    V. Bucuras, F. Stiuca-Seracu, R. Bardan

    Esquema Esquema
  • ·MP-03.17 : Impact of patient-physician communication on continuation of PDE5 inhibitor treatment: subset analysis of men with ED from the multinational Men’s Attitudes to Life Events and Sexuality (MALES) Phase II

    Página :66-67

    I. Eardley, R.C. Rosen, W.A. Fisher, M. Sand

    Esquema Esquema
  • ·MP-03.18 : Vardenafil improves treatment satisfaction and sexual pleasure in men with erectile dysfunction and their partners

    Página :67

    W. Fisher, R. Rosen, I. Eardley, G. Brock, G. Karlin, P. Pommerville, X.Y. Huang, K. Bangerter, M.S. Sand, Z. Herman-Gnjidic, L. Derogatis, Vardenafil Study Group 9

    Esquema Esquema
  • ·MP-03.19 : Sources of influence on continuation of PDE5 inhibitor therapy: analysis of men with erectile dysfunction from the Multinational Men’s Attitudes to Life Events and Sexuality (MALES) Phase II Study

    Página :67

    I. Eardley, R.C. Rosen, W. Fisher, S. Meryn, M. Sand

    Esquema Esquema
  • ·MP-03.20 : Female partners’ attitudes are associated with treatment seeking for erectile dysfunction (ED) in men with ED

    Página :67-68

    I. Eardley, R.C. Rosen, W. Fisher, M. Sand

    Esquema Esquema
  • ·MP-03.21 : Development and validation of a simple tool estimating the risk of erectile dysfunction

    Página :68

    M. Braun, T. Evers, S. Merchant, M. Hellmich, I. Eardley

    Esquema Esquema
  • ·MP-04.01 : Intermediate-term outcome of bone anchored male sling in stress urinary incontinence

    Página :68-69

    A. Singla, N. Aggarwal

    Esquema Esquema
  • ·MP-04.02 : Artificial urinary sphincter vs bone anchored male sling for post radical prostatectomy urinary incontinence

    Página :69

    A. Singla, N. Aggarwal, M. Samli

    Esquema Esquema
  • ·MP-04.03 : Feasibility of artificial urinary sphincter male slings failure

    Página :69

    A. Singla, N. Aggarwal

    Esquema Esquema
  • ·MP-04.04 : Urinary continence after nerve-sparing radical prostatectomy and its interference on sexual activity

    Página :69-70

    V. Li Marzi, G. Del Popolo, M. Filocamo, D. Villari, M. Marzocco, A. Delle Rose, G. Nicita

    Esquema Esquema
  • ·MP-04.05 : UK experience of 2-stage sacral neuromodulation for women with urinary retention

    Página :70

    S. Datta, R. Kavia, G. Gonzales, R. DasGupta, C. Fowler, S. Elneil

    Esquema Esquema
  • ·MP-04.06 : Impact of solifenacin on health utility, work productivity, and medical care utilization

    Página :70-71

    N. Zinner, L. Black, R. Seifeldin, L. Rasouliyan

    Esquema Esquema
  • ·MP-04.07 : Role of prostaglandin E2 and EP-1 receptor on detrusor overactivity in spinal cord injury

    Página :71

    K. Masunaga, M. Yoshida, A. Inadome, K. Matsumoto, M. Yono, Y. Sugiyama, Y. Maeda, Y. Satoji, W. Takahashi, S. Ueda

    Esquema Esquema
  • ·MP-04.08 : Evaluation of lower urinary tract symptoms with or without urinary incontinence: A study in apparently healthy Japanese persons of both sexes

    Página :71

    T. Shimabukuro, K. Naito

    Esquema Esquema
  • ·MP-04.09 : Cardiovascular safety of solifenacin in routine clinical use

    Página :71-72

    M. Michel, U. Wetterauer, M. Vogel, J. de la Rosette

    Esquema Esquema
  • ·MP-04.10 : The phantom bladder following cystectomy

    Página :72

    M. Sharma, R. Vaidyanathan, L. Kumar, A. Rao, O. Karim, H. Motiwala

    Esquema Esquema
  • ·MP-04.11 : Solifenacin significantly improves urgency in overactive bladder (OAB) patients compared to placebo

    Página :72

    S. Serels, M. Andoh, N. Smith

    Esquema Esquema
  • ·MP-04.12 : Solifenacin reduces overactive bladder symptoms and improves health-related quality of life in patients previously receiving tolterodine

    Página :72-73

    N. Zinner, K. Kobashi, M. Andoh, N. Smith

    Esquema Esquema
  • ·MP-04.14 : Pad testing and perineometry do not correlate with quality of life scores in women with stress incontinence

    Página :73

    P.J. Gilling, L.C. Wilson, D. Bell, K. Kennett, T. Wrigley, M.R. Fraundorfer

    Esquema Esquema
  • ·MP-04.15 : Solifenacin treatment in patients with OAB reduces symptom bother and improves health-related quality of life

    Página :73

    S. Serels, M. Andoh, N. Smith

    Esquema Esquema
  • ·MP-04.16 : Use of bilumen catheter for pressure flow study in the diagnosis of bladder outflow obstruction in men

    Página :73-74

    S. Yande

    Esquema Esquema
  • ·MP-04.17 : A comparison of two techniques for the implantation of the adjustable continence therapy (ProACT™) for the treatment of post-prostatectomy stress urinary incontinence

    Página :74

    P. Gilling, L. Wilson, A. Westenberg, M. Fraundorfer, D. Bell

    Esquema Esquema
  • ·MP-04.18 : Results of double blind placebo controlled crossover study of sildenafil citrate (Viagra) in women suffering from obstructed voiding or retention associated with the primary disorder of sphincter relaxation

    Página :74

    S.N. Datta, R.B.C. Kavia, G.E. Gonzales, C.J. Fowler

    Esquema Esquema
  • ·MP-04.19 : A prospective comparative study comparing transvaginal tapes (Sparc^™ sling system) and transobturator suburethral tapes (Monarc^™ sling system) for the surgical treatment of female stress urinary incontinence: 2 year short-term follow-up

    Página :74-75

    S. So, J. Shin, G. Gil, J. Lim, H. Kim, Y. Na, C. Sul, D. Kim

    Esquema Esquema
  • ·MP-04.20 : Surgical treatment for post prostatectomy urinary incontinence

    Página :75-76

    T. Beaven, A. Foliaki

    Esquema Esquema
  • ·MP-04.21 : Laparoscopic sacrocolpopexy with anterior and posterior mesh extension for treatment of severe pelvic organ prolapse: preliminary report of 42 procedures

    Página :76

    R. Mierzwinski, F. Nel, M. Conradie

    Esquema Esquema
  • ·MP-04.22 : Laparoscopic bladder autoaugmentation combined with intravesical Botox injection for treatment of poorly compliant bladder and urge type of urinary incontinence: initial report

    Página :76

    F. Nel, R. Mierzwinski, M. Conradie

    Esquema Esquema
  • ·MP-04.23 : A short-term comparison of 3 different transobturator vaginal tape procedures, TVT-O, MONARC, IRIS-TOT, for the treatment of female stress and mixed urinary incontinence in Korea

    Página :76-77

    T.G. Kwon, H.T. Kim, K.H. Kim, E.S. Yoo, S. Chung, B. Kim, Y. Park

    Esquema Esquema
  • ·MP-04.24 : The change of cognitive function after administration of tolterodine in brain disease patients with OAB

    Página :77

    W.Y. Cho, T.H. Kim, G.S. Kong, J.H. Yoon, M.J. Park

    Esquema Esquema
  • ·MP-04.25 : Altered expressions of calcium-activated potassium channel and connexin in bladder mucosa of stress urinary incontinence patients with overactive bladder

    Página :77

    D.Y. Kim, E.K. Yang, J.W. Kim, H.J. Kim, T. Yoo, T.G. Kwon, T.H. Oh

    Esquema Esquema
  • ·MP-04.26 : Clinical results of male transobturator sling suspension in the treatment of male urinary incontinence

    Página :77-78

    P. Rehder, G. Bartsch, C. Gozzi

    Esquema Esquema
  • ·MP-04.27 : Xenobiotics in genito-urology: pyrethroid-induced functional disturbances in vesical detrusor and vas deferens

    Página :78

    E. Neu, U. Haerlin, A. Hofstetter, S. Magour, M. Michailov, W. Seidenbusch

    Esquema Esquema
  • ·MP-04.28 : On physiological fundamentals of vesical dysfunction

    Página :78-79

    M. Michailov, E. Neu, D. Martin, E. Gornik, V. Foltin, G. Ernst, G. Staehler

    Esquema Esquema
  • ·MP-05.01 : Evaluation of the effect of bromhexine administration on urinary stone formation in rats

    Página :79

    H. Ahmadnia, A. Yarmohamadi, M.K. Daloei, K. Sardari

    Esquema Esquema
  • ·MP-05.02 : Management of lower third ureteral stones

    Página :79

    G. Bochorishvili, K. Tevzadze, L. Varshanidze, G. Managadze

    Esquema Esquema
  • ·MP-05.03 : Management of large (more than 1.5cm) upper third ureteric calculi with rigid URS and ESWL on daycare

    Página :79-80

    J.G. Lalmalani, R. Lalmalani

    Esquema Esquema
  • ·MP-05.04 : In vitro evaluation of ureteral perforation forces

    Página :80

    M. Monga, K. Hendlin, D. Weiland, A. Ramani, T. Kohler, K. Anderson

    Esquema Esquema
  • ·MP-05.05 : Intrarenal manipulation of flexible ureteroscopes: A comparative study

    Página :80

    M. Monga, D. Weiland, A.C. Lynch, H. Rashid, B. Canales, M. Jones, T.S. Kohler, N. Nakib, A. Ramani, J. Anderson

    Esquema Esquema
  • ·MP-05.06 : The effect of impaction on the outcome of treatment of pelvic kidney stones: Comparing shock wave lithotripsy and percutaneous nephrolithotomy

    Página :80-81

    A. Basiri, S. Ziaee, S. Hosseini Moghaddam, S.M. Hosseini, A. Danesh, F. Sharifi Aghdas

    Esquema Esquema
  • ·MP-05.07 : Blind access in comparison with fluoroscopic guidance in percutaneous nephrolithotripsy: A randomized controlled trial

    Página :81

    A. Basiri, S. Mehrabi, M. Kamran-Manesh

    Esquema Esquema
  • ·MP-05.08 : Role of tamsulosin in the management of patients with pre-vesical ureteral calculi

    Página :81

    R. Puthenveetil, P. Deka, S. Barua, S. Baruah

    Esquema Esquema
  • ·MP-05.09 : Diagnostic accuracy of ultrasonography for stone and obstruction in patients with renal failure

    Página :81

    M.H. Ather, A.H. Jafri, M.N. Sulaiman

    Esquema Esquema
  • ·MP-05.10 : Role of the inflammatory marker CRP as an aid to emergency management of the acutely obstructed kidney

    Página :81-82

    R. Vaidyanathan, M. Sharma, A. Hussain, V. Mishra, O. Karim, H. Motiwala

    Esquema Esquema
  • ·MP-05.11 : Correlation between urinary stone composition and 24-hour urinary metabolic stone screening results

    Página :82

    H. Ibrahim, N.N.K. Lynn, N. Hon, S.W.V. Coppinger

    Esquema Esquema
  • ·MP-05.12 : ESWL treatment of ureteric stones with an electromagnetic shockwave system – 12 year experience of a single center

    Página :82

    T. Bergsdorf, C. Chaussy, S. Thueroff

    Esquema Esquema
  • ·MP-05.13 : Urolithiasis in children and the value of ESWL

    Página :82-83

    C. Chaussy, T. Bergsdorf, S. Thueroff

    Esquema Esquema
  • ·MP-05.14 : ESWL with wide focal spot: first clinical experience with Siemens LITHOSKOP^®

    Página :83

    T. Bergsdorf, C. Chaussy, S. Thueroff

    Esquema Esquema
  • ·MP-05.15 : Risk factors for urinary stone formation in the morbidly obese

    Página :83

    B. Duffey, D. Weiland, J. Melquist, C. Kriedberg, S. Ikramuddin, T. Kellogg, B. Slusarek, K. Hendlin, M. Stessman, M. Monga

    Esquema Esquema
  • ·MP-05.16 : Adopting aggressive approach to staghorn calculi with experience- optimizing the outcome

    Página :83

    R. Kapoor, N. Gupta, D. Dubey, A. Mandhani, A. Srivastava, A. Kumar

    Esquema Esquema
  • ·MP-05.17 : ESWL versus PCNL for treatment of lower pole stones: Preliminary results of a prospective randomized study

    Página :84

    R.F. Youssef, A.R. El-Nahas, A.M. El-Assmy, A. Shoma, K.Z. Sheir, M. El-Kenawy

    Esquema Esquema
  • ·MP-05.18 : The role of serum testosterone and urinary citrate on urolithiasis

    Página :84

    H. Jamshidian, M. Ayati, M.R. Nowroozi, P. Jabalameli

    Esquema Esquema
  • ·MP-06.01 : Laparoscopic pyeloplasty - our experiences with resection method and flap technique

    Página :84

    J. Vseticka, M. Vrany, J. Luptak

    Esquema Esquema
  • ·MP-06.02 : Laparoscopic nephropexy improves quality of life in patients with symptomatic nephroptosis

    Página :84-85

    M. Slojewski, A. Kaliszczak, B. Gliniewicz, A. Sikorski

    Esquema Esquema
  • ·MP-06.03 : Laparoscopic bladder diverticulectomy

    Página :85

    M. Slojewski, A. Golab, A. Sikorski

    Esquema Esquema
  • ·MP-06.04 : Learning curve of laparoscopic radical prostatectomy: A junior surgeon’s experience in a laparoscopic center with 50 initial cases

    Página :85

    P. Bryckaert, E. Mandron, F. Blackburn, R. Sabbagh

    Esquema Esquema
  • ·MP-06.05 : Bilateral same session ureteroscopy

    Página :85-86

    M. Darabi Mahboob, M. Keshvari, H. Ahmadnia

    Esquema Esquema
  • ·MP-06.06 : Retroperitoneoscopic nephrectomy for renal autotransplantation and ex vivo surgery

    Página :86

    T. Seki, M. Nakamura, K. Hotta, A. Taniguchi, M. Miura, M. Togashi, H. Harada, T. Hirano

    Esquema Esquema
  • ·MP-06.07 : Retroperitoneal laparoscopic nephrectomy for giant hydronephrosis

    Página :86

    R. Rabii, S. Elmhef, B. Querfani, H. Essaki, A. Joual, F. Meziane

    Esquema Esquema
  • ·MP-06.08 : Laparoscopic treatment for renal hydatid cyst

    Página :86

    R. Rabii, B. Querfani, H. Essaki, S. Elmhef, A. Joual, M. Fathi

    Esquema Esquema
  • ·MP-06.09 : One hundred experiences and the oncological outcome of hand-assisted retroperitoneoscopic nephroureterectomy

    Página :86-87

    A. Kawauchi, K. Yoneda, J. Soh, Y. Naitoh, Y. Mizutani, T. Miki

    Esquema Esquema
  • ·MP-06.10 : Effect of obesity on the result of laparoscopic nephrectomy

    Página :87

    T. Oh, D. Ryu, J. Kwon, Y. Kim

    Esquema Esquema
  • ·MP-06.11 : The spectrum of use of the high-powered holmium laser in a laser training center

    Página :87

    P. Gilling, L. Wilson, P. Meiklejohn, A. Westenberg, M. Fraundorfer

    Esquema Esquema
  • ·MP-06.12 : The effects of carbon dioxide pneumoretroperitoneum on bacterial translocation in an experimental retroperitoneoscopy model

    Página :87

    E. Tüzel, C. Güler, O. Aktepe, K. Sarýtaþ, M. Þamlý, M. Demirbaþ

    Esquema Esquema
  • ·MP-06.13 : Laparoscopic training in urology: are we geared up for the future? Results of a UK-based questionnaire survey

    Página :87-88

    S. Ravichandran, G. Reddy, D. O’Sullivan, E. Williamson, D. Machin

    Esquema Esquema
  • ·MP-06.14 : Laparoscopic and endourological management of urological diseases: clinical experience at Binh Dan Hospital

    Página :88

    V. Chuyen

    Esquema Esquema
  • ·MP-06.15 : Point of technique: a novel use of the harmonic scalpel in partial nephrectomy

    Página :88

    S. Shahzad, O. Karim, H. Motiwala, G. Turner

    Esquema Esquema
  • ·MP-06.16 : Laparoscopic adrenalectomy early results: transperitoneal and retroperitoneal approaches

    Página :88-89

    M. Arslan, T. Degirmenci, B. Gunlusoy, T. Demir, S. Minareci, A. Ayder

    Esquema Esquema
  • ·MP-06.17 : Transperitoneal laparoscopic adrenalectomy: results of 134 consecutive procedures

    Página :89

    J. Luptak, J. Vseticka, M. Vrany, J. Svihra, B. Elias, R. Tomaskin, J. Kliment

    Esquema Esquema
  • ·MP-06.18 : Surgical complications in 707 laparoscopic procedures in general practice of urology in South Africa

    Página :89

    R. Mierzwinski, F. Nel, M. Conradie

    Esquema Esquema
  • ·MP-06.19 : Modified cost effective hand assisted laparoscopic nephrectomy

    Página :89-90

    N. Ujmajuridze, A. Ujmajuridze, S. Mshvildadze, L. Managadze

    Esquema Esquema
  • ·MP-06.20 : Retroperitoneal laparoscopic approach of symptomatic peripelvic renal cysts

    Página :90

    R. Rabii, H. Essaki, S. Elmhef, B. Querfani

    Esquema Esquema
  • ·MP-07.01 : Continent cutaneous urinary diversion: issues on quality of life. A decade later

    Página :90

    A. Bissada, A. Safwat, N. Bissada

    Esquema Esquema
  • ·MP-07.02 : Gastrointestinal functions and metabolic control after construction of orthotopic neobladder in bladder cancer

    Página :90

    A. Thorstenson, H. Jacobsson, E. Onelov, J. Holst, P. Hellstrom, A. Kinn

    Esquema Esquema
  • ·MP-07.03 : Randomized clinical trial of bowel preparation versus no preparation before ileal urinary diversion

    Página :90-91

    A. Tabibi, N. Simforoosh, A. Basiri, H. Abdi, F. Farrokhi

    Esquema Esquema
  • ·MP-07.04 : Uretero-ureterocutaneostomy (wrapped by omentum)

    Página :91

    L. Lusuardi, M. Lodde, A. Pycha, S. Palermo, E. Comploj, E. Valimberti, D. Signorello, R. Hohenfellner

    Esquema Esquema
  • ·MP-07.05 : Long-term multi institutional evaluation of classic Charleston pouch continent urinary diversion

    Página :91

    N. Bissada, M. Abdallah, H. Hammouda, I. Aaronson, M. Badreldin, O. Abdelgawad

    Esquema Esquema
  • ·MP-07.06 : Long-term outcome of reconstruction of the ileocecal valve in patients with impaired bowel function after continent urinary diversion

    Página :91-92

    R. Stein, A. Schroeder, A. Schenk, J. Thueroff

    Esquema Esquema
  • ·MP-07.07 : Changes of bowel movements after urinary diversion: matched pairs of ileal conduit and ileocecal pouch

    Página :92

    R. Stein, A. Schroeder, A. Schenk, C. Wiesner, A. Faldum, J. Thueroff

    Esquema Esquema
  • ·MP-07.08 : Functional results of the implementation of the serous-lined extramural tunnel technique of ureterointestinal reimplantation

    Página :92

    A. Hinev, S. Paunov, M. Kojuharova, R. Madjov

    Esquema Esquema
  • ·MP-07.09 : Long term outcome of tunnelled uretrocolonic implantation in orthotopic sigmoid bladder after radical cystectomy

    Página :92-93

    I. Khalaf, S. Hathout, M. Mahmoud

    Esquema Esquema
  • ·MP-07.10 : Quality of life in orthotopic neobladders performed in a district general hospital

    Página :93

    J. Beatty, E. Havranek, K. Yajnik, M. Mariappan, G. Reilly, M. Pancharatnam

    Esquema Esquema
  • ·MP-07.11 : Reduction of postoperative side effects associated with orthotopic neobladder by using a more proximal segment of ileum. A quality of life based analysis

    Página :93

    E. Havranek, J. Beatty, K. Yajnik, M. Mariappan, R. MacGregor, M. Pancharatnam

    Esquema Esquema
  • ·MP-07.12 : Integrative approach of urologic and orthopedic surgeons in extensive surgery needed for bladder exstrophy and oestrogenic or urogenic tumours

    Página :93-94

    G. Riedasch, M. Akbar, J. Hodzic, L. Bernd, K. Möhring

    Esquema Esquema
  • ·MP-07.13 : Bladder exstrophy and ureterosigmoidostomy: Late complications and secondary malignancies

    Página :94

    A. Schroeder, R. Stein, J. Thuroff

    Esquema Esquema
  • ·MP-07.14 : Ureterosigmoidostomy: a gold standard in orthotopic bladder era

    Página :94

    T. El-Leithy

    Esquema Esquema
  • ·MP-07.15 : The rate of occurrence of pouch stones in patients who underwent enterocystoplasty using absorbable sutures instead of staplers

    Página :94

    A. Danesh Dezfuli, M. Samimi

    Esquema Esquema
  • ·MP-07.16 : Memokath stent implantation in urogenital system

    Página :95

    R. Berdou

    Esquema Esquema
  • ·MP-07.17 : 10-year experience and evaluation of a personal modification of the ileal S-pouch

    Página :95

    C. Constantinides, S. Tyritzis, T. Manousakas, N. Panagis, E. Liatsikos, A. Zervas

    Esquema Esquema
  • ·MP-07.18 : Comparison between two continent techniques after cystectomy in females with 10-year follow-up

    Página :95-96

    M. Wishahi, T. Amin

    Esquema Esquema
  • ·MP-08.01 : Expression of hypoxia-inducible factor 1 (HIF-1) in benign prostate hyperplasia and prostate adenocarcinoma: Correlation with clinicopathological parameters

    Página :96

    A. Bantis, P. Athanassiadou, C. Tsolos, P. Sountoulidis, M. Gonidi, E. Agelonidou, A. Athanassiadou, P. Athanassiades, E. Patsouris

    Esquema Esquema
  • ·MP-08.02 : The value of DEAF-1 expression in smears of prostate cancer: correlation with prognostic factors and disease outcome

    Página :96

    A. Bantis, P. Athanassiadou, C. Tsolos, P. Sountoulidis, M. Gonidi, E. Agelonidou, A. Athanassiadou, P. Athanassiades, E. Patsouris

    Esquema Esquema
  • ·MP-08.03 : Plexin B1 and prostate cancer

    Página :96-97

    T. Nitkunan, J. Constantinou, M. Williamson, J. Masters

    Esquema Esquema
  • ·MP-08.04 : Does PTEN gene play a role in prostate cancer progression?

    Página :97

    G. Pourmand, A.R. Abedi, A.R. Mehrsai, H.A. Alavi, A. Ahmadi, A.A. Ziaee, A. Emamzadeh

    Esquema Esquema
  • ·MP-08.05 : HCG beta as a prognostic marker in adenocarcinoma of the prostate in men of multi-ethnic origins

    Página :97

    A. Thwaini, L. Ghali, S. Baithun, F. Chinegwundoh, R. Ahmed, I. Elterifi, D. Morgan, L. Richard, R. Iles

    Esquema Esquema
  • ·MP-08.06 : A table to predict final histopathology after radical prostatectomy for clinical unilateral T3a prostate cancer

    Página :97

    C. Hsu, S. Joniau, A. Van Baelen, T. Roskams, R. Oyen, H. Van Poppel

    Esquema Esquema
  • ·MP-08.07 : Immunohistochemical study of the robustness of prostate cancer

    Página :97-98

    M. Noguchi, S. Homma, Y. Komohara, M. Harada, K. Itoh, K. Matsuoka

    Esquema Esquema
  • ·MP-08.08 : Targeting suicide gene therapy using anti-prostate-specific membrane antigen monoclonal antibodies

    Página :98

    Y. Horiguchi, T. Gondo, S. Saito, A. Takayanagi, N. Shimizu, M. Murai, M. Tachibana

    Esquema Esquema
  • ·MP-08.09 : The influence of patient race and social vulnerability on urologist treatment: recommendations in localized prostate carcinoma

    Página :98-99

    R. Flanigan, T. Denberg, T. Melhado, F. Kim, D. Fairclough, B. Beaty, J. Steiner, R. Hoffman

    Esquema Esquema
  • ·MP-08.10 : LnCaP cell line subtypes, generated to show different degrees of androgen independent growth, is a model by which to identify potential therapeutic targets in androgen independent prostate cancer

    Página :99

    G. Shaw, T. Oliver, T. Purkiss, D. Prowse

    Esquema Esquema
  • ·MP-08.11 : Vitamin E succinate inactivates androgen receptor and enhances the cytotoxic effects of paclitaxel in prostate cancer cells

    Página :99

    T. Ohigashi, Y. Uchida, E. Kikuchi, A. Miyajima, J. Nakashima, M. Murai

    Esquema Esquema
  • ·MP-08.12 : Tamoxifen as prophylaxis for prevention of gynaecomastia and breast pain associated with Bicalutamide 150 mg monotherapy in patients with prostate cancer

    Página :99-100

    Y. Fradet, M. Andersen, T. Tammela, M. Nachabe, J. Armstrong, T. Morris, S. Navani

    Esquema Esquema
  • ·MP-08.13 : Gonadotropin-releasing hormone-II antagonist triptorelix-1 induces hormone-refractory prostate cancer cell death

    Página :100

    S. Kang, H. Park, J. Kim, J. Seong, J. Cheon

    Esquema Esquema
  • ·MP-08.14 : Ambulatory management of prostate cancer at Midtown Urology Surgical Center

    Página :100

    J. Bennett, P. Alphonse, N. Smith, S. Hill

    Esquema Esquema
  • ·MP-08.15 : Prolonged culture of LNCaP prostate cancer cells leads to androgen independence and resistance to doxazosin induced apoptosis with clusterin up-regulation

    Página :100-101

    T.K. Yoo, Y. Youm, H.J. Park, J.Y. Kang, J.Y. Park, T.W. Kim

    Esquema Esquema
  • ·MP-08.16 : Disruption of lipid raft cholesterol could cause apoptotic cell death and induce the alteration of Akt-1/Bad and ERK signal transductions

    Página :101

    H. Oh, E. Lee, K. Cho, B. Chung, S. Yoon, S. Hong

    Esquema Esquema
  • ·MP-08.17 : Mutations of epidermal growth factor receptor in hormone sensitive and refractory prostate cancers

    Página :101-102

    Y.D. Choi, N.H. Cho, K. Park, K.S. Cho, S.Y. Cho, W.K. Han, M.S. Lee, J.S. Lee

    Esquema Esquema
  • ·MP-08.18 : Determining the optimal initiation and maintenance dose of degarelix for hormone therapy of prostate cancer patients

    Página :102

    P. Iversen, H. Van Poppel, T. Tammela, J. de la Rosette, J.E. Johansson, B.E. Persson, J.K. Jensen, T.K. Olesen

    Esquema Esquema
  • ·MP-08.19 : Expression of Ki67, p21, p53 in prostate biopsy tissue

    Página :102

    C. Slavov, A. Vlahova, S. Christova, E. Popov

    Esquema Esquema
  • ·MP-08.20 : Observational multicenter study on prostate cancer (PCA) prevalence and risk factors in men with low urinary tract symptoms (LUTS) in Italy: preliminary report

    Página :102-103

    M. Brausi, D. Prezioso, G. Bianchi, M. Carini

    Esquema Esquema
  • ·MP-08.21 : Downregulation of peroxisome proliferator-activated receptor (PPAR)alpha, PPARgamma, and phosphoglycerate mutase 2 in prostate cancer

    Página :103

    D. Kim, T. Yoo, T.G. Kwon, T.H. Oh, H.J. Kim, J.W. Kim, E.K. Yang

    Esquema Esquema
  • ·MP-08.22 : The expression of microvessel density (MVD), vascular endothelial growth factor (VEGF) and hypoxia inducible factor (HIF-1a) in hyperplastic and malignant prostate tissue

    Página :103

    A. Lekas, A. Lazaris, L. Nakopoulou, M. Chrisofos, D. Lappas, T. Papathomas, I. Fokitis, S. Koritsiadis, C. Deliveliotis

    Esquema Esquema
  • ·MP-08.23 : The effects of NCX4040 on apoptosis in cultured prostate cells

    Página :103-104

    D. Brown, F. Habib

    Esquema Esquema
  • ·MP-08.24 : Expression of the urokinase-plasminogen-activator receptor (UPA-R) in disseminated tumor cells in bone marrow and peripheral blood specimens of patients with prostate cancer

    Página :104

    C. Thomas, S. Melchior, J. Pfitzenmaier, R. Gillitzer, J. Thuroff

    Esquema Esquema
  • ·MP-08.25 : Gleason score migration between prostate biopsy and prostatectomy specimens in a contemporary series of patients undergoing radical prostatectomy

    Página :104

    C. Thomas, R. Gillitzer, J. Thuroff, S. Melchior

    Esquema Esquema
  • ·MP-08.26 : Genetic polymorphisms of genes involved in androgen metabolism and synthesis pathway and prostate cancer risk among Chinese population

    Página :104-105

    M. Li, T. Guan, Y. Na

    Esquema Esquema
  • ·MP-09.01 : Correlation of prostate symptom score (IPSS) with quality of life, peak urine flow rate, post void residual urine volume and total TRUS prostate volume in Ghanaian men with LUTS due to prostatic enlargement

    Página :105

    M. Kyei, E. Yeboah, Y. Tettey, R. Kumoji

    Esquema Esquema
  • ·MP-09.02 : Development of a low cost urine flow rate meter for primary health care

    Página :105

    A. Van Der Merwe, H. Esterhuyse, A. Pontin

    Esquema Esquema
  • ·MP-09.03 : Non invasive transabdominal ultrasound classification of benign prostatic enlargement (BPE) to predict bladder outlet obstruction (BOO) in real life practice

    Página :105-106

    K. Foo, H. Ho, K. Lim, S. Fook

    Esquema Esquema
  • ·MP-09.04 : Prostate Awareness Week in Singapore

    Página :106

    C. Chin, W. Lau, S. Ho, J. Tan, S. Chia

    Esquema Esquema
  • ·MP-09.05 : The efficacy of every other day alpha-blocker therapy in men with benign prostatic hyperplasia

    Página :106-107

    D. Lee, D. Seong, I. Cho, S. Hong

    Esquema Esquema
  • ·MP-09.06 : Preliminary assessment of the Olympus Surgmaster^™ bipolar system: physiological changes, early complications, and short-term outcome

    Página :107

    H. Ibrahim, N. Lynn, N. Hon, H. Brace, S. Ghiblawi, S. Coppinger

    Esquema Esquema
  • ·MP-09.07 : Alfuzosin 10mg once daily prevents overall clinical progression of BPH but not acute urinary retention occurrence: results of a 2-year placebo-controlled study

    Página :107

    C. Roehrborn

    Esquema Esquema
  • ·MP-09.08 : CombAT and MTOPS: a comparison of the study designs and study populations

    Página :107-108

    C. Roehrborn, J. Barkin, D. Quast, A. Duggan, K. Major-Walker, B. Morrill

    Esquema Esquema
  • ·MP-09.09 : The effects of BMI, alcohol and smoking on measures of sexual dysfunction: baseline data from dutasteride studies involving a total of 18,966 subjects

    Página :108-109

    C. Roehrborn, M. Marberger, E. Wolford, T. Wilson

    Esquema Esquema
  • ·MP-09.10 : Role of nocturia for the quality of life of patients with benign prostatic hyperplasia

    Página :109

    M.M. van Dijk, H. Wijkstra, J.J.M.C.H. de la Rosette, M.C. Michel

    Esquema Esquema
  • ·MP-09.11 : The impact of nocturia on signs and symptoms associated with benign prostatic hyperplasia

    Página :109-110

    M. Michel, H. Schumacher, L. Mehlburger, J.J.M.C.H. de la Rosette

    Esquema Esquema
  • ·MP-09.12 : Factors associated with improvements of the nocturia quality of life score upon treatment of benign prostatic hyperplasia with tamsulosin oral-controlled absorption system

    Página :110

    M. Michel, H. Schumacher, M. Busse, J.J.M.C.H. de la Rosette

    Esquema Esquema
  • ·MP-09.13 : The frequency of pathologic findings in routine urethrocystoscopy before open prostatectomy

    Página :110

    D. Mehraban, G. Naderi, S. Tahvildar, A. Razi, M. Sedighi, S. Kazemeyni

    Esquema Esquema
  • ·MP-09.14 : Does sildenafil affect the uroflowmetry values in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia?

    Página :110-111

    E. Tüzel, C. Güler, E. Doðantekin, G. Kýzýltepe

    Esquema Esquema
  • ·MP-09.15 : Early results of transurethral ethanol ablation of the prostate for the treatment of benign prostatic hyperplasia in a resource-poor setting

    Página :111

    M. Labib

    Esquema Esquema
  • ·MP-09.16 : Differences between PCPs and urologists in the clinical evaluation of men with LUTS/BPH

    Página :111

    C. Roehrborn, J. Nuckolls, M. Miner, C. Metzger, J. Wei

    Esquema Esquema
  • ·MP-09.17 : Differences between PCPs and urologists in the medical treatment of men with LUTS/BPH

    Página :111-112

    C. Roehrborn, J. Nuckolls, M. Miner, C. Metzger, J. Wei

    Esquema Esquema
  • ·MP-09.18 : Use of alternative therapies by men enrolled in the USA BPH Registry & Patient Survey

    Página :112

    C. Roehrborn, W. Steers, M. Perelman, J. Wei

    Esquema Esquema
  • ·MP-09.19 : Why men on watchful waiting for LUTS/BPH start medical therapy: findings from the USA BPH Registry & Patient Survey

    Página :112-113

    C. Roehrborn, D. Penson, A. Te, J. Wei, J. Nuckolls

    Esquema Esquema
  • ·MP-09.20 : Management of patients with moderate to severe benign prostatic hyperplasia: treatment strategies in real-life practice of French urologists (the DUO study)

    Página :113

    R. Fourcade, M. Picot, A. Gaudin, N. Texier, A. Slama

    Esquema Esquema
  • ·MP-09.21 : Are Muscarinic Receptors of the Prostate Having Significant Role in the Pathophysiology of Bladder Outlet Obstruction? Phase I (In vitro-) Study

    Página :113

    M. Abdel-Khalek, M. El-Baz, A. Nabieh, I. El-Houssieny

    Esquema Esquema
  • ·MP-09.22 : Multicenter prospective study on the changes of sexual function following treatment with alfuzosin in patients with benign prostate hypertrophy

    Página :114

    S.W. Lee, T.Y. Ahn, J.K. Park, S.W. Kim, N.C. Park, K.S. Park, J.J. Kim, J.S. Paick, D.Y. Yang, H.Y. Park

    Esquema Esquema
  • ·MP-10.01 : Methylated glutathione-S-transferase P1 in prostate biopsy needle washing solution of the first biopsy setting as a potential diagnostic tool to avoid rebiopsies

    Página :114

    M. Auprich, H. Augustin, K. Pummer, S. Mannweiler, G. Tilz, P. Rehak, P. Petritsch

    Esquema Esquema
  • ·MP-10.02 : Sensitivity of digital rectal examination and various PSA levels in prostate cancer detection using transrectal ultrasound guided biopsy of the prostate in 464 Ghanaians presenting at an urology clinic

    Página :114-115

    E. Yeboah, M. Kyei, Y. Tettey, R. Kumoji

    Esquema Esquema
  • ·MP-10.03 : Comparison of four different anesthesia methods during transrectal ultrasound guided prostate biopsy

    Página :115

    G. Inal, O. Adsan, O. Ugurlu, O. Kaygisiz, M. Kosan, M. Cetinkaya

    Esquema Esquema
  • ·MP-10.04 : Effects of subclinical prostatitis in prostate needle biopsies on the serum prostate specific antigen: the role of pathology of inflammation

    Página :115

    J. Shin, D. Kim, S. Cho, J. Lee

    Esquema Esquema
  • ·MP-10.05 : Complexed PSA improves prostate cancer detection: results from a multicenter Japanese clinical trial

    Página :115

    K. Okihara, O. Ukimura, T. Nakamura, S. Ushijima, Y. Mizutani, A. Kawauchi, Y. Naya, M. Kojima, T. Miki

    Esquema Esquema
  • ·MP-10.06 : The rate of prostate cancer on needle biopsy is higher in HIV patients

    Página :116

    M. Issa, W. Hsiao, K. Anastasia, J. Hall, C. Ritenour

    Esquema Esquema
  • ·MP-10.07 : Repeat trans-rectal ultrasound (TRUS) guided prostate biopsies: our experience

    Página :116

    M. Quinlan, R. Casey, R. Flynn, R. Grainger, T. McDermott, J. Thornhill

    Esquema Esquema
  • ·MP-10.08 : Use of prostate-specific antigen and PSA-based parameters in the diagnosis of bone metastases in Chinese prostate cancer patients

    Página :116-117

    F. Jie, S. Xia, K. Cai, Y. Ruan, Y. He, Y. Zhu, J. Lu, X. Tang

    Esquema Esquema
  • ·MP-10.09 : How do we select patients for prostate biopsy and choose the treatment modality when PSA value is 4ng/ml or less?

    Página :117

    K. Nagao, Y. Baba, Y. Yamamoto, K. Matsuda, K. Fujikawa, T. Hiragino, H. Matsuyama, K. Naito

    Esquema Esquema
  • ·MP-10.10 : Identification of enhancer of zeste homolog 2 in peripheral circulating epithelial cells in metastatic prostate cancer patients

    Página :117

    S. Hong, K. Cho, H. Oh, E. Lee

    Esquema Esquema
  • ·MP-10.11 : In vivo stability of cPSA in comparison with tPSA and fPSA: a contribution to early detection diagnostics of prostate carcinoma

    Página :117-118

    W. Berg, C. Haas, U. Becker, T. Keller, A. Bürner, T. Deufel, J. Schubert

    Esquema Esquema
  • ·MP-10.12 : The significance of hypoechoic lesion on transrectal ultrasound for prostate cancer detection

    Página :118

    K. Yoo, S. Jeon, H. Lee, S. Chang, J. Lim

    Esquema Esquema
  • ·MP-10.13 : The spectrum of prostate cancer presentation among different racial groups in the Western Cape Province, South Africa, during the period 1995 to 2005

    Página :118

    M. Fisher, M. Pretorius, C. Heyns

    Esquema Esquema
  • ·MP-10.14 : Utility of total, free, and complexed PSA for detection of prostate cancer and high-grade disease in the contemporary extended biopsy era

    Página :118-119

    B. Mian, G. Bratslavsky, H. Fisher, R. Kaufman, D. Voskoboynik, T. Nazeer

    Esquema Esquema
  • ·MP-10.15 : Characteristics of serum prostate-specific antigen level according to age in healthy Korean men: a multicenter study

    Página :119

    K.S. Cho, S.J. Hong, J.S. Cho, S.J. Kim, C. Kim, B.H. Chung, Y.D. Choi, D.H. Seong, S.H. Cheon, Y.S. Kim, I.R. Cho, S. Kim, W.J. Yang, H. Lee D, J.S. Lee

    Esquema Esquema
  • ·MP-10.16 : Free/total PSA: a useful tool to select patients for biopsy in borderline cases

    Página :119

    S. Ravichandran, M. Lucky, A. Arulanandarajah, R. Stephenson

    Esquema Esquema
  • ·MP-10.17 : Are the volume of high-grade prostatic intraepithelial neoplasia (HG PIN) and the number of biopsies with HG PIN predictive for prostate cancer?

    Página :119-120

    D. Pushkar, A. Govorov, J. Kosko, M. Kovylina

    Esquema Esquema
  • ·MP-10.18 : Morbidity is not increased with extended 12 prostate biopsy protocol

    Página :120

    B. Trajcevska-Boskovska, V. Georgiev, Z. Popov, B. Bogoeva, S. Banev

    Esquema Esquema
  • ·MP-10.19 : Frequency of lymphatic invasion in prostatectomies for prostate cancer

    Página :120

    I.A. Sesterhenn, D. Cordaro, C.J. Davis, B. Furusato

    Esquema Esquema
  • ·MP-10.20 : Follow-up on patients with small prostate cancer following radical prostatectomy at Walter Reed Army Medical Center

    Página :120-121

    B. Furusato, D. Osborn, I. Rosner, J. Cullen, Y. Chen, C. Davis, J. Moul, D. McLeod, I. Sesterhenn

    Esquema Esquema
  • ·MP-10.21 : Prostate cancer screening decreases the absolute risk to be diagnosed with advanced prostate cancer – Results from a prospective, population-based randomized controlled trial

    Página :121

    G. Aus, S. Bergdahl, P. Lodding, H. Lilja, J. Hugosson

    Esquema Esquema
  • ·MP-10.22 : Current practice of PSA testing amongst hospital doctors in the United Kingdom

    Página :121

    A.A. Khan, A. Thwaini, S. Gupta, I.S. Shergill, M. Arya, H.R.H. Patel

    Esquema Esquema
  • ·MP-11.01 : One stage repair of iatrogenic trapped penis

    Página :121-122

    M. Djordjevic, S. Perovic

    Esquema Esquema
  • ·MP-11.02 : Choice of treatment of long segment anterior urethral stricture: pedicled skin flap urethroplasty or dorsal free graft urethroplasty

    Página :122

    S. Hossain, A. Hossain, S. Khan, M. Islam

    Esquema Esquema
  • ·MP-11.03 : Histologic type and staging distribution of germ cell tumors in Korean adults

    Página :122

    D. Park, M. Chung, J. Chung, H. Ahn, E. Lee, H. Choi, S. Hong, J. Cheon, D. Yoon, Y. Lee, S. Yoon, W. Kim, H. Kim, S. Ryu, S. Lee

    Esquema Esquema
  • ·MP-11.04 : Unusual genitourinary cancers: results of irradiation treatment for penile cancer

    Página :122-123

    R. Mayer, J. Poschauko, F. Quehenberger, T. Eder, K. Pummer

    Esquema Esquema
  • ·MP-11.05 : Importance of human papillomavirus in penile carcinoma

    Página :123

    A. Gil, A. Pompeo, P. Goldstein, L. Saldanha, J. Mesquita, A. Sarkis, M. Srougi

    Esquema Esquema
  • ·MP-11.06 : Buccal mucosal graft usage where treating tissue defects upon partial or total penectomy in the case of penile cancer

    Página :123

    G. Venkov

    Esquema Esquema
  • ·MP-11.07 : Increasing incidence with better survival of testicular cancer in Chile

    Página :123

    J. Dominguez, R. Pinochet, J. Cabello, P. Gonzalez

    Esquema Esquema
  • ·MP-11.08 : Penectomy with simultaneous compared to deferred bilateral inguinal lymph node dissection (ILND) for squamous carcinoma of the penis. Evaluation of surgical complications

    Página :124

    C. Heyns, P. Theron

    Esquema Esquema
  • ·MP-11.09 : Replication licensing factor Mcm2 predicts disease progression in penile cancer patients

    Página :124

    O. Kayes, D. Ralph, S. Minhas, A. Freeman, G. Williams

    Esquema Esquema
  • ·MP-11.10 : Early outcome data in advanced penile cancer

    Página :124

    O. Kayes, D. Ralph, S. Minhas

    Esquema Esquema
  • ·MP-11.11 : Frenular grafting: an alternative to circumcision

    Página :124-125

    O. Kayes, S. Minhas, D. Ralph

    Esquema Esquema
  • ·MP-11.12 : Penile preserving surgery for anterior urethral cancers

    Página :125

    Y. Smith, P. Hadway, S. Ahmed, M. Perry, C. Corbishley, N. Watkin

    Esquema Esquema
  • ·MP-11.13 : Dynamic sentinel lymph node biopsy for penile cancer: Initial experience from a UK centre

    Página :125

    P. Hadway, Y. Smith, C. Corbishley, S. Heenan, M. Perry, N. Watkin

    Esquema Esquema
  • ·MP-11.14 : The outcome of glansectomy for invasive penile cancer

    Página :125-126

    Y. Smith, P. Hadway, M. Perry, C. Corbishley, N. Watkin

    Esquema Esquema
  • ·MP-11.15 : M2A antigen (podoplanin) distribution in prepubertal and adult testes and testicular tumors

    Página :126

    I. Sesterhenn, C. Davis, B. Furusato

    Esquema Esquema
  • ·MP-11.16 : Malignant mesotheliomas of tunica vaginalis

    Página :126

    I. Sesterhenn, C. Davis

    Esquema Esquema
  • ·MP-11.17 : Management of tumors in undescended testis: Experience of Tata Memorial Hospital, India

    Página :126

    Y. Thyavihally, H. Tongaonkar, K. Prabhash, A. Kakade

    Esquema Esquema
  • ·MP-11.18 : Clinical stage-A (CS-A) germ cell testicular tumors (GCTT) with normal values of serum tumor markers (STM) post orchiectomy

    Página :126-127

    D. Argirovic, L. Jelic

    Esquema Esquema
  • ·MP-11.19 : Bilateral germ cell testicular tumors: a report of 44 patients with long term follow-up

    Página :127

    D. Argirovic

    Esquema Esquema
  • ·MP-11.20 : A prospective 10 year audit of a single Irish centre’s experience of retroperitoneal lymph node dissection for metastatic testis cancer

    Página :127-128

    R. Casey, M. Aktar, P. Hegarty, M. Butler, J. Thornhill

    Esquema Esquema
  • ·MP-11.21 : Public awareness of testis cancer and the prevalence of testis self-examination – is there a further role for physician directed screening?

    Página :128

    R. Casey, F. O’Brien, P. Hegarty, R. Grainger, M. Butler, T. McDermott, J. Thornhill

    Esquema Esquema
  • ·MP-12.01 : Immunohistochemical demonstration of the gamma-2 chain of laminin-5 in urinary bladder urothelial carcinoma- impact for diagnosis and prognosis

    Página :128

    H. Wunderlich, A. Berndt, D. Katenkamp, J. Schubert, H. Kosmehl

    Esquema Esquema
  • ·MP-12.02 : Prognostic value of the differential expression of tenascin-C splicing domains in urothelial carcinomas of the urinary bladder

    Página :128-129

    H. Wunderlich, A. Berndt, K. Anger, L. Borsi, S. Brack, M. Silacci, M. Gajda, L. Zardi, D. Neri, H. Kosmehl

    Esquema Esquema
  • ·MP-12.03 : Expression of the novel isoform VEGF165b in transitional cell carcinoma of bladder

    Página :129

    W. Lau, K. Das, Y. Zhao, M. Sugiono, P.H. Tan, C. Cheng

    Esquema Esquema
  • ·MP-12.04 : Low frequency of chromosomal alterations in CGH analysis in low-risk papillary bladder tumors with FGFR3 mutations

    Página :129

    K. Junker, J. van Oers, E. Zwarthoff, I. Kania, J. Schubert, A. Hartmann

    Esquema Esquema
  • ·MP-12.05 : DNA damage repair in urinary bladder carcinogenesis induced by chronic low-dose ionizing radiation after the Chernobyl accident in Ukraine

    Página :129-130

    A. Romanenko, A. Vozianov, S. Fukushima

    Esquema Esquema
  • ·MP-12.06 : Abstract Withdrawn

    Página :130

    
  • ·MP-12.07 : Comparative study of bladder biopsies performed by using flexible and rigid cystoscopes

    Página :130

    P. Chandrasekar, G. Krishnamoorthy, M. Gopal, F. Kapasi, B. Potluri

    Esquema Esquema
  • ·MP-12.08 : Nuclear morphometry for predicting outcome in patients with invasive bladder cancer following radical cystectomy

    Página :130-131

    A. Kravtsov, E. Sabo, M. Mullerad, G. Meyer, M. Gross, E. Issaq, B. Moskovitz, O. Nativ

    Esquema Esquema
  • ·MP-12.09 : Urinary expression and activity of metalloproteinases (MMPs) in bladder cancer: Detection using specific fluorogenic substrates

    Página :131

    R. Cursio, N. Belhacene, C. Choquenet, F. Dupre, C. Mainguene, V. Dive, P. Auberger, B. Mari

    Esquema Esquema
  • ·MP-12.10 : Therapeutic impact of NF-kB Inhibitor against human bladder cancer in murine xenograft model

    Página :131

    Y. Horiguchi, M. Kosugi, E. Kikuchi, A. Miyajima, J. Nakashima, M. Murai, K. Umezawa, M. Tachibana

    Esquema Esquema
  • ·MP-12.11 : An experimental model of bladder cancer using nonviral vector expressing uroplakin II promoter and SV40 T antigen

    Página :131-132

    J. Koh, D. Sohn, D. Kim, H. Kim, S. Paik, J. Lee

    Esquema Esquema
  • ·MP-12.12 : Significance of target cell infection and NK cells in the antitumor effects of bacillus Calmette-Guérin (BCG) in murine bladder cancer

    Página :132

    T. Sonoda, K. Sugimura, K. Matsumura, S. Ikemoto, T. Nakatani

    Esquema Esquema
  • ·MP-12.13 : The role of sequential evaluation of BTA TRAK and UBC IRMA in urine during follow-up in patients with Ta T1 bladder transitional cell carcinoma (TCC)

    Página :132

    M. Babjuk, V. Soukup, M. Pesl, M. Kostirova, J. Tejckova, J. Dvoracek, I. Pavlik

    Esquema Esquema
  • ·MP-12.14 : Fluorescence-in-situ hybridisation (FISH) for the non-invasive bladder cancer detection

    Página :132-133

    M. Babjuk, L. Houskova, M. Pesl, V. Soukup, Z. Zemanova, K. Michalova, J. Dvoracek, I. Pavlik

    Esquema Esquema
  • ·MP-12.15 : The role of transforming growth factor-Beta1 in human bladder cancer cell lines

    Página :133

    C. Lee, S. Lee, D. Kim, Y. Jeon, N. Lee

    Esquema Esquema
  • ·MP-12.16 : Analysis of human V-erbA related Ear-3 gene in the development of bladder transitional cell carcinoma

    Página :133

    Y. Choi, W. Ham, S. Cho, M. Lee, K. Cho, S. Hong, W. Han

    Esquema Esquema
  • ·MP-12.17 : Human papillomavirus DNA and p53 mutation analysis in relation to clinical outcome of bladder cancer

    Página :133

    P. Moonen, J. Bakkers, W. Melchers, J. Witjes

    Esquema Esquema
  • ·MP-12.18 : The regulation of apoptosis related molecules in bladder cancer T24 cell following Taxol treatment

    Página :133-134

    C. Yang, Y.-C. Ou, S.-Y. Yuan

    Esquema Esquema
  • ·MP-12.19 : Differentiation of normal and tumor tissue of the urinary bladder by high-resolution optical coherence tomography

    Página :134

    J. Grosse, B. Hermes, J. Bornemann, F. Spöler, M. Först, G. Jakse

    Esquema Esquema
  • ·MP-12.20 : Downregulation of X-linked inhibitor of apoptosis protein sensitizes bladder cancer cell to chemotherapeutics

    Página :134

    M. Li, Z. Yin, Y. Na

    Esquema Esquema
  • ·MP-12.21 : Anti-tumor effect of ADI on bladder tumor is correlated with ASS expression

    Página :134-135

    C.Y. Yoon, D.H. Yoon, Y.J. Shim, E.H. Kim, B.H. Min, D.K. Yoon

    Esquema Esquema
  • ·MP-13.01 : Minimally invasive radical cystectomy (RC) with prostate and seminal sparing: A good option for selected young patients with transitional cell carcinoma (TCC) of the bladder

    Página :135

    M. Brausi, M. Gavioli, G.L. Simonini, G. Peracchia, M. Viola, G. Verrini, G. De Luca, M. Viola

    Esquema Esquema
  • ·MP-13.02 : Multiprobe-FISH: Prognostic perspectives in superficial bladder cancer

    Página :135

    C. Mian, M. Lodde, E. Comploj, S. Palermo, E. Trenti, L. Lusuardi, M. Mian, K. Maier, A. Pycha

    Esquema Esquema
  • ·MP-13.03 : Hypercontinence in women undergoing orthotopic diversion

    Página :135-136

    M. Ismail, S. Ghobashi, M. Helal, M. Wishahi

    Esquema Esquema
  • ·MP-13.04 : Hand assisted laparoscopic radical cystectomy and formation of ileal conduit

    Página :136

    P.J. Meffan

    Esquema Esquema
  • ·MP-13.05 : Quality of life after radical cystectomy and orthotopic bladder substitution in Sweden and in Egypt: a prospective, comparative study

    Página :136

    Å. Månsson, M. al Amin, P. Malmström, H. Wijkström, H. Abol Enein, W. Månsson

    Esquema Esquema
  • ·MP-13.06 : Expression of S100A2 and A4 in radical cystectomy predicts bladder cancer disease progression and survival

    Página :136-137

    K. Matsumoto, A. Irie, T. Satoh, J. Ishii, T. Fujita, E. Satoh, K. Iwabuchi, M. Iwamura, S. Baba

    Esquema Esquema
  • ·MP-13.07 : Downstaging and pathoanatomical outcome following neoadjuvant cisplatinum based combination chemotherapy for muscle invasive bladder carcinoma: An analysis of selected patients from two combined randomised prospective Nordic trials

    Página :137

    A. Sherif, E. Rintala, O. Mestad, J. Nilsson, L. Holmberg, S. Nilsson, P. Malmström, H. Wijkstrom

    Esquema Esquema
  • ·MP-13.08 : Detection of immune responses against urinary bladder cancer in sentinel lymph nodes

    Página :137

    P. Marits, M. Karlsson, A. Sherif, U. Garske, M. Thorn, O. Winqvist

    Esquema Esquema
  • ·MP-13.09 : Surgical volume and post-operative mortality after radical cystectomy in the province of Quebec

    Página :137-138

    N. Fahmy, S. Jeyaganth, S. Mahmud, S. Tanguay, A. Aprikian

    Esquema Esquema
  • ·MP-13.10 : Bladder cancer after radical prostatectomy and external beam radiotherapy: is it any difference?

    Página :138

    J. Palou, N. De Graeve, G. Sancho, O. Rodrı́guez, H. Manavella, J. Huguet, A. Rosales, H. Villavicencio

    Esquema Esquema
  • ·MP-13.11 : Urethral tumor following cystectomy: patients with orthotopic diversion do not have less urethral recurrences

    Página :138

    J. Huguet, V. Monllau, S. Sabate, J. Palou, H. Villavicencio

    Esquema Esquema
  • ·MP-13.12 : Feasibility of real time TRUS during laparoscopic radical cystectomy

    Página :138-139

    J. Clavijo Eisele, P. Rimington, R. Paul, P. Dasgupta

    Esquema Esquema
  • ·MP-13.13 : Icodextrin solution for adhesions prevention after laparoscopic radical cystectomy

    Página :139

    J. Clavijo Eisele, P. Rimington, R. Paul, T. Kamani, P. Dasgupta

    Esquema Esquema
  • ·MP-13.14 : Cisplatin with concurrent radiation therapy for patients with muscle-invasive bladder cancer

    Página :139

    S. Eguchi, Y. Kawai, J. Akao, T. Hara, K. Nagao, C. Ohmi, S. Sakano, H. Matsuyama, K. Naito

    Esquema Esquema
  • ·MP-13.15 : Intra-arterial chemotherapy for extravesical and intrapelvic recurrence of bladder transitional cell carcinoma

    Página :139

    F. Zhou, S. Yu, Z. Liu

    Esquema Esquema
  • ·MP-14.01 : Brachytherapy for prostate cancer: is pre-treatment prostate volume important?

    Página :139-140

    J. Meyer, R. Bell, R. Kunkler, P. Golding, S. Duggleby, C. Elwell

    Esquema Esquema
  • ·MP-14.02 : Stage migration in clinically localised prostate cancer treated with radical prostatectomy between 1993 and 2004

    Página :140

    H. Augustin, M. Auprich, P. Stummvoll, K. Lipsky, K. Pummer, P. Petritsch

    Esquema Esquema
  • ·MP-14.03 : Prostate brachytherapy: risk factors, sexual function and results after 5-year experience

    Página :140

    A. Rempelakos, A. Palantzas, I. Katsilieris, T. Arvanitakis, G. Ioannidou, A. Thanos

    Esquema Esquema
  • ·MP-14.04 : Factors predicting PSA recurrence after cryoablation of the prostate

    Página :141

    A. Perlmutter, S. Prettyman, H. Farivar-Mohseni

    Esquema Esquema
  • ·MP-14.05 : Impact of the variations in shapes of prostatic apex on early recovery of urinary continence after radical retropubic prostatectomy

    Página :141

    S. Lee, S. Hong, Y. Kim, I. Chang, J. Han, B. Han, J. Yu, S. Byun

    Esquema Esquema
  • ·MP-14.06 : Oncological and functional results after laparoscopic extraperitoneal radical prostatectomy: Experience with 200 cases

    Página :141-142

    P. Bryckaert, E. Mandron, F. Blackburn, R. Sabbagh

    Esquema Esquema
  • ·MP-14.07 : Laparoscopic nerve sparing and bladder neck sparing radical prostatectomy: preliminary evaluation after 15 interventions

    Página :142

    F. Nel, R. Mierzwinski, M. Conradie

    Esquema Esquema
  • ·MP-14.08 : Precision external beam radiation therapy for prostate cancer using real-time image-guidance

    Página :142

    K. Godette, T. Fox, J. Bennett

    Esquema Esquema
  • ·MP-14.09 : The prognostic significance of angiogenesis and matrix metalloproteinase expression in prostate cancer: a multivariate analysis study

    Página :142-143

    M. Abdel-Khalek, M. Abdel-Hamid, E. Ibrahiem

    Esquema Esquema
  • ·MP-14.10 : Radical nerve sparing perineal prostatectomy: point of technique leading to improved potency rates in 565 patients operated on over 10 years

    Página :143

    L. Coetzee, R. Campbell

    Esquema Esquema
  • ·MP-14.11 : Histopathological findings after radiofrequency in treatment for prostate cancer

    Página :143

    C. Patriarca, F. Bergamaschi, G. Gazzano, P. Corrada, G. Ordesi, L. Zanitzer, M. DiPasquale, P. Giunta, R. Macchi, B. Campo

    Esquema Esquema
  • ·MP-14.12 : Radical perineal prostatectomy: a combined UK and South African series of 752 patients

    Página :143-144

    G. Boustead, L. Coetzee

    Esquema Esquema
  • ·MP-14.13 : Site of positive surgical margins in laparoscopic prostatectomy: the impact of apical dissection

    Página :144

    T. Satoh, M. Iwamura, S. Egawa, A. Irie, H. Tsumura, K. Matsumoto, M. Kimura, H. Okusa, S. Baba

    Esquema Esquema
  • ·MP-14.14 : Laparoscopic radical prostatectomy: perioperative complications in 100 cases in Catholic University of Korea

    Página :144

    T. Hwang, S. Hong, S. Seo, J. Kim

    Esquema Esquema
  • ·MP-14.15 : Transperineal injection of the tetradecilsolfatum sodium 3% in the treatment of pelvic lymphocele after lymphodenectomia for prostatic cancer

    Página :144-145

    M. Madonia, M. Deriu, G. Barabino, S. Canessa, F. Pirozzi Farina, G. Morgia

    Esquema Esquema
  • ·MP-14.16 : Minimizing risk of rectourethral fistula during cryosurgical ablation of prostate cancer using ultrasound probe placement

    Página :145

    J. Jones

    Esquema Esquema
  • ·MP-14.17 : Is there any difference in Gleason score between prostate biopsy and prostatectomy specimen?

    Página :145

    V. Študent, R. Fiala, A. VidláŠ, M. Hrabec, M. M. Grepl

    Esquema Esquema
  • ·MP-14.18 : Peri-operative complications with radical perineal prostatectomy: joint South African and UK experience of 1000 consecutive cases

    Página :145-146

    G. Boustead, L. Coetzee

    Esquema Esquema
  • ·MP-14.19 : Training for robotic radical prostatectomy: A strategy for residents

    Página :146

    D. Albala, G. Haleblian, R. Sur, G. Preminger

    Esquema Esquema
  • ·MP-14.20 : Intermediate-term outcome and morbidity of high-dose-rate brachytherapy (HDR-BT) combined with external beam radiotherapy (EBRT) for clinically localized prostate cancer

    Página :146

    T. Inagaki, T. Mori

    Esquema Esquema
  • ·MP-14.21 : Early quality of life assessment in men treated with visually directed HIFU for clinically localized prostate cancer

    Página :146

    R.O. Illing, S. Dawkins, C.W. Ogden, M. Emberton

    Esquema Esquema
  • ·MP-14.22 : The effect of neo-adjuvant androgen suppression on prostate cancer related outcomes following HIFU therapy

    Página :146-147

    T. Uchida, R.O. Illing, P.J. Cathcart, M. Emberton

    Esquema Esquema
  • ·MP-14.23 : Retropubic radical prostatectomy (rRPE) following bilateral laparoscopic hernia repair with mesh: urologist nightmare or awful reality?

    Página :147

    U. Hanschmann, U. Humke

    Esquema Esquema
  • ·MP-15.01 : Cystodiathermy under flexible cystoscopy and its proposed benefits

    Página :147-148

    N. Vasdev, A. Thwaini, N. Sezhian, S. Kothandaraman, G. Suresh

    Esquema Esquema
  • ·MP-15.02 : Efficacy of managing small recurrent bladder tumours by diathermy using the CYF-4 Olympus flexible cystoscope in the day surgery unit

    Página :148

    P. Chandrasekar, G. Krishnamoorthy, G. Walkay, J. Calleary, R. Samman, J. Virdi, B. Potluri

    Esquema Esquema
  • ·MP-15.03 : Initial experience with intravesical gemcitabine treatment of urinary bladder superficial transitional cell carcinoma

    Página :148

    M. Mullerad, A. Kravtzov, G. Meyer, A. Kastin, M. Gross, K. Biton, I. Elias, M. Boaz, N. Ofer

    Esquema Esquema
  • ·MP-15.04 : Hybrid SPECT-CT, an additional technique for sentinel node detection of patients with invasive bladder cancer

    Página :148-149

    A. Sherif, U. Garske, M. de La Torre, M. Thorn

    Esquema Esquema
  • ·MP-15.05 : Intermediate-risk urothelial carcinoma: an unresolved problem?

    Página :149

    L. Lusuardi, A. Pycha, M. Lodde, E. Comploj, G. Negri, E. Edgarter-Vigl, S. Palermo, C. Mian

    Esquema Esquema
  • ·MP-15.06 : Pattern of recurrence and progression according to substaging and with or without BCG treatment in T1G3 urothelial bladder carcinoma

    Página :149

    J. Palou, J. Huguet, O. Rodriguez, J. Vayreda, J. Gómez, F. Algaba, H. Villavicencio

    Esquema Esquema
  • ·MP-15.07 : Retinoblastoma protein expression is a predictor of response to BCG and interferon alpha treatment for superficial bladder cancer

    Página :149-150

    E. Chiong, T. Thamboo, M. Teh, Y. Chan, K. Esuvaranathan

    Esquema Esquema
  • ·MP-15.08 : Clinical evaluation of bacillus Calmette-Guerin for eradication of superficial bladder cancers: focus on dose and pretreatment episodes

    Página :150

    T. Okamura, K. Mizuno, M. Kato, K. Yamada, Y. Iwase, K. Kohri

    Esquema Esquema
  • ·MP-15.09 : The significance of simultaneous transurethral resection of bladder tumor and prostate in the bladder tumor patients with infravesical obstruction

    Página :150

    Y. Choi, S. Cho, D. Lee, H. Jeon, K. Cho, M. Lee, Y.D. Choi

    Esquema Esquema
  • ·MP-15.10 : The influence of thermo-chemotherapy on bladder tumours. An immunohistochemical analysis

    Página :150-151

    A. van der Heijden, C. Hulsbergen-van de Kaa, J. Witjes

    Esquema Esquema
  • ·MP-15.11 : Prognostic value of P53 in high-risk superficial bladder cancer with long-term follow-up

    Página :151

    P. Moonen, B. van Balken-Ory, L. Kiemeny, J. Witjes

    Esquema Esquema
  • ·MP-15.12 : UroVysion® compared to cytology and quantitative cytology in the surveillance of superficial bladder cancer

    Página :151

    P. Moonen, G. Merckx, P. Peelen, D. Smeets, J. Witjes

    Esquema Esquema
  • ·MP-15.13 : Post TURBT intensive and long-term maintenance intravesical mitomycin C for managing superficial TCC in Bangladeshi patients: interim results of an ongoing prospective study

    Página :151-152

    M. Islam, Z. Bhuiyan, S. Khan, K. Tawhid

    Esquema Esquema
  • ·MP-15.14 : Immediate intraoperative instillation of mitomycin-C following TURBT: An analysis of 195 instillations in 170 patients with non-invasive bladder cancer, including effect on recurrence rate

    Página :152

    H. Mostafid, D. Moon, S. Biers

    Esquema Esquema
  • ·MP-15.15 : Outpatient endoscopic management of non-invasive bladder cancer using intravesical electromotive drug administration (EMDA) of local anaesthetic

    Página :152

    H. Mostafid, R. Rajkumar, S. Biers

    Esquema Esquema
  • ·MP-15.16 : Sensitivity and specificity of urinary hyaluronic acid and hyaluronidase in detection of bladder TCC

    Página :152-153

    J. Hassan, M.R. Nowroozi, M. Ayati, M. Hashemi

    Esquema Esquema
  • ·MP-15.17 : Comparison of efficacy of post-TURBT adjuvant intravesical mitomycin C therapy in preventing the recurrence of intermediate risk superficial TCC: peri-operative single dose versus delayed multi-dose regimen, short- versus long-term result

    Página :153

    Z. Bhuiyan, M. Islam, S. Khan, K. Tawhid

    Esquema Esquema
  • ·MP-15.18 : Pseudosarcomatous fibromyxoid tumor of the urinary bladder: an extremely rare tumor

    Página :153

    A. Lekas, I. Fokitis, G. Doumanis, A. Parasi, V. Politis, M. Karagianni, S. Koritsiadis

    Esquema Esquema
  • ·MP-15.19 : Impact of age on outcome of patients with superficial bladder cancer

    Página :153-154

    Y. Kohjimoto, A. Iba, T. Kuramoto, Y. Shintani, T. Inagaki, Y. Uekado, T. Shinka

    Esquema Esquema
  • ·MP-15.20 : Evaluating the novel photosensitizer Hexvix® in photodynamic diagnosis of superficial bladder cancer

    Página :154

    E. Ray, K. Thomas, L. Ajayi, K. Chatterton, S. Khan, T. O’Brien

    Esquema Esquema
  • ·MP-15.21 : New staging system for squamous cell carcinoma of the urinary bladder

    Página :154

    M. Wishahi

    Esquema Esquema
  • ·MP-16.01 : The clinical impact of urolithiasis in childhood: 254 clinical cases

    Página :154-155

    H. Wunderlich, C. Klitsch, O. Reichelt, J. Baumgart, P. Höntzsch, J. Schubert

    Esquema Esquema
  • ·MP-16.02 : Tubularization of incised urethral plate in the repair of severe proximal hypospadias

    Página :155

    W. Abu Arafeh, M. Zilberman, R. Salah Eddin

    Esquema Esquema
  • ·MP-16.03 : A study of spontaneous cure of hydrocele in children

    Página :155

    M. Tsugaya, T. Ito, S. Endo, S. Okada, Y. Ito

    Esquema Esquema
  • ·MP-16.04 : Childhood urolithiasis: safety of holmium laser ureterolithotripsy

    Página :155

    A. Safwat, A. Bissada, M. Taha, A. Gafaar, A. El-Taher, M. Abdalla, N. Bissada

    Esquema Esquema
  • ·MP-16.05 : Characteristics of pheochromocytoma in children

    Página :155-156

    M. Bissada, A. Safwat, R. Jackson, N. Sakati, A. El-Zawahry, N. Bissada

    Esquema Esquema
  • ·MP-16.06 : Comparison of Snodgrass and Mathieu surgical techniques in anterior distal shaft hypospadias repair

    Página :156

    M. Moradi, A. Moradi

    Esquema Esquema
  • ·MP-16.07 : Pathophysiology of high pressure voiding in male infants: longitudinal analysis of repeated video urodynamic studies

    Página :156

    M. Ichino, Y. Igawa, S. Seki, O. Ishizuka, O. Nishizawa

    Esquema Esquema
  • ·MP-16.08 : Reconstruction of urothelium on the scaffold using vascular acellular matrix graft in rat

    Página :156-157

    Y. Tokuda, C. Fujiyama, A. Kaneko, Y. Sato, J. Uozumi

    Esquema Esquema
  • ·MP-16.09 : Acute urinary retention in children

    Página :157

    M. Mansour Ghanai, S. Asgari

    Esquema Esquema
  • ·MP-16.10 : Children with a primary non-refluxing megaureter: a shift in presentation and treatment

    Página :157

    R. Stein, R. Beetz, A. Schroeder, S. Woelfle, J. Thüroff

    Esquema Esquema
  • ·MP-16.11 : Incidence of vesicoureteral reflux in Korean children according to the clinical indications, gender and age

    Página :157-158

    J. Park, K. Lee, H. Jung, G. Moon

    Esquema Esquema
  • ·MP-16.12 : Snodgrass technique of urethroplasty modified with the adjunct of techniques of substitution urethroplasty: experience in 125 cases in a prospective study

    Página :158

    Z.H. Bhuiyan, M.F. Islam, S.A. Khan, K.M.H. Tawhid

    Esquema Esquema
  • ·MP-16.13 : Long-term patient-reported outcome of urinary symptoms after hypospadias surgery: norm-related study in adolescents

    Página :158

    K. Moriya, H. Kakizaki, H. Tanaka, T. Mitsui, T. Furuno, T. Kitta, H. Sano, H. Higashiyama, K. Nonomura

    Esquema Esquema
  • ·MP-16.14 : Lich-Gregoir ureteral reimplantation of the ureter with fixation during detrusorraphy as a reliable and effective procedure

    Página :158-159

    S. Onol, F. Onol, H. Inal, S. Onur, H. Hayýt, A. Akbas

    Esquema Esquema
  • ·MP-16.15 : Long-term outcome of ventral penile lengthening for correction of severe curvature in boys with proximal hypospadias

    Página :159

    L. Braga, J. Pippi Salle, A. Lorenzo, D. Bagli, A. Khoury

    Esquema Esquema
  • ·MP-16.16 : The search for predictive factors in patients with posterior urethral valves: analysis of a single institution experience over 20 years

    Página :159

    A. Lorenzo, N. Macedo, A. Cook, M. Del Valle, D. Bagli, A. Khoury, J. Pippi Salle

    Esquema Esquema
  • ·MP-16.17 : The impact of prenatal diagnosis in complete duplex system

    Página :159-160

    M. Baek, S. Paick, S. Jeong, H. Choi

    Esquema Esquema
  • ·MP-16.18 : Histological alterations in the ipsilateral and contralateral testes and epididymides of the rat following unilateral torsion and detorsion of testis

    Página :160

    M. Baek, S. Oh, H. Choi

    Esquema Esquema
  • ·MP-16.19 : West Virginia University Deflux experience and the utility of an intra-operative cystogram with a simulated voiding phase

    Página :160

    A. Perlmutter, W. Tarry, H. Farivar-Mohseni

    Esquema Esquema
  • ·MP-16.20 : Acute epididymitis in children: the role of radiological studies

    Página :160-161

    K. Al-Taheini, J. Pike, M. Leonard

    Esquema Esquema
  • ·MP-16.21 : Management of renal abscess in children

    Página :161

    K. Al-Taheini, M. Leonard, J. Pike

    Esquema Esquema
  • ·MP-16.22 : Prevalence and risk factors of nocturnal enuresis in Egyptian school children

    Página :161

    A. Elbakry, A. Taman

    Esquema Esquema
  • ·MP-17.01 : Fistula and fetal outcomes in patients achieving pregnancy after vesicovaginal fistula repair in Nigeria

    Página :161-162

    K. Chrouser, D. Lightner, C. Kirschner

    Esquema Esquema
  • ·MP-17.02 : The burden of male urethral stricture disease in the USA

    Página :162

    R. Santucci

    Esquema Esquema
  • ·MP-17.03 : Buccal mucosal onlay urethroplasty or anastomotic urethroplasty for short and medium length urethral strictures: Which is better?

    Página :162

    R. Santucci, H. Al-Qudah

    Esquema Esquema
  • ·MP-17.04 : Treatment of urinary bladder sphincter insufficiency grade III with autologous unipotent skeletal muscle cells

    Página :162

    T. Otto, K. Schwartmann, D. Betz, K. Bornemeyer, J. Bagner

    Esquema Esquema
  • ·MP-17.05 : Outcomes with bone anchored male Bulbourethral Sling

    Página :162-163

    B. Gallagher, N. Dwyer, D. Gaynor-Krupnick, J. Latini, K. Kreder

    Esquema Esquema
  • ·MP-17.06 : Approach to complications of traditional circumcision in Transkei, South Africa

    Página :163

    N. Bustamante Sigarroa, L. Mazwai, N. Bustamante Salazar, Y. Ordaz Fuentes

    Esquema Esquema
  • ·MP-17.07 : Management of severe urethral complications of prostate cancer therapy

    Página :163

    S. Elliott, J. McAninch, T. Chi, S. Doyle, V. Master

    Esquema Esquema
  • ·MP-17.08 : Single-stage fasciocutaneous flap urethral reconstruction of strictures involving the fossa navicularis

    Página :164

    M. Garcia, S. Elliott, J. McAninch

    Esquema Esquema
  • ·MP-17.09 : Prospective study on male sexual function after urethroplasty

    Página :164

    J. Ponce-De-León, J. Sarquella, L. Gausa, M. Montlleó, J. Caparrós

    Esquema Esquema
  • ·MP-17.10 : Augmentation by buccal mucosa in ureteric strictures

    Página :164

    C. Mallikarjuna, A. Suri Babu

    Esquema Esquema
  • ·MP-17.11 : Closure and continence in obstetric VVF involving the continence mechanism

    Página :165

    I. Vaz, J. Naude

    Esquema Esquema
  • ·MP-17.12 : Staging of rectourinary fistulas to guide surgical treatment

    Página :165

    R. Rivera, P. Barboglio, M. Hellinger, A. Gousse

    Esquema Esquema
  • ·MP-17.13 : Single-stage perineal repair of panurethral stricture disease with buccal mucosal grafting

    Página :165

    F.E. Martins, T.M. Lopes

    Esquema Esquema
  • ·MP-17.14 : Direct vision internal urethrotomy: predictors of success

    Página :165-166

    R. Gomez, C. Ramos, P. Marchetti

    Esquema Esquema
  • ·MP-17.15 : Twenty years of urethroplasty: fate of each option

    Página :166

    R. Gomez, C. Ramos, P. Marchetti, P. Gonzalez

    Esquema Esquema
  • ·MP-17.16 : Clinical features of urologic complications following obstetric and gynecological surgery

    Página :166

    J.S. Lee, K.T. Kim, J.T. Seo, D.H. Lee, W.J. Ko

    Esquema Esquema
  • ·MP-17.17 : Comparison of outcomes in immediate cystostomy with delayed repair and immediate cystostomy with primary urethral realignment in severe urethral injuries

    Página :166-167

    K. Kim, J.S. Nas, S.T. Cho

    Esquema Esquema
  • ·MP-17.18 : Beta-2 microglobulin in urinary sample: a reliable marker of renal injury

    Página :167

    A. Lekas, I. Fokitis, V. Politis, K. Mitsios, V. Charalampidis, S. Tsalavoutas, K. Sotirios

    Esquema Esquema
  • ·MP-17.19 : Renal trauma: our experience in the diagnosis and treatment of renal injuries in the past decade

    Página :167

    A. Lekas, I. Fokitis, G. Lefakis, V. Charalampidis, S. Tsalavoutas, K. Filis, S. Koritsiadis

    Esquema Esquema
  • ·MP-17.20 : Augmentation cystoplasty in patients with multiple sclerosis: long term follow-up

    Página :168

    R. Zachoval, V. Vik, M. Urban, M. Zalesky, J. Heracek, M. Lukes, K. Mayerova, E. Medova, J. Pitha

    Esquema Esquema
  • ·MP-17.21 : New insights of male transobturator sling suspension: mechanism of action

    Página :168

    P. Rehder, G. Bartsch, C. Gozzi

    Esquema Esquema
  • ·MP-17.22 : Musculocutaneous latissmus dorsi free transfer flap for total phalloplasty

    Página :168

    M. Djordjevic, S. Perovic, R. Djinovic

    Esquema Esquema
  • ·MP-17.23 : The surgical management of obstructive Urolume® stents used for urethral strictures

    Página :168-169

    A. Elkassaby, A. Al-Kandari

    Esquema Esquema
  • ·MP-17.24 : Surgical management of constrictive penile tie with urethrocutaneous and corporeal mutilation

    Página :169

    A.-W. Elkassaby, A.M. Al-Kandari, S. Elazzazy, T. Elzayat

    Esquema Esquema
  • ·MP-17.25 : The benefits of early reconstructive repair in genitourinary fistulas as compared to classical approach

    Página :169

    S. Onol, F. Onol, H. Inal, H. Hayýt, S. Onur, H. Cam

    Esquema Esquema
  • ·MP-18.01 : Management of complete duplication of bladder, urethra, vagina and uterus in a woman

    Página :170

    J. Zhao, F. Zhang, W. Lv, L. Du

    Esquema Esquema
  • ·MP-18.02 : Fascial slings for stress incontinence: outcome of 44 procedures over 10 years

    Página :170

    R. Rajasundaram, R. Montague, E. Lupton

    Esquema Esquema
  • ·MP-18.03 : Primary vesico ureteral reflux in adult females: late diagnosis and result of surgical treatment

    Página :170

    F. Sharifi-Aghdas, H. Akhavizadegan

    Esquema Esquema
  • ·MP-18.04 : Pubovaginal sling using autologous dermis for stress incontinence

    Página :170-171

    H. Jeong, S.O. Park, S.J. Oh, I.Y. Seo, J.S. Rim, D.D. Kwon, S. Kim, S.H. Baek, S.C. Park

    Esquema Esquema
  • ·MP-18.05 : Efficacy and complications of posterior IVS for patients with uterine and vaginal vault prolapse

    Página :171

    S. Choi, H. Kim

    Esquema Esquema
  • ·MP-18.06 : Surgical interventions following Interstim® sacral nerve modulation implant: 11 years’ experience

    Página :171

    J. Gajewski

    Esquema Esquema
  • ·MP-18.07 : Hui-Yin: the pelvic floor as center of mental energy

    Página :171-172

    K. Stifter

    Esquema Esquema
  • ·MP-18.08 : A prospective comparative study of tension-free vaginal tape and tension-free vaginal tape obturator inside-out for the treatment of female stress urinary incontinence

    Página :172

    D.H. Lim, C. Moon, H.Y. Moon, C.S. Kim, J. Rho

    Esquema Esquema
  • ·MP-18.09 : Efficacy and complications of the TVT operation: 6 year clinical experience

    Página :172

    M. Roslan, M. Lubocki, M. Wasyl, J. Gabiga, K. Wêgrzyn

    Esquema Esquema
  • ·MP-18.10 : Safety and efficacy of tension-free vaginal slings in older women comparing to younger patients

    Página :172-173

    C. Konstantinidis, A. Siatelis, D. Volanis, P. Kartsaklis, I. Karyotis, S. Andreadakis, S. Vlachos, P. Melidis, A. Gekas, D. Delakas

    Esquema Esquema
  • ·MP-18.11 : Tension-free vaginal slings in obese patients

    Página :173

    C. Konstantinidis, A. Siatelis, D. Volanis, P. Kartsaklis, I. Paleodimos, S. Andreadakis, P. Melidis, I. Karyotis, A. Gekas, D. Delakas

    Esquema Esquema
  • ·MP-18.12 : Our experience of ablation of Ho:YAG laser in the complex treatment of patients with recurrent and interstitial cystitis

    Página :173

    A.V. Zaitcev, D.U. Pushkar, V.V. Djakov, I.V. Galchikov

    Esquema Esquema
  • ·MP-18.13 : Should every wet woman get tension-free vaginal tape for stress urinary incontinence? Five years’ experience from a single institution

    Página :173-174

    M. Scholz, W. Lüftenegger, M. Wallis, W. Höltl

    Esquema Esquema
  • ·MP-18.14 : The “Manchester” procedure, a simple and durable no-prosthesis technique for the treatment of vaginal prolapse

    Página :174

    R. Fourcade, A. Qarro, R. Hajj Hassan, B. Makhoul

    Esquema Esquema
  • ·MP-18.15 : Treatment of stress urinary incontinence: pubovaginal sling or transobturator?

    Página :174

    M. Arslan, T. Degirmenci, B. Gunlusoy, K. Ilhan, N. Nergiz, S. Minareci, A. Ayder

    Esquema Esquema
  • ·MP-18.16 : Endometriosis with severe functional impairment of the urological tract at first diagnosis successfully treated with surgery

    Página :174-175

    P. Rehder, N. Leonhartsberger, K. Tosun, G. Pinggera, G. Bartsch, C. Gozzi

    Esquema Esquema
  • ·MP-18.17 : Comparison of retropubic and transobturator approach for surgical treatment of female stress incontinence

    Página :175

    T. Realfonso, U. Di Mauro, G. Napodano, O. Intilla, R. Sanseverino

    Esquema Esquema
  • ·MP-18.18 : TVT placed via the obturator route is safer than the retropubic approach

    Página :175

    G. Boustead, J. Constantinou

    Esquema Esquema
  • ·MP-18.19 : Comparison of the short-term result of tension-free vaginal tape (TVT) and trans-obturator vaginal tape (TOT) for the treatment of female stress urinary incontinence: multicenter study

    Página :175-176

    Y.J. Seo, D.G. Kim, W.H. Cha, J.W. Lee, T.G. Kwon, D.Y. Kim

    Esquema Esquema
  • ·MP-18.20 : Comparison of the results of tension-free vaginal tape and intra-vaginal sling in bladder neck suspension for patients with stress urinary incontinence

    Página :176

    K. Radkhah, M. Nowroozi

    Esquema Esquema
  • ·MP-19.01 : The effect of a nephroureterectomy upon glomerular filtration rate

    Página :176

    J. Meyer, G. Delves, M. Sullivan, S. Keoghane

    Esquema Esquema
  • ·MP-19.02 : How safe it is to combine radical nephrectomy with other major abdominal surgical procedures? Sixteen year single centre experience

    Página :176

    B. Somani, G. Nabi, J. N’Dow, S. Swami

    Esquema Esquema
  • ·MP-19.03 : Retroperitoneoscopy for treatment of ureteral stones

    Página :177

    S. Hossain, A. Hossain, S. Khan, M. Islam, S. Rahman, A. Wahab

    Esquema Esquema
  • ·MP-19.04 : Flexible retrograde ureteroscopy in pyelocalyceal diverticulum treatment

    Página :177

    R. Multescu, P. Geavlete, D. Georgescu, C. Persu

    Esquema Esquema
  • ·MP-19.05 : Percutaneous nephrolithotomy (PCNL) in horseshoe kidneys

    Página :177

    M. Darabi Mahboob, R. Taghavi, R. Mahdavi, H. Ahmadnia

    Esquema Esquema
  • ·MP-19.06 : Familial pheochromocytoma: Comparison with sporadic form

    Página :177-178

    A. Safwat, M. Bissada, R. Jackson, N. Sakati, A. El-Zawahry, N. Bissada

    Esquema Esquema
  • ·MP-19.07 : Long-term results of endoureterotomy employing a holmium laser

    Página :178

    H. Hibi, T. Ohori, Y. Yamada, N. Honda

    Esquema Esquema
  • ·MP-19.08 : Evaluation of prolonged warm and cold ischemia on the solitary kidney during partial nephrectomy in a rabbit model

    Página :178

    S. Tyritzis, A. Kyroudi, C. Evangelou, M. Peroulis, G. Mantziaras, N. Kostomitsopoulos, P. Karayannacos, C. Constantinides

    Esquema Esquema
  • ·MP-19.09 : Interventional management of renal angiomyolipoma associated with tuberous sclerosis complex: our experience

    Página :178-179

    S. Misra, J. Cox, C. Kingswood

    Esquema Esquema
  • ·MP-19.10 : Does intermittent low weekly doses of docetaxel-estramustine have an impact on treatment outcome in hormone refractory prostate cancer?

    Página :179

    H. El-Shawaf, K.M. Galal, A.-M.M. Mourad

    Esquema Esquema
  • ·MP-19.11 : The effect of ring-NF-kB decoy oligonucleotide on the kidney for the experimental unilateral ureteral obstruction of mouse

    Página :179-180

    J. Park, K. Park, K. Lee, H. Jung, G. Moon

    Esquema Esquema
  • ·MP-19.12 : Cytoreductive nephrectomy for metastatic renal cell carcinoma In the presence of nonconventional histology

    Página :180

    W. Kassouf, R. Sanchez-Ortiz, P. Tamboli, S. Matin, D. Swanson, C. Wood

    Esquema Esquema
  • ·MP-19.13 : A multicenter, randomized, phase III trial of a novel autologous therapeutic vaccine (vitespen) vs. observation as adjuvant therapy in patients at high risk of recurrence after nephrectomy for renal cell carcinoma

    Página :180

    C. Wood, B. Escudier, L. Lacombe, A. Hoos, R. Gupta, R. Flanigan, R. Figlin, P. Srivastava

    Esquema Esquema
  • ·MP-19.14 : Comparison of laparoscopic and open adrenalectomy: a Czech experience

    Página :180-181

    V. Student, M. Hrabec, I. Hartmann, A. Vidlar

    Esquema Esquema
  • ·MP-19.15 : Balloon assisted nephrectomy for the huge hydronephrotic kidney; Minilaparotomy using naturally obtained giant kidney balloon and artificial PTB balloon

    Página :181

    S. Yoon, J. Lee, H. Jung, M. Lee, J. Yun, E. Lee, J. Paick

    Esquema Esquema
  • ·MP-19.16 : Abstract Withdrawn

    Página :181

    
  • ·MP-19.17 : Recipient outcome in laparoscopic vs open live donor nephrectomy

    Página :181

    A. Kumar, R. Pamposh, S. Anees, D. Deepak, V. Pamposh

    Esquema Esquema
  • ·MP-19.18 : Retroperitoneoscopic live donor nephrectomy for allotransplantation: An initial experience

    Página :182

    A. Kumar, D. Dubey, A. Srivastava, R. Goyal

    Esquema Esquema
  • ·MP-19.19 : The suppressive effect of selenium on renal inflammation in a rat model of pyelonephritis with delayed treatment

    Página :182

    J.S. Park, K.S. Lee, H.C. Jung, G.H. Moon

    Esquema Esquema
  • ·MP-20.01 : The clinical importance of very small renal tumors

    Página :182

    H. Wunderlich, A. Berndt, K. Junker, J. Schubert

    Esquema Esquema
  • ·MP-20.02 : Nephron sparing surgery in cases of multifocal renal cell carcinoma: sense and senselessness

    Página :183

    H. Wunderlich, K. Junker, O. Reichelt, A. Schlichter, A. Berndt, J. Schubert

    Esquema Esquema
  • ·MP-20.03 : Molecular mechanisms of nonsteroidal anti-inflammatory drugs induced apoptosis

    Página :183

    Y. Ou, C. Chen, C. Yang, C. Chen

    Esquema Esquema
  • ·MP-20.04 : Analysis of the cooling effect in the urinary system during renal radiofrequency thermoablation in pigs

    Página :183

    A. Santos, G. D’Ippolito, L. Castilho, M. Amilcar, M. Srougi

    Esquema Esquema
  • ·MP-20.05 : Local recurrence of renal cell carcinoma after radical nephrectomy: analysis of 10 clinical cases

    Página :183-184

    A. Pertia, L. Mangadze, G. Bochorishvili

    Esquema Esquema
  • ·MP-20.06 : Prognostic significance of common preoperative laboratory parameters in renal cell carcinoma

    Página :184

    S. Lee, S. Hong, Y. Kim, I. Chang, J. Han, B. Han, J. Yu, S. Byun

    Esquema Esquema
  • ·MP-20.07 : Adipocyte modulates cell proliferation in the renal cell carcinoma

    Página :184

    Y. Satoh, A. Kaneko, Y. Tokuda, C. Fujiyama, J. Uozumi

    Esquema Esquema
  • ·MP-20.08 : When is a renal tumour palpable?

    Página :184-185

    S. Ramsey, M. Aitchison

    Esquema Esquema
  • ·MP-20.09 : Natural T cell responses to tumour antigen CA9 in a cohort of renal cell carcinoma patients

    Página :185

    T. Chong, D. Cranston, V. Cerundolo

    Esquema Esquema
  • ·MP-20.10 : The development of tumor specific immunity induced by cryosurgery in murine renal cell carcinoma animal model

    Página :185

    S. Kang, H. Park, J. Bae, K. Shim, D. Moon, J. Lee, D. Yoon, J. Kim, J. Cheon

    Esquema Esquema
  • ·MP-20.11 : Comparison of proteomic profiles of renal cell carcinoma between conventional type and papillary type

    Página :185

    J. Hwa, J. Jung, J. Hyun, K. Chung

    Esquema Esquema
  • ·MP-20.12 : Vascular endothelial growth factor (VEGF), fibroblast growth factor basic (FGFb) and endothelial growth factor receptor (EGFR) expression in kidney tumors

    Página :185-186

    O. Blanco, A. Tejido, F. Cabrera, I. Vegh, O. Leiva

    Esquema Esquema
  • ·MP-20.13 : Is current staging defined by TNM appropriate in renal cell carcinoma?

    Página :186

    J. Dominguez, J. Salvadó, A. Velasco, A. Bustamante, P. Troncoso, R. Pinochet

    Esquema Esquema
  • ·MP-20.14 : Two serum biomarkers of renal cell carcinoma by surface enhanced laser desorption / ionization mass spectrometry

    Página :186

    T. Hara, K. Honda, T. Umaki, M. Ono, Y. Hayashida, K. Naito, S. Hirohashi, T. Yamada

    Esquema Esquema
  • ·MP-20.15 : Late onset of metastasis after surgery for renal cell cancer prefers unusual locations

    Página :186-187

    K. Lipsky, R. Zigeuner, L. Schips, P. Rehak, C. Langner

    Esquema Esquema
  • ·MP-20.16 : Trends in laparoscopic radical urological procedures in England

    Página :187

    V. Hanchanale, A. Al-Sarira, J. McCabe, P. Javle

    Esquema Esquema
  • ·MP-20.17 : Antitumor and antiangiogenic effect of arginine deiminase on renal cell carcinoma

    Página :187-188

    C.Y. Yoon, D.H. Yoon, Y.J. Shim, E.H. Kim, K.Y. Chae, J.H. Lee, C.G. Kim, N.H. Won, B.H. Min, D.K. Yoon

    Esquema Esquema
  • ·MP-20.18 : Correlation of caveolin-1 expression on tissue microarray with prognosis in renal cell carcinoma

    Página :188

    S. Kim, Y. Won, H. Joo, S. Kim, H. Ahn, Y. Kim

    Esquema Esquema
  • ·MP-20.19 : Is frozen biopsy from the tumor bed a must in nephron sparing surgery?

    Página :188

    S. Onol, F. Onol, H. Inal, S. Onur, H. Hayýt, A. Akbas

    Esquema Esquema
  • ·MP-21.01 : Holmium laser ablation of large prostate glands (HoLAP): an endourological alternative to open prostatectomy

    Página :188-189

    S. Kumar

    Esquema Esquema
  • ·MP-21.02 : Redo surgery after transurethral vaporization-resection of the prostate

    Página :189

    R. Talic, A. El Tiraifi

    Esquema Esquema
  • ·MP-21.03 : Influence of bladder contractility on short-term outcomes of high-power potassium-titanyl-phosphate photoselective vaporization of the prostate

    Página :189

    J. Paick, S. Song, J. Ku, S. Oh, S. Kim

    Esquema Esquema
  • ·MP-21.04 : Gadolinium MRI defects correlated to TUNA treatments; understanding the heating capabilities, patterns, and amount of necrosis

    Página :189-190

    T. Larson, L. Mynderse, C. Huidobro, J. Meyers

    Esquema Esquema
  • ·MP-21.05 : Efficacy and safety of intravesical Botulinum A toxin for primary bladder neck obstruction in males

    Página :190

    L. Sey Kiat, Q. Leng Choo

    Esquema Esquema
  • ·MP-21.06 : Safety and efficacy of Gyrus PlasmaKinetic bipolar energy in transurethral resection of the prostate

    Página :190

    T. Brancato, F. Corvese, G. Baffigo, P. Aloisi, R. Alvaro, P. Valenti

    Esquema Esquema
  • ·MP-21.07 : Correlation between extent of resection during TURP and outcome

    Página :190

    H. Ibrahim, N. Lynn, N. Hon, H. Brace, S. Ghiblawi, S. Coppinger

    Esquema Esquema
  • ·MP-21.08 : Erectile function after photoselective vaporisation for symptomatic hyperplasia of the prostate

    Página :190-191

    L. Daehlin, J. Frugård, T. Torkelsen

    Esquema Esquema
  • ·MP-21.09 : Effects of photoselective vaporisation of the prostate (PVP) on symptom score, uroflowmetry and prostate volume

    Página :191

    L. Daehlin, J. Frugård, T. Torkelsen

    Esquema Esquema
  • ·MP-21.10 : Postoperative prostate specific antigen (PSA) decline can predict the adequacy of adenoma removal with BPH surgical techniques

    Página :191

    P. Gilling, E. Fong, A. Westenberg, L. Wilson, M. Fraundorfer

    Esquema Esquema
  • ·MP-21.11 : The impact of nandrolone on post-prostatectomy bothersome symptoms

    Página :191-192

    G. Pourmand, K. Moradi, S. Moosavi, A. Abedi, R. Fateh, H. Salehinejad, A. Emamzadeh

    Esquema Esquema
  • ·MP-21.12 : A prospective randomised study between transurethral vaporisation using plasmakinetic energy and transurethral resection of prostate: five-year results

    Página :192

    P. Chandrasekar, F. Kapasi, J. Virdi

    Esquema Esquema
  • ·MP-21.13 : Plasmakinetic Superpulse™ TUR compared Plasmakinetic™ enucleation of the prostate

    Página :192

    P. Gilling, A. Westenberg, L. Wilson, M. Fraundorfer

    Esquema Esquema
  • ·MP-21.14 : Tempro, a new transurethral bipolar radio frequency device for BPH thermal treatment: one-year follow-up

    Página :192-193

    C. Beck

    Esquema Esquema
  • ·MP-21.15 : Holmium laser enucleation of prostate with mechanical morcellation. The platinum standard

    Página :193

    A. Varshney, A. Agarwal, B. Bansal, M. Bansal

    Esquema Esquema
  • ·MP-21.16 : Bilobar enucleation of prostate by holmium laser. Is it time saving?

    Página :193

    A. Varshney, A. Agarwal, B. Bansal, M. Bansal

    Esquema Esquema
  • ·MP-21.17 : Improved endoscope for laser induced resection

    Página :193-194

    M. Reuter, W. Epple, G. Ungemach, A. Verger-Kuhnke

    Esquema Esquema
  • ·MP-21.18 : Transurethral resection of prostate for large benign prostatic hyperplasia: a comparative study with open prostatectomy

    Página :194

    T. Kwon, H. Kim, K. Kim, E. Yoo, S. Chung, B. Kim, Y. Park

    Esquema Esquema
  • ·MP-21.19 : The effects of URO-Dr^® treatment and finasteride on the apoptosis of prostate in beagle dogs

    Página :194

    T. Yoo, H. Cho, Y. Youm, J. Park, T. Kim, H. Kim

    Esquema Esquema
  • ·MP-21.20 : Transurethral microwave thermotherapy (TUMT) using the TherMatrx TMX-2000™ for treatment of benign prostatic hyperplasia: five-year follow-up of multicenter randomized pivotal trial

    Página :194-195

    D. Albala, G. Andriole, B. Davis, G. Eure, J. Kabalian, J. Lingeman, J. Nuzzarello

    Esquema Esquema
  • ·MP-21.21 : The 2 micron CW laser, a new era for the ablation of prostate obstruction

    Página :195

    M.R. Mahran

    Esquema Esquema
  • ·MP-22.01 : Molecular changes during intermittent androgen suppression and their prognostic impact in advanced prostate cancer

    Página :195

    H. Augustin, C. Freibauer, L. Bayer, G. Lunglmayr, F. Tschurlovich, W. Kuber, K. Pummer

    Esquema Esquema
  • ·MP-22.02 : PSA recurrence rates and positive margins after radical retropubic prostatectomy

    Página :195-196

    A. Rempelakos, A. Georgalis, A. Pappas, A. Palantzas, A. Thanos

    Esquema Esquema
  • ·MP-22.03 : Estimate of rectal complications prior to external radiotherapy for prostate cancer

    Página :196

    A. Rempelakos, A. Koligliatis, V. Kouridou, A. Palantzas, A. Thanos, I. Katsilieris

    Esquema Esquema
  • ·MP-22.04 : Pilot study of PC-Spes2 in the treatment of hormone refractory prostate cancer (HRPC). Is hope renewed?

    Página :196

    M. Shabbir, R. Cetti, J. Love, B.S.I. Montgomery

    Esquema Esquema
  • ·MP-22.05 : Nutrition therapy in hormone refractory prostate cancer patients with a polyamine reduced diet. The sooner the better?

    Página :196

    B. Cipolla, R. Havouis, J.P. Moulinoux

    Esquema Esquema
  • ·MP-22.06 : Phase I study of a novel polyamine free formula as nutrition therapy of metastatic hormone-refractory prostate cancer (HRPC) patients

    Página :196-197

    B. Cipolla, J.Y. Bansard, J.P. Moulinoux

    Esquema Esquema
  • ·MP-22.07 : Long-term androgen deprivation and cognitive function in men with prostate cancer

    Página :197

    G. Lunglmayr, B. Weidlich, C. Kratzik

    Esquema Esquema
  • ·MP-22.08 : Phase II study of two doses of ketoconazole (keto) in hormone refractory prostate cancer (HRPC)

    Página :197

    O. Blanco, D. Castellano, A. Rodrı́guez-Antolı́n, L. Paz-Ares, O. Leiva

    Esquema Esquema
  • ·MP-22.09 : Complete remission in metastatic prostate cancer after combined local and systemic therapy

    Página :197-198

    C. Chaussy, S. Thueroff

    Esquema Esquema
  • ·MP-22.10 : The efficacy of PC-SPES in hormone refractory prostate cancer

    Página :198

    K.W. Kwak, J. Hong, C. Kim, H. Lee, H. Choi

    Esquema Esquema
  • ·MP-22.11 : Phase II clinical trial of dutasteride in castration-recurrent prostate cancer

    Página :198

    J. Mohler, J. Yu, O. Sartor, D. Trump

    Esquema Esquema
  • ·MP-22.12 : The effect of risedronate for prostate cancer patients with lower bone mineral density under androgen-deprivation therapy

    Página :198-199

    K. Ishizaka, T. Machida, N. Kanbe, M. Miyao, Y. Mizuno, S. Masuda, T. Kamai, K. Arai, M. Honda, K. Yoshida

    Esquema Esquema
  • ·MP-22.13 : A comparative head on efficacy study of three monthly leuprolide depot vs goserelin depot preparations for treatment in patients with prostate cancer

    Página :199

    R. Sood, V. Jain

    Esquema Esquema
  • ·MP-22.14 : Prospective assessment of hot flashes during treatment with maximum androgen blockade using steroidal or non-steroidal antiandrogens for prostate cancer

    Página :200

    H. Sakai, T. Igawa, H. Kanetake, M. Hayashi, S. Iwasaki, Y. Kusaba, H. Hakariya, T. Hara

    Esquema Esquema
  • ·MP-22.15 : Effect of thalidomide on plasma vascular endothelial growth factor and serum prostate specific antigen in patients with hormone resistant prostate cancer

    Página :200

    S. Singh, A. Kishore, A. Mandal, M. Agarwal, V. Jha

    Esquema Esquema
  • ·MP-22.16 : Characteristic in long term survival patient with prostate cancer managed by androgen suppression therapy

    Página :200

    Y.J. Seo, K.S. Sim, J.M. Heo, U. Kim

    Esquema Esquema

• Video Sessions

  • ·V-01.01 : Laparoscopic ureteroureterostomy for retrocaval ureter

    Página :201

    C. Mallikarjuna, A. Suri Babu

    Esquema Esquema
  • ·V-01.02 : Novel technique for radical nephroureteretomy and resection of bladder cuff through a single incision with the video-assisted minilaparotomy surgery (VAMS)

    Página :201

    S.C. Yang, W.K. Han, S.J. Hong, M.S. Lee

    Esquema Esquema
  • ·V-01.03 : Laparoscopic resolution of severe complications during renal surgery

    Página :201

    R. Sanseverino, O. Intilla, U. Di Mauro, G. Napodano, A. Baio, G. Miracolo

    Esquema Esquema
  • ·V-01.04 : Transmesocolic laparoscopic pyeloplasty in pediatric age group

    Página :201-202

    R. Kapoor, N. Gupta, A. Mandhani

    Esquema Esquema
  • ·V-01.05 : Laparoscopic adrenalectomy: retroperitoneal access

    Página :202

    C. Ramos, J.M. Campero, N. Zambrano

    Esquema Esquema
  • ·V-01.06 : Alternative method for renal vein closure in laparoscopic radical nephrectomy

    Página :202

    A. Kheifets, A. Tsivian, S. Benjamin, A. Sidi

    Esquema Esquema
  • ·V-01.07 : Laparoscopic radical cystectomy: our experience

    Página :202

    I. Coman, A. Cota, C. Rusu, I. Sarb, B. Petrut, B. Feciche, F. Nechita

    Esquema Esquema
  • ·V-01.08 : Laparoscopic retroperitoneal adrenalectomy and laparoscopic treatment of vena cava injury

    Página :202-203

    M. Arslan, T. Degirmenci, B. Gunlusoy, S. Minareci, A. Ayder

    Esquema Esquema
  • ·V-01.09 : Hand-assisted laparoscopic approach for T3b radical nephrectomy

    Página :203

    D. Murphy, A. Henderson, A. Rane

    Esquema Esquema
  • ·V-01.10 : Transperitoneal laparoscopic nephrectomy for giant kidney

    Página :203

    R. Sanseverino, O. Intilla, U. Di Mauro, G. Napodano, A. Barela, T. Realfonso

    Esquema Esquema
  • ·V-02.01 : Double double J indwelling in neoplastic extrinsic ureteral obstruction

    Página :203

    G. Nita, P. Geavlete, V. Mirciulescu, D. Georgescu

    Esquema Esquema
  • ·V-02.02 : Urethral-vesical angle for treatment of female stress urinary incontinence: A novel technique

    Página :203-204

    M. Kilinc

    Esquema Esquema
  • ·V-02.03 : Cystocele repair by vaginal approach with a modified T-shaped tension-free polypropylene mesh. Technique and results

    Página :204

    R. Kapoor, N. Gupta, A. Mandhani

    Esquema Esquema
  • ·V-02.04 : Endourological stone treatment in pregnant woman

    Página :204

    D. Georgescu, P. Geavlete, D. Soroiu, E. Alexandrescu, C. Persu

    Esquema Esquema
  • ·V-02.05 : Second-look flexible nephroscopy for restant caliceal stones

    Página :205

    V. Mirciulescu, P. Geavlete, R. Multescu, V. Cauni

    Esquema Esquema
  • ·V-02.06 : Retrograde intrarenal surgery (RIRS), study of 31 cases

    Página :205

    S. Bapat, K. Pai, S. Purnapatre, P. Yadav, A. Padhye

    Esquema Esquema
  • ·V-02.07 : Use of Kuntz laser carrier (Karl Storz) and Sachse urethrotome sheath (Karl Storz) in PCNL, a point of technique

    Página :205

    S. Bapat, S. Purnapatre, K. Pai, P. Yadav, A. Padhye

    Esquema Esquema
  • ·V-02.08 : The role of laparoscopy in the treatment of difficult ureteral stones

    Página :205-206

    M. Yazdani Kachuii, M. Gharaati

    Esquema Esquema
  • ·V-02.09 : Potency- and continence preserving radical cystectomy with hemiprostatectomy

    Página :206

    M. Wolf, H. Wunderlich, J. Schubert

    Esquema Esquema
  • ·V-02.10 : Laparoscopic radical cystoprostatectomy (LRC)

    Página :206

    J. Peña, A. Prera, J. Gonzalez, N. Hannaoui, E. Vicente, D. Garcia, C. Abad, J. Prats

    Esquema Esquema
  • ·V-02.11 : Photodynamic assisted detection and treatment of superficial bladder cancer using the photosensitizer Hexvix®

    Página :206

    K. Thomas, E. Ray, D. Murphy, K. Chatterton, S. Khan, T. O’Brien

    Esquema Esquema
  • ·V-03.01 : Laparoscopic partial nephrectomy: retroperitoneal access

    Página :207

    C. Ramos, J.M. Campero, N. Zambrano

    Esquema Esquema
  • ·V-03.02 : Endo-laparoscopic nephrouretherectomy with uretheral blocking by Chevassu catheter: a personal experience

    Página :207

    G. Morgia, M. Deriu, S. Canessa, D. Brotza, M. Madonia

    Esquema Esquema
  • ·V-03.03 : Laser vaporization in inflammatory ureteral stenosis

    Página :207

    C. Nita, P. Geavlete, V. Mirciulescu, S. Aghamiri

    Esquema Esquema
  • ·V-03.04 : Ureteroscopy in ureter fissus pathology

    Página :207-208

    V. Mirciulescu, P. Geavlete, D. Georgescu, G. Nita

    Esquema Esquema
  • ·V-03.05 : Endoscopic treatment in calcified ureteral stents

    Página :208

    V. Cauni, P. Geavlete, D. Georgescu, V. Mirciulescu, C. Persu

    Esquema Esquema
  • ·V-03.06 : Cooling the urinary system during renal radiofrequency thermoablation in pigs

    Página :208

    A. Santos, G. D’Ippolito, L. Castilho, M. Amilcar, M. Srougi, A. Valim

    Esquema Esquema
  • ·V-03.07 : Transvesical endoscopic excision of vesical diverticulum

    Página :208-209

    C. Mallikarjuna, A. Suri Babu, K. Vijaya Kumar

    Esquema Esquema
  • ·V-03.08 : Intrahepatic IVC dissection: An alternative approach for venous thrombectomy in renal cell carcinoma with level III IVC thrombus

    Página :209

    A. Seth, N. Gupta, A. Hemal, P. Dogra, R. Kumar, P. Wadhwa

    Esquema Esquema
  • ·V-03.09 : Partial circulatory arrest and cardio-pulmonary bypass for removing IVC thrombus extending up to right atrium

    Página :209

    A. Seth, U. Chowdhary, A. Bhan, N. Gupta, A. Dhar

    Esquema Esquema
  • ·V-03.10 : ReMeEx device (External Mechanical Regulator) for incontinence: implantation and regulation procedure, complications and results at 5 years follow-up

    Página :209-210

    F. Mantovani, S. Paparella, V. Inneo

    Esquema Esquema
  • ·V-03.11 : Simultaneous repair of the anteroposterior defects and infracoccygeal sacropexy during intravaginal suburethral sling procedure for stress urinary incontinence

    Página :210

    S. Onol, F. Onol, H. Inal, H. Hayýt, S. Onur, O. Kose

    Esquema Esquema
  • ·V-03.12 : Antegrade miniinvasive nephroureterectomy (AMNUE - laparoscopic nephrectomy, transurethral excision of ureterovesical junction and pararectal incision)

    Página :210

    M. Hora, J. Kleèka, V. Eret, T. Ürge, J. Ferda, O. Hes

    Esquema Esquema
  • ·V-04.01 : Laparoscopic treatment of retrocaval ureter: our experience and literature review

    Página :210-211

    F. Bagheri, Á. Szántó, C. Pusztai, E. Holman, L. Farkas

    Esquema Esquema
  • ·V-04.02 : Transperitoneal laparoscopic partial nephrectomy in a horseshoe kidney

    Página :211

    A. Kheifets, A. Tsivian, S. Benjamin, L. Agulansky, A. Sidi

    Esquema Esquema
  • ·V-04.03 : Y-V pyeloplasty revisited

    Página :211

    A. Kheifets

    Esquema Esquema
  • ·V-04.04 : Laparoscopic pyeloplasty: retroperitoneal approach

    Página :211-212

    J. Campero, C. Ramos, N. Zambrano

    Esquema Esquema
  • ·V-04.05 : Laparoscopic treatment for bilateral varicocele

    Página :212

    R. Rabii, B. Querfani, H. Essaki, E. Salim, A. Joual, F. Meziane

    Esquema Esquema
  • ·V-04.06 : Laparoscopic ureteral reimplantation for an ectopic ureter: a case report

    Página :212

    A. Basiri, F. Mohammad Ali Beigi, H. Abdi, N. Mahmoudnejad

    Esquema Esquema
  • ·V-04.07 : Left vena cava discovered during laparoscopic donor nephrectomy report of two cases

    Página :212

    N. Simforoosh, F.-M.A. Beygi

    Esquema Esquema
  • ·V-04.08 : Laparoscopic ureteral reimplantation in ureterovesical junction obstruction, transperitoneal and extra peritoneal method: Initial report

    Página :212-213

    N. Simforoosh, F.-M.A. Beygi

    Esquema Esquema
  • ·V-04.09 : Laparoscopic partial nephrectomy in a transplanted kidney

    Página :213

    N. De Graeve, A. Rosales, J. Salvador, J. Caffaratti, J. Ponce de Leon, J. Huguet, H. Villavicencio

    Esquema Esquema
  • ·V-04.10 : Laparoscopic repair of iatrogenic long ureteral injury

    Página :213

    A. Basiri, S. Shahrokhi, H. Shayani-Nasab, H. Karami, F. Mohammad Ali Beigi

    Esquema Esquema
  • ·V-05.01 : Laser vaporization in recurrent inflammatory urethral strictures

    Página :213-214

    G. Nita, P. Geavlete, S. Bancu

    Esquema Esquema
  • ·V-05.02 : Transurethral approach in multilocular large prostatic abscesses

    Página :214

    G. Nita, P. Geavlete, V. Mirciulescu, D. Georgescu

    Esquema Esquema
  • ·V-05.03 : Bipolar endoscopic procedures in complicated urethral strictures

    Página :214

    D. Georgescu, P. Geavlete, V. Cauni, V. Mirciulescu

    Esquema Esquema
  • ·V-05.04 : Treatment of urethral condyloma by IL-2

    Página :214

    W. Ko, J. Lee

    Esquema Esquema
  • ·V-05.05 : Sexual rehabilitation after penile plastic surgery

    Página :215

    K. Krajka, W. Lauer, D. Perkowski, M. Markuszewski, M. Matuszewski

    Esquema Esquema
  • ·V-05.06 : Surgical treatment of Peyronie’s disease

    Página :215

    K. Krajka, M. Markuszewski, M. Matuszewski, W. Moszczyñski

    Esquema Esquema
  • ·V-05.07 : Darewicts operation for Peyronie’s disease: A preliminary report

    Página :215

    F. Mantovani, S. Paparella, V. Inneo

    Esquema Esquema
  • ·V-05.08 : The use of buccal mucosal grafts in reconstructive urethral surgery

    Página :215

    G. Barbagli, S. Balò, M. Raber, S. De Stefani, G. Guazzoni, P. Rigatti

    
  • ·V-05.09 : Retroperitoneal lymph node dissection with caval thrombectomy for advanced nonsemonimatous germ cell tumor of the left testicle

    Página :215

    F. Martins, J. Alves, J. Freeman, J. Lencastre, J. Varela

    Esquema Esquema
  • ·V-05.10 : Urethral hemangioma-laser treatment: point of technique

    Página :216

    E. Abara, J. Doucet

    Esquema Esquema
  • ·V-05.11 : Penile carcinoma: organ sparing surgery

    Página :216

    M. Djordjevic, S. Perovic, G. Korac

    Esquema Esquema
  • ·V-06.01 : Extraperitoneal Laparoscopic Radical Prostatectomy (ELRP)

    Página :216

    J. Penña, J. Gonzalez, N. Hannaoui, E. Vicente, D. Garcia, C. Abad, A. Prera, J. Prats

    Esquema Esquema
  • ·V-06.02 : Laparoscopic radical cystoprostatic adenectomy

    Página :216

    A. Basiri, F. Mohammad Ali Beigi

    Esquema Esquema
  • ·V-06.03 : Nerve sparing robotic da Vinci radical prostatectomy

    Página :216-217

    N. De Graeve, H. Villavicencio, J. Salvador, J. Palou, J. Gomez

    Esquema Esquema
  • ·V-06.04 : Retrograde extraperitoneal laparoscopic prostatectomy (RELP): Ascending dissection of the erectile neurovascular bundles

    Página :217

    P. Dubernard, P. Chaffange, P. Chalabreysse, B. Cuzin, P. Pacheco

    Esquema Esquema
  • ·V-06.05 : HIFU treatment of prostate cancer with Ablatherm® integrated imaging

    Página :217

    C. Chaussy, S. Thueroff

    
  • ·V-06.06 : Interstitial prostatic brachyteraphy: new technique with intraoperative dosimetric evaluation and real time modification of treatment plan

    Página :217

    M. Madonia, G. Barabino, L. Cau, M. Catania, F. Pirozzi Farina, A. Pischedda, M. Dedola, G. Ghisu, G. Canalis, G. Morgia

    Esquema Esquema
  • ·V-06.07 : Laparoscopic preperitoneal radical prostatectomy: preliminary experience

    Página :217-218

    R. Sanseverino, O. Intilla, U. Di Mauro, G. Napodano, A. Campitelli, R. Angrisani

    Esquema Esquema
  • ·V-06.08 : Technique for transverse colon continent cutaneous diversion

    Página :218

    N. Bissada, M. Abdallah

    Esquema Esquema
  • ·V-06.09 : Continent reservoir with hydraulic valve mechanism

    Página :218

    K. Krajka, W. Lauer, M. Markuszewski, M. Matuszewski

    Esquema Esquema
  • ·V-06.10 : Photoselective vaporization of the prostate: the technique

    Página :218

    C. Ramos, J.M. Campero, N. Zambrano

    Esquema Esquema
  • ·V-06.11 : Millin operation using new surgical technologies

    Página :218-219

    K. Krajka, M. Markuszewski, M. Matuszewski, D. Perkowski, W. Piaskowski

    Esquema Esquema
  • ·V-07.01 : Double layer dartos flap coverage of the neourethra in tubularized incised plate urethroplasty (TIPU) repair

    Página :219

    S. Onol, F. Onol, H. Inal, H. Hayýt, S. Onur, A. Akbas

    Esquema Esquema
  • ·V-07.02 : Reconstructive urethroplasty using porcine acellular matrix: Evolution of the grafting procedure

    Página :219

    F. Mantovani, V. Inneo, S. Paparella

    Esquema Esquema
  • ·V-07.03 : Evaluation and reconstruction of an extremely rare genitourinary abnormality

    Página :219-220

    U. Altug, M. Cakan, F. Yalçýnkaya, F. Demirel, M. Topçuoðlu

    Esquema Esquema
  • ·V-07.04 : Membranous urethral rupture endoscopic realignment

    Página :220

    J. Ponce-De-León, L. Gausa, J. Arce, H. Villavicencio

    Esquema Esquema
  • ·V-07.05 : Buccal mucosa: Versatile graft in anterior urethroplasty

    Página :220

    F. Martins, J. Badona, R. Rodrigues, J. Marcelino, J. Varela, T. Lopes

    
  • ·V-07.06 : Simplified repair of post-pelvic fracture anterior-posterior urethral distraction defect

    Página :220-221

    F. Martins, T. Lopes, S. Boyd

    Esquema Esquema
  • ·V-07.07 : York Mason trans-sphincteric trans-rectal repair of iatrogenic recto-urinary fistula: case report

    Página :221

    R. Sanseverino, O. Intilla, G. Napodano, A. Barela, U. Di Mauro, T. Realfonso

    Esquema Esquema
  • ·V-07.08 : Dorsal buccal mucosa onlay graft bulbar urethroplasty by means of fibrin glue

    Página :221

    G. Barbagli, S. De Stefani, M. Sighinolfi, S. Micali, F. Annino, G. Bianchi

    Esquema Esquema
  • ·V-07.09 : Single stage approach for the reconstruction of exstrophy epispadias cases admitted in aduthood

    Página :221-222

    S. Onol, F. Onol, H. Inal, S. Onur, H. Hayit, H. Cam

    Esquema Esquema
  • ·V-07.10 : Laparoscopic treatment of benign urachus cyst

    Página :222

    J. Peña, J. Gonzalez, N. Hannaoui, E. Vicente, D. Garcia, C. Abad, A. Prera, J. Prats

    Esquema Esquema

• Unmoderated Poster Sessions

  • ·UP-01.01 : Antegrade flexible ureteroscopy in lower ureteral stenosis

    Página :223

    R. Multescu, P. Geavlete, D. Soroiu, G. Nita

    Esquema Esquema
  • ·UP-01.02 : Management of tuberculous strictures of ureter by endourology

    Página :223

    P.C.H. Nguyen, L.C. Vu, V.H. Nguyen, Q.T. Duong, T.M. Ngo

    Esquema Esquema
  • ·UP-01.03 : Reliability of teleradiology using mobile phone-camera digitally photographed radiographs in making prompt treatment decisions on urological conditions

    Página :223-224

    E. Arada, T. Trinidad

    Esquema Esquema
  • ·UP-01.04 : Mini-incision muscle-sparing lumbar approach to the kidney, the renal pelvis and the upper ureter

    Página :224

    A. Hinev, S. Paunov

    Esquema Esquema
  • ·UP-01.05 : Portless endoscopic radical nephrectomy via a single minimum skin incision: experience with initial 11 cases

    Página :224

    T. Yamane, K. Nishiyama, Y. Uchida, H. Kubo, M. Kawahara, M. Nakagawa

    Esquema Esquema
  • ·UP-01.06 : Permanent metallic stents in ureteric strictures

    Página :224-225

    C. Mallikarjuna, A. Suri Babu, K. Vijaya Kumar

    Esquema Esquema
  • ·UP-01.07 : A case of 18-OH-DOC and corticosterone producing adrenal adenoma combined with pre-clinical Cushing’s syndrome

    Página :225

    R. Machino, H. Kijima, T. Mizushima, H. Sasano

    Esquema Esquema
  • ·UP-01.08 : The effect of main symptoms on outcome of blood pressure after nephrectomy

    Página :225

    A. Basiri, N. Simforoosh, S. Shahrokhi, A. Danesh, H. Abdi

    Esquema Esquema
  • ·UP-01.09 : The glucose metabolism in clear cell and papillary renal cell carcinomas - A structural analysis of components

    Página :225-226

    T. Herrmann, A. Gross, L. Binder, M. Burchardt, U. Jonas, B. Hemmerlein

    Esquema Esquema
  • ·UP-01.10 : Renal hypertension in patients 10 years after ESWL treatment for renal calculosis

    Página :226

    L. Lekovski, S. Stavridis, M. Kuzmanovski, A. Stavridis

    Esquema Esquema
  • ·UP-01.11 : The use of Tachosil® surgical patch in partial nephrectomy

    Página :226

    A. Siatelis, C. Konstantinidis, D. Volanis, P. Melidis, I. Karyotis, D. Delakas

    Esquema Esquema
  • ·UP-01.12 : Double-blind, placebo-controlled, multi-center study for the therapeutic effects of mountain panax ginseng C.A. Meyer extract in males with erectile dysfunction: a preliminary report

    Página :226

    H. Kim, S. Woo, S. Jo, E. Hahn, N. Youn, H. Lee, C. Sul

    Esquema Esquema
  • ·UP-01.13 : Photoselective vaporization of the prostate: short term results of a new technique for benign prostatic hyperplasia

    Página :226-227

    N. Zambrano, C. Ramos, J. Campero, S. Dietsch, A. Hinrichs, R. Rosenfeld

    Esquema Esquema
  • ·UP-01.14 : Percutaneous nephropexy with U-tube nephrostomy: long-term follow-up of an alternative technique for treatment of symptomatic nephroptosis

    Página :227

    J. Székely, F. Bagheri, K. Villányi, C. Pusztai, Á. Szántó, T. Beöthe, L. Farkas

    Esquema Esquema
  • ·UP-01.15 : Pathology of 68 renal epithelial - stromal tumors

    Página :227

    C. Davis, I. Sesterhenn

    Esquema Esquema
  • ·UP-01.16 : Retroperitoneal versus transperitoneal laparoscopic live donor nephrectomy: results from a prospective randomized trial

    Página :227-228

    A. Kumar, R. Goyal, A. Srivastava, D. Dubey

    Esquema Esquema
  • ·UP-01.17 : Use of diagnostic percutaneous needle biopsy for indeterminate renal masses: current practice in the UK

    Página :228

    A. Khan, I. Shergill, S. Quereshi, M. Vandal, S. Gujral

    Esquema Esquema
  • ·UP-01.18 : Effect of the herbal medicine bu-zhong-yi-ki-tang on semen parameters and seminal plasma cytokine levels in idiopathic male infertility

    Página :228

    T. Akashi, A. Watanabe, A. Morii, I. Mizuno, H. Fuse

    Esquema Esquema
  • ·UP-01.19 : Oligospermic men treated by carnitine and acetylcarnitine

    Página :228

    S. Micic, D. Djordjevic, N. Bojanic, N. Lalic, D. Nale, A. Vuksanovic

    Esquema Esquema
  • ·UP-01.20 : The use of water jet dissection for nephron sparing surgery in patients with renal cell cancer

    Página :228-229

    J. Djozic, J. Bogdanovic, G. Marusic, V. Sekulic, M. Dukic, Z. Dimitric, R. Herin, M. Djozic, S. Djozic

    Esquema Esquema
  • ·UP-01.21 : A retrospective study of implications on survival of histopathological subtyping and nuclear grading of renal cell carcinoma

    Página :229

    Y. Kim, J. Huh, J. Lee, S. Chang, S. Jeon

    Esquema Esquema
  • ·UP-01.22 : Clinical characteristics of xanthogranulomatous pyelonephritis

    Página :229

    Y. Kim, J. Huh, J. Lee

    Esquema Esquema
  • ·UP-01.23 : Tumour in end-stage kidney

    Página :229-230

    M. Hora, T. Ürge, J. Klečka, T. Reischig, O. Hes, J. Ferda, M. Michal

    Esquema Esquema
  • ·UP-01.24 : Spontaneous rupture of renal cell carcinoma: a rare acute emergency

    Página :230

    N. Vasdev, S. Kothandaraman, N. Sezhian, A. Thwaini, G. Suresh

    Esquema Esquema
  • ·UP-01.25 : Stagewise survival in renal cell carcinoma - a single centre experience

    Página :230

    P. Deka, R. Puthenveetil, S. Barua, S. Baruah

    Esquema Esquema
  • ·UP-01.26 : The impact of tumor associated symptoms on the prognosis of the patients with renal cell carcinoma

    Página :230-231

    K. Lee, T. Kwon, B. Kim, D. Kim, J. Park, C. Kim, H. Jung, D. Kim, I. Cho, H. Lee

    Esquema Esquema
  • ·UP-01.27 : Renal tumor with tumor thrombosis of inferior vena cava or right atrium: clinicopathological features, surgical techniques and outcomes

    Página :231

    M. Ayati

    Esquema Esquema
  • ·UP-01.28 : Changing practice patterns in the treatment of small renal tumors

    Página :231

    T. Moon, S. Nakada, S. Hedican, D. Jarrard, J. Gee, R. Bruskewitz

    Esquema Esquema
  • ·UP-01.29 : Laparoscopic radical nephrectomy compared with open radical nephrectomy. Initial experience of Tata memorial hospital, India

    Página :231-232

    Y. Thyavihally, H. Tongaonkar, A. Kakade

    Esquema Esquema
  • ·UP-01.30 : Does the microvascular invasion of perirenal fat have a role in the outcome of patients with renal cell carcinoma?

    Página :232

    V. Bucuras, A. Dema, M. Botoca, A. Cumpanas, R. Bardan

    Esquema Esquema
  • ·UP-01.31 : Therapeutic procedure in pyeloureteric obstruction and associated segmental ureteric hypoplasia in childhood

    Página :232

    U. Friedrich, R. Vetter

    Esquema Esquema
  • ·UP-01.32 : Postoperative renal function of ureteropelvic junction obstruction

    Página :232-233

    Y. Koikawa, T. Yamaguchi, T. Konomoto, Y. Akita

    Esquema Esquema
  • ·UP-01.33 : HLA antigens system and congenital ureteropelvic junction obstruction

    Página :233

    S. Falahatkar, S. Tavasoli Yousefabad, A. Shamsa, S. Nikpoor

    Esquema Esquema
  • ·UP-01.34 : Giant ureterocele causing outflow obstruction

    Página :233

    P. Deka, R. Puthenveetil, S. Barua, S. Baruah

    Esquema Esquema
  • ·UP-01.35 : Hypospadias surgery at Red Cross Children’s Hospital: 10 years, 600 cases

    Página :233

    J. Lazarus, L. Jee

    Esquema Esquema
  • ·UP-01.36 : Hypospadias repair: a surgeon’s 25-year experience

    Página :233-234

    H. Chang, K. Kim

    Esquema Esquema
  • ·UP-01.37 : Differential diagnostic of priapism in childhood

    Página :234

    A. Schlichter, U. Löffler, M. Beintker, J. Schubert

    Esquema Esquema
  • ·UP-01.38 : Results of primary bladder exstrophy closure, at Mulago Hospital (Uganda)

    Página :234

    S. Watya, S. Muwazi, I. Kajja

    Esquema Esquema
  • ·UP-01.39 : Ventral penile curvature without hypospadias: points to consider in diagnosis and surgical treatment

    Página :234

    H. Inal

    Esquema Esquema
  • ·UP-01.40 : The comparison of the therapeutic effect of oral diclofenac sodium, imipiramin and their combination in the treatment of primary nocturnal enuresis

    Página :235

    M. Hosseini, L. Ghahramani, M. Amini, D. Irani, F. Emamghorayshi

    Esquema Esquema
  • ·UP-01.41 : Paediatric balanitis xerotica obliterans: an 8-year experience

    Página :235

    A. Khan, B. Madhok, I. Shergill, M. Arya, J. Barua

    Esquema Esquema
  • ·UP-01.42 : Detrusor injections with botulinum toxin A (BTX-A) for detrusor overactivity (DO): is there a difference in congenital spinal cord defects (CCD) and traumatic spinal cord injuries (SCI)?

    Página :235

    J. Grosse, G. Kramer, D. Rohrmann, G. Jakse

    Esquema Esquema
  • ·UP-01.43 : Optimizing the results of tubular incised plate urethroplasty using double breasted deepithelialized skin flap in hypospadias repair

    Página :236

    A. Elkassaby, A. Al-Kandari, T. Elzayat

    Esquema Esquema
  • ·UP-01.44 : Snodgrass technique of urethroplasty modified with the adjunct of techniques of substitution urethroplasty: experience in 125 cases in prospective study

    Página :236

    Z. Bhuiyan, M.F. Islam, S.A. Khan, K.M.H. Tawhid

    Esquema Esquema
  • ·UP-01.45 : Squamous cell carcinoma of the penis: prognostic factors

    Página :236-237

    P. Nunes, N. Maia, B. Parada, V. Dias, F. Rolo, A. Mota

    Esquema Esquema
  • ·UP-01.46 : Combined chemotherapy in metastatic penile cancer

    Página :237

    A. Rempelakos, T. Arvanitakis, A. Palantzas, A. Georgalis, A. Thanos

    Esquema Esquema
  • ·UP-01.47 : Testicular cancer: two years’ experience of multidisciplinary approach in KwaZulu Natal, Durban, South Africa

    Página :237

    E. Abdel Goad, S. Jhugroo, A. Jodan, R. Venter, Z. Bereczky

    Esquema Esquema
  • ·UP-01.48 : The diagnostic value of C-reactive protein and erythrocyte sedimentation rate for patients with an acute scrotum

    Página :237-238

    S. Asgari, M. Mansourghanai, A. Roshani, G. Mokhtari

    Esquema Esquema
  • ·UP-01.49 : Prostatic abscess - Indian scenario

    Página :238

    C. Mallikarjuna, A. Suri Babu

    Esquema Esquema
  • ·UP-01.50 : Primary cancer of the penis among Xhosa population in Transkei, South Africa

    Página :238

    N. Bustamante Salazar, N. Bustamante Sigarroa, Y. Ordaz Fuentes, M. Garcia Jardon

    Esquema Esquema
  • ·UP-01.51 : Abstract Unavailable

    Página :238

    
  • ·UP-01.52 : Penile cancer: Do GUM clinic referrals delay the diagnosis?

    Página :238

    S. Ravichandran, A. Arulanandarajah, N. Parr

    Esquema Esquema
  • ·UP-01.53 : Surgical management of penile fracture: our experience

    Página :239

    F. Cabrera Meirás, O. Blanco Carballo, A. Sanchı́s Bonet, G. Duque Ruiz, J. Duarte Ojeda, A. Tejido Sánchez, E. Alvarez González, A. Martin Parada, O. Leiva Galvis

    Esquema Esquema
  • ·UP-01.54 : ‘Desperation’ retroperitoneal lymph node dissection for post chemotherapy residual nodal masses in NSGCT of testis

    Página :239

    A. Seth, P. Wadhwa, N. Gupta, A. Hemal, P. Dogra, R. Kumar

    Esquema Esquema
  • ·UP-01.55 : Radiological surveillance for simple intratesticular cysts: an 11-year experience

    Página :239

    A. Khan, F. Kapasi, I. Shergill, B. Potluri, C. Barber

    Esquema Esquema
  • ·UP-01.56 : The correlation of parooxonase/arylesterase activities with lipoproteins and apolipoprotein Al and B in renal transplant patients

    Página :239-240

    A. Afshari Taghizadeh, M. Ansari Khadem, S. Samadzadeh

    Esquema Esquema
  • ·UP-01.57 : Malignancy in renal transplanted patients

    Página :240

    A. Afshari Taghizadeh, M. Fallah Mohmmadi, A. Tehranchi, M. Sadehdel

    Esquema Esquema
  • ·UP-01.58 : Transplantation of enbloc cadaveric pediatric kidney to adult

    Página :240

    R. Mahdavi Zafarghandi, D. Arab, R. Taghavi, H. Gholmrezaee, M. Yazdani, N. Simforosh, A. Tabibi

    Esquema Esquema
  • ·UP-01.59 : Effects of papaverin hydrochloride in diuresis and function of graft after kidney transplantation, comparison with lidocaine and furozemide

    Página :240

    R. Zafarghandi Mahdavi, R. Taghavi, M. Mahdavi, M. Darabi, D. Arab, A. Delijani, H. Mejramian, F. Fathi

    Esquema Esquema
  • ·UP-01.60 : Microchimerism and renal transplantation: doubt still persists

    Página :240-241

    G. Pourmand, M. Nikoobakht, A. Mehrsai, M. Taherimahmoudi, A. Saraji, A. Emamzadeh

    Esquema Esquema
  • ·UP-01.61 : Results of the first 40 laparoscopic donor nephrectomies

    Página :241

    H. Gholamrezaie, A. Shahrazad, A. Shadab, A. Khalili

    Esquema Esquema
  • ·UP-01.62 : Live open donor nephrectomy: a multidisciplinary approach facilitates post operative recovery

    Página :241

    J. Beatty, K. Junejo, J. McNeill, M. Chawdhery

    Esquema Esquema
  • ·UP-01.63 : Postoperative lymphoceles in renal transplantation

    Página :241-242

    D. Basic, D. Milutinovic, M. Djokic, J. Hadzi Djokic, Z. Dzamic, D. Radivojevic, R. Blagojevic-Lazic

    Esquema Esquema
  • ·UP-01.64 : Vascular graft interposition in renal allograft implantation

    Página :242

    D. Milutinovic, D. Basic, M. Djokic, Djokic J. Hadzi

    Esquema Esquema
  • ·UP-01.65 : New technique for allograft ureteral ureteroneocystostomy to make possible endoscopic handling of allograft urologic complications

    Página :242

    A. Zomorrodi, A. Buhluli

    Esquema Esquema
  • ·UP-01.66 : Renal transplantation in patients with hepatitis B or C

    Página :242

    B. Parada, A. Figueiredo, P. Nunes, F. Macário, R. Alves, A. Carvalho, A. Mota

    Esquema Esquema
  • ·UP-01.67 : Evolution of renal transplantation over time. Comparative study of two different periods: 1980-1995 vs. 1996-2005

    Página :242-243

    B. Parada, A. Figueiredo, P. Nunes, C. Bastos, F. Rolo, A. Mota

    Esquema Esquema
  • ·UP-01.68 : Influence of the immunological factors in renal transplantation: one-single center experience

    Página :243

    B. Parada, A. Figueiredo, P. Nunes, F. Macário, A. Mota

    Esquema Esquema
  • ·UP-01.69 : A comparative study of urological complications between fine prolene with catgut chromic suture material in ureteral anastomosis in renal transplantation

    Página :243-244

    A. Pasha Akbarzadeh, H. Gholamrezaie

    Esquema Esquema
  • ·UP-01.70 : Comparative study of two techniques of ureteroneocystostomy (Taguchi and Lich-Gregoir)

    Página :244

    P. Moreira, B. Parada, A. Figueiredo, N. Maia, P. Nunes, C. Bastos, A. Mota

    Esquema Esquema
  • ·UP-01.71 : Patients submitted to a second or third renal transplant: evaluation of results

    Página :244-245

    P. Moreira, P. Nunes, A. Figueiredo, N. Maia, B. Parada, A. Roseiro, A. Mota

    Esquema Esquema
  • ·UP-01.72 : Risk factors for delayed graft function and their influence in renal graft outcome

    Página :245

    A. Figueiredo, P. Moreira, B. Parada, P. Nunes, F. Macario, C. Bastos, A. Mota

    Esquema Esquema
  • ·UP-01.73 : Our experience with early postoperative vascular complications in living vs cadaveric renal transplantation

    Página :245

    D. Milutinovic, D. Basic, Z. Boric, M. Djokic, R. Blagojevic-Lazic, D. Radivojevic, Z. Dzamic, J. Djokic Hadzi

    Esquema Esquema
  • ·UP-01.74 : Efficacy of foreskin grafts for bulbopendulous urethral strictures

    Página :245-246

    A. Lecki

    Esquema Esquema
  • ·UP-01.75 : Adult urethral stricture disease after childhood hypospadias repair: an unexpected source of severe urethral stricture

    Página :246

    R.S. Santucci, C. Hammer

    Esquema Esquema
  • ·UP-01.76 : Changing patterns of adult and paediatric genito-urinary reconstruction in southern Nigeria

    Página :246

    L. Akporiaye

    Esquema Esquema
  • ·UP-01.77 : Long-term results of endoscopic primary realignment of posterior urethral injury accompanied with pelvic bone fracture

    Página :246-247

    J. Lee, H. Chung, W. Na, M. Choi

    Esquema Esquema
  • ·UP-01.78 : Dorsal onlay graft urethroplasty using buccal mucosa in extensive anterior urethral strictures

    Página :247

    Zafarghandi R. Mahdavi, Kachooe M. Yazdani, D. Arab, A. Ahanian, M. Mahdavi

    Esquema Esquema
  • ·UP-01.79 : The good and bad of urethral stents

    Página :247

    M. Eisenberg, S. Elliott, J. McAninch

    Esquema Esquema
  • ·UP-01.80 : Closure and continence in obstetric VVF involving the continence mechanism

    Página :247

    J. Naude, I. Vaz

    Esquema Esquema
  • ·UP-01.81 : Maintaining long term patency of the Mitrofanoff stoma

    Página :248

    J. Naude

    Esquema Esquema
  • ·UP-01.82 : Testis injury: efficacy of American Association for the Surgery of Trauma organ injury scale

    Página :248

    K. Yoo, J. Kim, S. Lee, S. Chang, K. Ahn

    Esquema Esquema
  • ·UP-01.83 : Comparison of the curative potencial of direct vision internal urethrotomy versus open uretroplasty

    Página :248

    R. Gomez, P. Marchetti, C. Ramos

    Esquema Esquema
  • ·UP-01.84 : Initial experience and challenges of urethroplasty in a new urology unit in Nigeria

    Página :248-249

    I. Mungadi, I. Ntia

    Esquema Esquema
  • ·UP-01.85 : Injuries to the pelvis in andrology

    Página :249

    R. Grill, V. Džupa, V. Báca

    Esquema Esquema
  • ·UP-01.86 : The influence of visitorship program on the development of urethroplasty service for complicated urethral cases in a general hospital in Kuwait

    Página :249

    A. Al-Kandari, Y. Elshebiny, H. Ibrahim, H. Shaaban, H. Al-Enezi, A. Elkassaby

    Esquema Esquema
  • ·UP-01.87 : The use of buccal mucosa in urethroplasty

    Página :249-250

    K.E.K. Aboah

    Esquema Esquema
  • ·UP-01.88 : Darifenacin is also effective in neurogenic bladder dysfunction (multiple sclerosis)

    Página :250

    S. Carl, S. Laschke

    Esquema Esquema
  • ·UP-01.89 : A comparison of the results of intravaginal suburethral sling and transobturator tape procedures in the surgical treatment of stress urinary incontinence

    Página :250

    S. Onol, F. Onol, H. Inal, S. Onur, O. Köse

    Esquema Esquema
  • ·UP-01.90 : Effect of lumbar-epidural administration of tramadol on neurophysiology of bladder

    Página :250

    S. Singh, M. Agarwal, Y. Batra, A. Mandal

    Esquema Esquema
  • ·UP-01.91 : Effects of estrogen on postmenopausal urinary incontinence rat model

    Página :251

    Hayashi N. Narihiko, Y. Kubota Yoshinobu, T.X. Minor, T.F. Lue

    Esquema Esquema
  • ·UP-01.92 : Tumor necrosis as prognostic indicator in urothelial carcinoma of the upper urinary tract

    Página :251

    R. Zigeuner, G. Hutterer, T. Chromecki, S. Leibl, P. Rehak, C. Langner

    Esquema Esquema
  • ·UP-02.01 : Erectile dysfunction: a dilemma and man’s solutions through the ages

    Página :252

    M. Omar, O. Karim, H. Motiwala

    Esquema Esquema
  • ·UP-02.02 : History of brachytherapy in prostate cancer

    Página :252

    A. Rempelakos, E. Koutsiaris, A. Thanos, E. Poulakou-Rebelakou

    Esquema Esquema
  • ·UP-02.03 : History of vasectomy

    Página :252

    P. Kumar, A. Chowdhury, J. Pati

    Esquema Esquema
  • ·UP-02.04 : The renal colic of the Byzantine emperor John VI Cantacuzenus (1347-1354)

    Página :252-253

    E. Poulakou-Rebelakou, E. Koutsiaris, C. Tsiamis, A. Rempelakos

    Esquema Esquema
  • ·UP-02.05 : Venereal diseases in early 20th century Greece

    Página :253

    E. Poulakou-Rebelakou, C. Tsiamis, E. Koutsiaris

    Esquema Esquema
  • ·UP-02.06 : Urology in Islamic medicine

    Página :253

    A. Al Dayel

    
  • ·UP-02.07 : Single drug therapy in the treatment of male sexual/erectile dysfunction in Islamic medicine

    Página :253-254

    A. Al Dayel, N. Al Zuhair

    Esquema Esquema
  • ·UP-02.08 : The history of the first urology department in the world

    Página :254

    R. Sosnowski, T. Demkow, W. Rogowski, A. Borowka

    Esquema Esquema
  • ·UP-02.09 : Penile adorning through ages, from “way of life” to “life style”

    Página :254

    M. Omar, A. Hussain, H. Motiwala, O. Karim

    Esquema Esquema
  • ·UP-02.10 : On social responsibility of genito-urology in Agenda 21

    Página :254

    E. Neu, M. Michailov, J. Stiglmayr, J. Hess, C. Reiser, B. Zoepfl, H. Zoepfl

    Esquema Esquema
  • ·UP-02.11 : Psychosomatics in genito-urology

    Página :255

    M. Michailov, L. Steib, E. Neu, H. Schumitz, U. Welscher, G. Weber

    Esquema Esquema
  • ·UP-02.12 : Long-term experience with Memotherm urethral stents in the management of BPH and urethral strictures

    Página :255

    R. Shimpi

    Esquema Esquema
  • ·UP-02.13 : Urology in Iraqi Kurdistan

    Página :255

    C. Evans

    
  • ·UP-02.14 : Scrotoscopy: a new diagnostic and therapeutic tool

    Página :255-256

    R. Shimpi

    Esquema Esquema
  • ·UP-02.15 : A prospective study on therapeutic advice provided by an expert computer system designed to assess lower urinary tract symptoms

    Página :256

    R. John, P. Sanders, C. Chilton, M. Henley

    Esquema Esquema
  • ·UP-02.16 : Global better sex survey: South Africa

    Página :256

    E. Baraldi

    Esquema Esquema
  • ·UP-02.17 : Development of a Farsi questionnaire to assess the knowledge of primary school teachers about voiding dysfunction of students in West Azerbaijan Province, Iran

    Página :256

    D. Mehraban, S. Samadzadeh, M. Moosavi, M. Salehi

    Esquema Esquema
  • ·UP-02.18 : Laparoscopic training protocol using small animal model in urology

    Página :257

    W. Cho, T. Kim, G. Kong, J. Yoon, K. Sung

    Esquema Esquema
  • ·UP-02.19 : Prostate cancer detection in men with an initial diagnosis of atypical small acinar proliferations

    Página :257

    C. Chabert, S. Napaki, P. Mancuso

    Esquema Esquema
  • ·UP-02.20 : Predicting the risk factors of inguinal hernia following radical retropubic prostatectomy

    Página :257

    Y. Ou, C. Twu, C. Cheng, H. Ho, C. Yang

    Esquema Esquema
  • ·UP-02.21 : The evolution of radioimmunoscintigraphy: sharper images and outcomes data

    Página :257-258

    M. Manyak

    Esquema Esquema
  • ·UP-02.22 : Superior anti-tumor immune response of dendritic cells fused with prostate cancer cells compared with tumor lysate-pulsed dendritic cells

    Página :258

    C.S. Kim, J.M. Lee, B.H. Chung, H.Y. Choi

    Esquema Esquema
  • ·UP-02.23 : Biochemoimmunotherapy (BCITx) consisting of autologous tumour derived freeze-dried exosomes with resuspended encapsulated vinorelbine termed as exosomal-vinorelbine-tartrate (EVT) (under patent) induces apoptosis in metastatic hormone refractory prostate Ca (MHRPC)

    Página :258-259

    J. Giannios, P. Lambrinos, N. Alexandropoulos

    
  • ·UP-02.24 : Clinical value of PSA parameters for detection of prostate cancer in Chinese people: 325 cases

    Página :259

    X.R. Zhang, Y.M. Xu, J. Zhang

    Esquema Esquema
  • ·UP-02.25 : Fatigue, prostate cancer and exercise

    Página :259

    B. Serdà

    Esquema Esquema
  • ·UP-02.26 : Use of intravesical temperature as core body temperature following kidney transplantation and comparision with rectal, axillary and oral measurement

    Página :259

    H. Ahmadnia, M. Khaje Daluee, M. Mojahedi, D. Soroush

    Esquema Esquema
  • ·UP-02.27 : The association between genetic variant of luteinizing hormone and the incidence and prognosis of prostate cancer in groups of multi-ethnic origin

    Página :259-260

    A. Thwaini, M. Naase, F. Chinegwundoh, S. Baithun, R. Ahmed, D. Morgan, L. Richard, R. Iles

    Esquema Esquema
  • ·UP-02.28 : Effect of finasteride flutamide, cyproterone acetate and castration on rat’s prostate vascularity

    Página :260

    A. Yarmohamadi, H. Ahmadnia, M. Darabi, B. Feizzadeh, A. Gaviandam Titkanlo

    Esquema Esquema
  • ·UP-02.29 : Molecular biological analysis of the heterogeneous prostate cancer group Gleason score 7

    Página :260

    C. Mian, M. Lodde, E. Comploj, F. Marziani, A. Chicchetti, A. Spada, M. Mian, A. Pycha, L. Lusuardi

    Esquema Esquema
  • ·UP-02.30 : Analysis of gene expression in prostate cancer circulating tumour cells (CTCs) allows rational targeting of therapy for androgen independent prostate cancer

    Página :260-261

    G. Shaw, T. Purkiss, D. Prowse, T. Oliver

    Esquema Esquema
  • ·UP-02.31 : The role of body-coil MR imaging in the preoperative staging of prostate cancer patients before radical protstatectomy

    Página :261

    M. Abdel-Khalek, A.F. El-Sherbeny, E. Ibrahiem

    Esquema Esquema
  • ·UP-02.32 : Does transrectal ultrasound add value in the staging of clinical T3a prostate cancer?

    Página :261

    C. Hsu, S. Joniau, R. Oyen, T. Roskams, H. Van Poppel

    Esquema Esquema
  • ·UP-02.33 : Anatomical basis for pelvic lymph node dissection during radical perineal prostatectomy: results of an autopsy study and implications for the clinic

    Página :261-262

    E. Veliev, I. Li, V. Motalov

    Esquema Esquema
  • ·UP-02.34 : Early use of the vacuum constriction device following radical retropubic prostatectomy: a randomized clinical trial

    Página :262

    M. Monga, T. Kohler, K. Hendlin, I. Ryndin, B. Canales, D. Weiland, N. Nakib, A. Ramani, K. Anderson, P. Reddy, R. Ugarte

    Esquema Esquema
  • ·UP-02.35 : Clinicopathological evaluation of radical retropubic prostatectomy: positive outcome even at institutes with very few experiences

    Página :262

    T. Okamura, H. Akita, Y. Hashimoto, K. Tozawa, K. Kohri

    Esquema Esquema
  • ·UP-02.36 : Immune response and anti-tumor activity of preoperative peptide vaccination for patients with localized prostate cancer

    Página :262-263

    M. Noguchi, Y. Akihisa, M. Harada, J. Mizoguchi, O. Nakashima, K. Itoh, K. Matsuoka

    Esquema Esquema
  • ·UP-02.37 : The role of testosterone in regulation of the expression of genes of several proliferation factors

    Página :263

    A. Pechersky, O. Loran, V. Pechersky, M. Vonsky, A. Mittenberg, V. Semiglazov

    Esquema Esquema
  • ·UP-02.38 : The role of testosterone in regulation of the pulse mode of incretion of some hormones and mytotic activity

    Página :263

    A. Pechersky, V. Semiglazov, O. Loran, A. Karpischenko, V. Pechersky, V. Mazurov

    Esquema Esquema
  • ·UP-02.39 : Important role of the adipocyte-cancer cell interaction in the prostate cancer

    Página :263-264

    Y. Satoh, A. Kaneko, Y. Tokuda, C. Fujiyama, J. Uozumi

    Esquema Esquema
  • ·UP-02.40 : Transrectal color Doppler ultrasonography monitoring neurovascular bundle blockade relieves pain during prostate biopsy

    Página :264

    Y. Nasu, N. Ono, E. Ando

    Esquema Esquema
  • ·UP-02.41 : A comparative study of fascin expression in adenocarcinomas of the prostate gland and urothelial carcinomas

    Página :264

    F. Karasavvidou, T. Anagnostou, E. Tziastoudi, V. Tzortzis, G. Moutzouris, M. Melekos, G. Koukoulis

    Esquema Esquema
  • ·UP-02.42 : Quantitative proteomic approaches for the determination of carcinogenesis biomarkers in prostate tissue

    Página :264-265

    S. Tyritzis, G. Spiros, P. Zerefos, A. Papadopoulou, A. Vlahou, C. Tamvakopoulos, S. Kossida, J. Diaz, K. Pavlakis, C. Constantinides

    Esquema Esquema
  • ·UP-02.43 : A single surgeons’ experience in the efficacy of three modalities for the management of prostate cancer

    Página :265

    J. Bennett, P. Alphonse, N. Smith, S. Hill

    Esquema Esquema
  • ·UP-02.44 : Review of 220 radical prostatecomies done by one surgeon

    Página :265

    P. De Bruin, P. Nicolle

    Esquema Esquema
  • ·UP-02.45 : Should radical prostatectomy become standard procedure at low-volume hospitals? Findings of a patient survey

    Página :265-266

    X. Krah, G. Atanassov, E. Klose, G. Eschholz

    Esquema Esquema
  • ·UP-02.46 : Dynamic contrast enhanced magnetic resonance (DCE-MR) imaging: a useful modality for the early diagnosis of prostate cancer

    Página :266

    T. Watanabe, K. Wada, M. Inoue, S. Uehara, K. Monden, T. Saika, Y. Nasu, H. Kumon, N. Akazawa, I. Togami

    Esquema Esquema
  • ·UP-02.47 : Laparoscopy assisted radical retropubic prostatectomy (LARRP): initial experience

    Página :266

    W. Ko

    Esquema Esquema
  • ·UP-02.48 : The sensitivity of prostate octant biopsy in detection of clinical T1c prostate cancer

    Página :266-267

    B. Elias, R. Tomaskin, K. Kajo, J. Luptak, J. Svihra, J. Kliment

    Esquema Esquema
  • ·UP-02.49 : Prophylactic per-operative narrowing of the internal inguinal annulus at radical retropubic prostatectomy decreases the risk of post-operative inguinal hernia

    Página :267

    J. Stranne, G. Aus, S. Bergdahl, J. Damber, J. Hugosson, A. Khatami, L. Roxvall, P. Lodding

    Esquema Esquema
  • ·UP-02.50 : A study of the role of insulin like growth factor 1 (IGF1) and rapamycin sensitive signaling in an androgen independent prostate cancer cell line

    Página :267

    R. John, M. Larvin, S. Thomas, M. Henley

    Esquema Esquema
  • ·UP-02.51 : Initial experience with PET-CT imaging for staging and follow-up of patients with prostate cancer

    Página :268

    P. Malmström, V. Iyer, J. Sörensen, G. Sandblom, M. Häggman, B. Långström

    Esquema Esquema
  • ·UP-02.52 : Prostate cancer treatment with high intensity focused ultrasound (HIFU) by Ablatherm® with real time integrated imaging

    Página :268

    C. Chaussy, S. Thueroff

    Esquema Esquema
  • ·UP-02.53 : High-dose rate iridium-192 afterloading therapy combined with external beam radiotherapy for T1c-T3bN0M0 prostate cancer

    Página :268

    Y. Jo, R. Hara, T. Fujii, M. Yokoyama, S. Miyaji, A. Nagai

    Esquema Esquema
  • ·UP-02.54 : Ten years local high intensity focused ultrasound (HIFU) by Ablatherm® for prostate cancer: profile of side effects

    Página :268-269

    C. Chaussy, S. Thueroff

    Esquema Esquema
  • ·UP-02.55 : Transrectal non-invasive prostate cancer treatment by high intensity focused ultrasound (HIFU). Is available technology identical?

    Página :269

    C. Chaussy, S. Thueroff

    Esquema Esquema
  • ·UP-02.56 : C-reactive protein and white blood cell count after prostate biopsy in patients under antibiotic coverage

    Página :269

    M. Basar, D. Kýlýc, H. Unal, O. Ozluk, H. Basar, E. Batislam

    Esquema Esquema
  • ·UP-02.57 : The effects of garlic on serum prostatic specific antigen

    Página :269

    D. Mehraban, G. Naderi, R. Akbari Gilani, F. Esfahani

    Esquema Esquema
  • ·UP-02.58 : High intensity focused ultrasound therapy for localized prostate cancer

    Página :270

    K.W. Kwak, J. Hong, C. Kim, W. Park, H. Lee, H. Choi

    Esquema Esquema
  • ·UP-02.59 : Laparoscopic radical prostatectomy by a single surgeon in South Korea

    Página :270

    T. Hwang, S. Hong, S. Seo, J. Kim

    Esquema Esquema
  • ·UP-02.60 : Strategy of the treatment for localized prostatic cancer

    Página :270-271

    A. Yasukawa, S. Kouda, T. Oguchi

    Esquema Esquema
  • ·UP-02.61 : Value of the percentage of positive cores in prostatic biopsy to detect extracapsular extension

    Página :271

    A. Barbagelata, F. Gómez Veiga, J. Ponce Dı́az Reixa, L. Alvarez Castelo, E. Romero Selas, S. Pertega, J. Janeiro, P. Casas, M. Gonzalez-Martin

    Esquema Esquema  
  • ·UP-02.62 : Latent carcinoma of the prostate in Turkey: an autopsy study

    Página :271

    C. Güler, F. Aktepe, E. Tüzel, H. Dilek, H. Küçüker, B. Akdoðan, I. Uzun, K. Polat

    Esquema Esquema
  • ·UP-02.63 : Extended 12 systematic prostate biopsy protocol can improve prostate cancer detection

    Página :271-272

    B. Trajcevska-Boskovska, V. Georgiev, Z. Popov, B. Bogoeva, S. Banev

    Esquema Esquema
  • ·UP-02.64 : The results of the study KAPROS in the region of Olomouc

    Página :272

    V. Student, R. Fiala, A. Vidlář, M. Hrabec, M. Grepl

    Esquema Esquema
  • ·UP-02.65 : The relationship of preoperative PSA levels to prostatic weight and tumor size

    Página :272

    B. Furusato, I. Sesterhenn, I. Rosner, D. Osborn, J. Cullen, Y. Chen, C. Davis, D. McLeod

    Esquema Esquema
  • ·UP-02.66 : Can urinary PSA determination improve T-staging of prostate cancer?

    Página :272

    T. Pejcic, J. Hadzi-Djokic, R. Radosavljevic, L. Hajdukovic, B. Milkovic

    Esquema Esquema
  • ·UP-02.67 : Is it possible to predict exact PSA behavior during long-term interval of tumor growth using the mathematical model?

    Página :273

    T. Pejcic, A. Marjanovic, J. Hadzi-Djokic

    Esquema Esquema
  • ·UP-02.68 : Urinary prostate specific antigen: the novel tool for prostate cancer response assessment?

    Página :273

    T. Pejcic, J. Hadzi-Djokic, M. Acimovic, L. Hajdukovic, A. Janjic

    Esquema Esquema
  • ·UP-02.69 : Open radical retropubic prostatectomy: results on 83 patients

    Página :273

    J. Hadzi-Djokic, T. Pejcic, V. Colovic, Z. Filipovic, D. Basic, A. Janjic

    Esquema Esquema
  • ·UP-02.70 : Analysis of complexed prostatic specific antigen and their ratios to detect prostate cancer undergoing a first biopsy with total PSA 4-10ng/ml: a series of 1055 patients

    Página :273-274

    F. Gómez Veiga, A. Barbagelata López, J. Ponce Dı́az-Reixa, S. Pertega, L. Alvarez Castelo, E. Romero Selas, P. Casas Agudo, J. Janeiro Pais, M. Gonzalez Martin

    Esquema Esquema
  • ·UP-02.71 : Application of fractal analysis in the study of prostatic biopsies

    Página :274

    P. Pavlopoulos, N. Kavantzas, P. Kakouri, S. Touloupides, S. Bouzoukas

    Esquema Esquema
  • ·UP-02.72 : Immunohistochemical study of chromogranin A and HER-2 expression in bone metastatic prostate cancer

    Página :274

    T. Taki, Y. Yamada, S. Aoki, K. Nakamura, K. Naruse, M. Tobiume, K. Zennami, R. Katsuda, N. Honda

    Esquema Esquema
  • ·UP-02.73 : High intensity focused ultrasound in the treatment of prostate cancer: preliminary experience

    Página :274-275

    R. Sanseverino, O. Intilla, A. Campitelli, R. Angrisani, U. Di Mauro, G. Napodano

    Esquema Esquema
  • ·UP-02.74 : The relationship between serum PSA level and tumor volume persists in current ERA

    Página :275

    A. Ochiai, P. Troncoso, R.J. Babaian

    Esquema Esquema
  • ·UP-02.75 : The value of PSA in diagnosis of prostate cancer in non-screened population

    Página :275

    V. Vukotic Maletic, S. Cerovic, M. Lazic, S. Savic, M. Kozomara

    Esquema Esquema
  • ·UP-02.76 : The bone loss in patients with prostate cancer treated by different approaches: radical prostatectomy, orchiectomy or hormonal therapy

    Página :275-276

    V. Bucuras, D. Bucuras, R. Bardan

    Esquema Esquema
  • ·UP-02.77 : Challenges to research and management of prostate cancer in a developing economy: A call for international cooperation and support

    Página :276

    A. Popoola, S. Kuranga

    Esquema Esquema
  • ·UP-02.78 : Should we anesthetize for transrectal ultrasound guided biopsy of prostate? A randomized trial comparing local anesthesia versus no anesthesia

    Página :276

    S. Sambandam, N. Sezhian, S. Kothandaraman, G. Suresh, N. Vasdev

    Esquema Esquema
  • ·UP-02.79 : Does methylprednisolone acetate increase the success rate of medical therapy for passing distal ureteral stone?

    Página :276

    S. Falahatkar, S. Tavasoli Yousefabad, M. Salehi, H. Shiri, S. Nikpoor

    Esquema Esquema
  • ·UP-02.80 : Asymptomatic microscopic hematuria and urinary lithiasis

    Página :276-277

    S. Falahatkar, S. Tavasoli Yousefabad, S. Nikpour

    Esquema Esquema
  • ·UP-02.81 : Reliability of dipstick test in urine analysis

    Página :277

    S.A. Asgari, S. Falahatkar, S. Tavasoli Yousefabad, M.B. Mogaddam, S.K. Agamir, M.M. Ghanaei

    Esquema Esquema
  • ·UP-02.82 : Complications of treatment dendritic nephrolithiasis at advanced stages

    Página :277

    E.K. Yanenko, N.A. Lopatkin, A.G. Martov, N.K. Dzeranov

    
  • ·UP-02.83 : Open surgical treatment of patients with dendritic nephrolithiasis

    Página :277-278

    E. Yanenko, N. Lopatkin, A. Martov, N. Dzeranov

    Esquema Esquema
  • ·UP-02.84 : Analysis of the subjective pain and need of analgesics during shockwave lithotripsy

    Página :278

    S. Paick, B. Lee, H. Kim, Y. Lho

    Esquema Esquema
  • ·UP-02.85 : Comparison color Doppler ultrasonography with IVP in ureteral obstruction due to ureteral stone

    Página :278

    H. Ahmadnia, S. Nekoee, A. Yarmohamadi

    Esquema Esquema
  • ·UP-02.86 : The safety of bilateral ureteroscopy for ureteral obstructing calculi

    Página :278

    W. Abu Arafeh, R. Salah Eddin, M. Zilberman

    Esquema Esquema
  • ·UP-02.87 : Comparison of urinary proteins in calcium stone formers and healthy individuals: a case-control study

    Página :278-279

    G. Pourmand, H. Nasseh, A. Sarrafnejad, A. Mojtahedi, A. Mehrsai, D. Hamidi Alamdari, K. Nourijelyani, A. Emamzadeh

    Esquema Esquema
  • ·UP-02.88 : Results of percutaneous nephrostolithotomy (PCNL) in lower calyceal stones

    Página :279

    M.R. Darabi Mahboob, R. Taghavi, R. Mahdavi, H. Ahmadnia

    Esquema Esquema
  • ·UP-02.89 : A comparison between percutaneous nephrolithotomy (PCNL) and open renal surgery for treatment of renal stones: outcomes and complications

    Página :279

    M. Darabi Mahboob, H. Ahmadnia

    Esquema Esquema
  • ·UP-02.90 : Head down, side up: rigid ureteroscopic removal of renal, renal pelvis and upper 1/3 ureteric calculi

    Página :279-280

    D. Sharma

    Esquema Esquema
  • ·UP-02.91 : Treatment of distal ureteric stones: Comparing Dornier S II lithotriptor versus semi-rigid ureteroscopy

    Página :280

    T. Anagnostou, V. Tzortzis, E. Aravantinos, A. Karatzas, G. Moutzouris, M. Melekos

    Esquema Esquema
  • ·UP-02.92 : Selective renal embolization: a successful way to control significant bleeding after percutaneous nephrolithotomy (PCNL)

    Página :280

    T. El-Leithy

    Esquema Esquema
  • ·UP-02.93 : Pitfalls of ESWL referral system in patients with renal stones who had JJ stent insertion

    Página :280

    A. Khan, P. Duncann, B. Maraj, R. Miller

    Esquema Esquema
  • ·UP-02.94 : Safety, efficacy and outcome of holmium laser ureterolithotripsy in patients with renal impairment

    Página :280-281

    A. Safwat, N. Bissada, U. Kumar, M. Taha, A. Gafaar, A. El-Taher, M. Abdalla

    Esquema Esquema
  • ·UP-02.95 : Holmium laser ureterolithotripsy: when is a stent indicated?

    Página :281

    A. Safwat, A. Bissada, U. Kumar, M. Taha, A. Gafaar, M. Abdalla, N. Bissada

    Esquema Esquema
  • ·UP-02.96 : Effects of stone location on outcome of ureteric stones managed by holmium laser lithotripsy

    Página :281

    A. Safwat, N. Bissada, U. Kumar, A. Finkbeiner, M. Taha, A. Gafaar, A. El-Taher, M. Abdalla

    Esquema Esquema
  • ·UP-02.97 : A silent giant ureteric calculus with giant hydronephrosis

    Página :281-282

    R. Puthenveetil, P. Deka, S. Barua, S. Baruah

    Esquema Esquema
  • ·UP-02.98 : Complication of the results and complications between standard and tubeless PCNL

    Página :282

    M. Darabi Mahboob, R. Taghavi, R. Mahdavi, M. Keshvari, K. Tavakoli

    Esquema Esquema
  • ·UP-02.99 : Use of holmium:YAG laser for endoscopic lithotripsy

    Página :282

    A. Hossain, S. Hossain, S. Khan, A. Salam

    Esquema Esquema
  • ·UP-02.100 : Randomized prospective evaluation of nephrostomy tube configuration on post-operative pain

    Página :282

    M. Monga, D. Weiland, J. Kim, S. Best, C. Lee, K. Hendlin, K. Anderson

    Esquema Esquema
  • ·UP-02.101 : Laparoscopic pyelolithotomy in a pelvic kidney and use of nephroscope for stone extraction

    Página :282-283

    R. Maghsoudi, A. Zolfaghari, J. Gholivandan, N. Ghorbani

    Esquema Esquema
  • ·UP-02.102 : Lower tract urinary calculi as an index of urological services in a developing country

    Página :283

    K. Bowa, M. Labib

    Esquema Esquema
  • ·UP-02.103 : Ureteroscopic extraction of difficult ureteral stone

    Página :283

    K. Kim, S. Cho

    Esquema Esquema
  • ·UP-02.104 : Validation of the ureteral stent symptom questionnaire in Turkish patients

    Página :283-284

    L. Tunc, B. Kupeli, M. Ilhan, C. Acar, O. Kara, I. Bozkirli

    Esquema Esquema
  • ·UP-02.105 : Prospective evaluation of interannual variation in 24 hour urine risk factors of CA-Oxalate stone patients and healthy individuals

    Página :284

    S. Yesil, B. Kupeli, L. Tunc, U. Karaoglan, I. Bozkirli

    Esquema Esquema
  • ·UP-02.106 : Is pneumatic ureteroscopic lithotripsy an alternative to extracorporeal shock wave lithotripsy in the treatment of large upper ureteral stones bigger than 10mm?

    Página :284

    M. Arslan, B. Gunlusoy, T. Degirmenci, N. Nergiz, S. Minareci, A. Ayder

    Esquema Esquema
  • ·UP-02.107 : The results of ureteroscopic lithotripsy in the treatment of bilateral ureter stones with different localizations

    Página :284

    M. Arslan, B. Gunlusoy, T. Degirmenci, N. Nergiz, S. Minareci, A. Ayder

    Esquema Esquema
  • ·UP-02.108 : Presentation, outcomes and interventions for renal and ureteric stones presenting in a defined community

    Página :284-285

    P. Davidson, I. Sheerin, C. Frampton

    Esquema Esquema
  • ·UP-02.109 : Comparison of patient-controlled analgesia using alfentanil with intramuscular pethidine in extracorporeal shock wave lithotripsy (ESWL)

    Página :285

    H. Ibrahim, N. Hon, Z. Hussain, D. Brathwaite, K. Hickmott, S. Coppinger

    Esquema Esquema
  • ·UP-02.110 : Results of SWL therapy for renal stone by Storz Modulith SLK

    Página :285

    S. Mousavi-Bahar, S. Amirhasani

    Esquema Esquema
  • ·UP-02.111 : Comparative analysis of age specific values of PSA, free to total PSA ratio, and PSA density in Korean men

    Página :285

    C.Y. Yoon, D.H. Yoon, J.W. Kim, J. Lee, N.S. Kim, D.K. Yoon

    Esquema Esquema
  • ·UP-03.01 : Feasibility of open simple prostatectomy with early vascular control

    Página :286

    M. Labib

    Esquema Esquema
  • ·UP-03.02 : Comparison of selective biochemical and hormonal factors in men with BPH

    Página :286

    A. Lecki

    Esquema Esquema
  • ·UP-03.03 : Disposable bladder (Ellik) evacuators: are they different?

    Página :286

    S. Ravichandran, G. Reddy, D. O’Sullivan

    Esquema Esquema
  • ·UP-03.04 : Is transition zone index useful in assessing bladder outflow obstruction due to benign prostatic hyperplasia? A prospective study

    Página :286-287

    S.L. Sailo, B. Viswaroop, S. Kumar, G. Gopalakrishnan, N.S. Kekre

    Esquema Esquema
  • ·UP-03.05 : Predictive factors affecting urethral stricture development after transurethral resection of the prostate in patients with benign prostatic hyperplasia

    Página :287

    Y. Jeong, J. Lim, B. Park, J. Park, H. Kim, Y. Kim, Y. Park, M. Kim

    Esquema Esquema
  • ·UP-03.06 : A modification in our current TWOC (trial without catheter) methodology and its proposed benefits – A prospective randomized study

    Página :287

    N. Vasdev, A. Thwaini, N. Sezhian, S. Kothandaraman, G. Suresh

    Esquema Esquema
  • ·UP-03.07 : The management of benign prostatic obstruction (BPO) in the third world

    Página :287

    D. Sharma

    Esquema Esquema
  • ·UP-03.09 : The relationship between PSA and prostate volume

    Página :288

    J. Rim, H. Rhew, S. Park, H. Jeong, S. Baik, S. Oh

    Esquema Esquema
  • ·UP-03.10 : The risk factor of delirium after transurethral resection of prostate

    Página :288

    J. Rim, H. Rhew, S. Park, H. Jeong, S. Baik

    Esquema Esquema
  • ·UP-03.11 : Abstract Withdrawn

    Página :288

    
  • ·UP-03.12 : Evaluation of prostate volume, age, serum prostate specific antigen and testosterone in patients with benign prostate hyperplasia with lower urinary tract symptoms

    Página :288-289

    J. Park, M. Lee, Y. Park

    Esquema Esquema
  • ·UP-03.13 : The role of PSA in predicting TURP specimen weight

    Página :289

    H. Ibrahim, N. Lynn, A. Elves, S. Ghiblawi, C. Beacock, S. Coppinger

    Esquema Esquema
  • ·UP-03.14 : Holmium laser enucleation of the prostate combined with mechanical morcellation: The early clinical experience with 44 patients

    Página :289

    Y. Shiraishi, H. Negoro, K. Okubo, T. Okada, S. Moroi, M. Kawakita

    Esquema Esquema
  • ·UP-03.15 : Does detrusor thickness estimated by ultrasound correlate with obstructed urine flowmetry in men with LUTS? A pilot study

    Página :289

    R. Surange, P. Joshi, C. Ong, N. Jeygopal, N. Sharma, M. Gupta

    Esquema Esquema
  • ·UP-03.16 : The importance of intravesical prostate protrusion in predicting bladder outlet obstruction in patients with good urinary flow

    Página :289-290

    H. Ho, K. Lim, K. Foo, M. Wong

    Esquema Esquema
  • ·UP-03.17 : Radiofrequency induced thermotherapy for BPH – 2 year clinical experience

    Página :290

    M. Roslan, M. Wasyl, M. Strzyzewski, J. Gabiga, K. Wegrzyn

    Esquema Esquema
  • ·UP-03.19 : Clinical correlation of prostatic calculi with lower urinary tract symptoms

    Página :290

    K. Ahn, B. Park, S. Jeon, S. Lee, S. Chang

    Esquema Esquema
  • ·UP-03.20 : Comparison of clinical effect after alpha-blocker monotherapy and combination therapy with finasteride in respect of transitional zone volume and transitional zone index in prostate volume less than 40g

    Página :290-291

    S. Yoon, D. Seong, Y. Kim

    Esquema Esquema
  • ·UP-03.21 : Compliance with treatment and surveillance in LUTS/BPH: ensuring evidence based practice

    Página :291

    M. Hehir, J. Graham, K. Riddle, V. Crispin

    Esquema Esquema
  • ·UP-03.22 : Is acute urinary retention (AUR) really linked to prostate volume?

    Página :291

    R. Fourcade, R. Hajj Hassan, A. Qarro, B. Makhoul

    Esquema Esquema
  • ·UP-03.23 : The importance of the role of the cytochrome P450 system in potential drug-drug and drug-herb interactions in the treatment of incontinence and lower urinary tract symptoms

    Página :291

    P. Hartman, T. Larson, L. Mynderse

    Esquema Esquema
  • ·UP-03.24 : The safety and efficacy evaluation of Tamsulosin and Dutasteride and combination therapy in patients with benign prostatic hypertrophy (BPH): a single-blind parallel, randomized, comparative, prospective, phase III trial

    Página :292

    R. Sood, V. Jain

    Esquema Esquema
  • ·UP-03.25 : The effects of finasteride on the expression of hypoxia inducible factor (HIF-1a) and vascular endothelial growth factor (VEGF) in benign prostatic hyperplasia

    Página :292

    A. Lekas, A. Lazaris, M. Chrisofos, A. Papatsoris, D. Lappas, E. Patsouris, C. Deliveliotis

    Esquema Esquema
  • ·UP-03.26 : What is effective and safe dose-raising method in patients with concomitant benign prostatic hyperplasia and hypertension after initial doxazosin 4mg: doxazosin 8mg versus combined therapy with doxazosin 4mg and tamsulosin 0.2mg

    Página :292-293

    I. Cho, J. Kim, K. Lee, K.S. Lee, Y. Chang

    Esquema Esquema
  • ·UP-03.27 : BPO: suprapubic prostatectomy, no cystostomy

    Página :293

    M. Hosseini

    Esquema Esquema
  • ·UP-03.28 : Treatment of benign prostatic hyperplasia through transurethral needle ablation (TUNA): preliminary results

    Página :293

    T. Realfonso, A. Barela, G. Napodano, A. Baio, G. Miracolo, R. Sanseverino

    Esquema Esquema
  • ·UP-03.29 : Preliminary result of a study of converting patients on uroselective alpha-adrenergic blockers to a generic alpha-blocker, Prazosin

    Página :293

    W.J. Chua, G.E. Chiong, R. Kamaraj, E. Kesavan

    Esquema Esquema
  • ·UP-03.30 : A retrospective cost benefit analysis of photoselective vaporization of the prostate (PVP) versus transurethral resection of the prostate (TURP): The UCLA experience

    Página :293-294

    R. Reiter, B. Shurtleff, J. Lam

    Esquema Esquema
  • ·UP-03.31 : Clinical evaluation of urine tumor marker in the diagnosis of urothelial cancer

    Página :294

    H. Ikeda, S. Seko, R. Kanaoka, M. Oki, M. Mizutani, S. Matsuki, H. Sonobe

    Esquema Esquema
  • ·UP-03.32 : A prospective study into the tolerability of side effects of intravesical BCG in the management of superficial bladder cancer

    Página :294-295

    B. Poh, F. Ng

    Esquema Esquema
  • ·UP-03.33 : Relation of lymph node positivity and the periods elapsed between the initial and last TURBT with radical cystectomy and number of TURBT in invasive bladder tumors

    Página :295

    O. Ugurlu, O. Adsan, U. Gonulalan, M. Kosan, O. Akdemir, M. Cetinkaya

    Esquema Esquema
  • ·UP-03.34 : Radical cystectomy and creation of new badder using intestine in bladder cancer

    Página :295

    M. Darabi Mahboob, H. Ahmadnia

    Esquema Esquema
  • ·UP-03.35 : Comparison of the different intravesical chemotherapy agents effects (mitomycin-C, thiotepa, mitomycin-C+thiotepa, BCG) on superficial transitional cell carcinoma of the bladder after TURBT (over 5 years of experience)

    Página :295-296

    A. Yarmohamadi, S. Yarmohamadi

    Esquema Esquema
  • ·UP-03.36 : Immunohistochemical analysis of fascin in low and high grade urothelial carcinomas

    Página :296

    F. Karasavvidou, T. Anagnostou, D. Pappa, V. Tzortzis, G. Moutzouris, M. Melekos, G. Koukoulis

    Esquema Esquema
  • ·UP-03.37 : Preoperative selective internal iliac arterial chemotherapy for invasive bladder cancer

    Página :296

    M. Li, N. Li, Y. Na

    Esquema Esquema
  • ·UP-03.38 : Comparison of urine nuclear matrix protein 22 (NMP22) qualitative tests and urine cytology in the detection of bladder cancer at first presentation and during surveillance

    Página :296-297

    E. Kehinde, K. Kapila, J. Anim, F. Al-Mulla, O. Mojiminiyi, V. Abraham-Varghese

    Esquema Esquema
  • ·UP-03.39 : The XPC genotype might affect p53 alteration in muscle-invasive bladder cancer

    Página :297

    S. Sakano, H. Matsumoto, Y. Kawai, J. Akao, S. Eguchi, T. Hara, K. Nagao, C. Ohmi, H. Matsuyama, K. Naito

    Esquema Esquema
  • ·UP-03.40 : Comparative evaluation of diagnostic performance of urinary bladder cancer antigen and urine cytology in transitional cell carcinoma of the bladder

    Página :297

    D. Mehraban, S. Samadzadeh, M. Moosavi, H. Kayhan

    Esquema Esquema
  • ·UP-03.41 : Atypical urine cytology: wastebasket or valid diagnostic category?

    Página :297-298

    S. Misra, A. Berresford, G. Stockford

    Esquema Esquema
  • ·UP-03.42 : A comparison of the urine ThinPrep® test and MAGE A1-6 RT-nested PCR for the diagnosis of bladder cancer with voided, drainage, and irrigated urine samples

    Página :298

    D. Kim, T. Oh, T. Kwon, Y. Seo

    Esquema Esquema
  • ·UP-03.43 : CT scan and MRI scan findings in metastatic mucin secreting adenocarcinoma of urachal remnant

    Página :298

    M. Omar, M. Sharma, V. Mishra, O. Karim, H. Motiwala

    Esquema Esquema
  • ·UP-03.44 : False-positive lesions detected by fluorescence cystoscopy: A clue to early malignancy?

    Página :298

    K. Hendricksen, P. Moonen, A. van der Heijden, J. Witjes

    Esquema Esquema
  • ·UP-03.45 : Limitations of computerized tomography in staging invasive bladder cancer before radical cystectomy

    Página :298-299

    F. Cabrera Meirás, O. Blanco Carballo, A. Sanchı́s Bonet, G. Duque Ruiz, A. Martin Parada, A. Tejido Sánchez, O. Leiva Galvis

    Esquema Esquema
  • ·UP-03.46 : Assessment of levels of amino acids, polyamines, metanephrines and catheholamines in serum and urine samples in patients with carcinoma of the bladder, adenocarcinoma of the prostate and BPH

    Página :299

    C. Slavov, V. Mitev, L. Mateva, B. Benkova, V. Lozanov, E. Popov

    Esquema Esquema
  • ·UP-03.47 : Efficacy and toxicity of gemcitabine plus cisplatin chemotherapy in advanced or metastatic urothelial carcinoma: The largest single center study from Turkey

    Página :299

    M. Arslan, B. Gunlusoy, T. Degirmenci, N. Nergiz, K. Ýlhan, S. Minareci, A. Ayder

    Esquema Esquema
  • ·UP-03.48 : Apical injection of periprostatic block gives better pain control than traditional basilar injection

    Página :299-300

    J. Jones, C. Nguyen

    Esquema Esquema
  • ·UP-03.49 : Gemcitabine plus cisplatine versus methotrexate, vinblastine, doxorubicin and cisplatin in advanced or metastatic transitional cell carcinoma of bladder

    Página :300

    M. Arslan, B. Gunlusoy, T. Degirmenci, N. Nergiz, S. Minareci, A. Ayder

    Esquema Esquema
  • ·UP-03.50 : Laparoscopic radical cystoprostatectomy with ileal conduit and laparoscopic simple cystectomy with orthotopic bladder reconstruction: Initial 2 cases

    Página :300

    M. Conradie, R. Mierzwinski, F. Nel, G. Dawber

    Esquema Esquema
  • ·UP-03.51 : “Le Bag” ileocaecal neobladder after radical cystectomy for bladder cancer: results from a contemporary experience

    Página :300

    A. Khan, I. Shergill, M. Arya, K. Mammen

    Esquema Esquema
  • ·UP-03.52 : Imaging of renal cell carcinoma and prostate cancer using refractive index radiology

    Página :300-301

    C. Yoon, D. Yoon, D. Sung, J. Lee, A. Kim, C. Oh, J. Je, D. Yoon

    Esquema Esquema
  • ·UP-03.53 : Superficial perineal pouch in males: multidetector-row ct (MDCT) cadaveric study

    Página :301

    C.Y. Yoon, D.J. Sung, D.H. Yoon, S.W. Park, Y.W. Kim, J.J. Kim, D.K. Yoon

    Esquema Esquema
  • ·UP-03.55 : 11C-acetate PET imaging for renal tumor

    Página :301

    N. Oyama, T. Kaneda, M. Nakai, N. Shioyama, Y. Matsuta, Y. Miwa, O. Yokoyama, H. Okazawa, Y. Fujibayashi, Y. Yonekura

    Esquema Esquema
  • ·UP-03.56 : Outcome analysis following surgery for female urethral diverticula using validated instruments

    Página :301-302

    R. Rivera, H. Tunuguntla, P. Barboglio, J. Lone, S. Kim, A. Gousse

    Esquema Esquema
  • ·UP-03.57 : The role of nephrostomy and antegrade stenting in malignant ureteric obstruction

    Página :302

    A. Chowdhury, P. Kumar, C. Lee, V. Nargund, J. Pati

    Esquema Esquema
  • ·UP-03.58 : Clinical implications of image guided biopsy of the indeterminate renal masses

    Página :302

    B. Somani, G. Nabi, J. Hussey, P. Thorpe, J. N’Dow, S. McClinton

    Esquema Esquema
  • ·UP-03.59 : Initial clinical experience and design of a custom trans-urethral ultrasound probe for prostate imaging and guidance during minimally invasive prostate procedures

    Página :302-303

    B. Davis, T. Wilson, L. Mynderse, M. Kadri, D. Dull, S. Barnes, N. Hangiandreaou, J. Greenleaf, R. Robb, D. Holmes

    Esquema Esquema
  • ·UP-03.60 : Does image orientation make a difference in percutaneous renal access?

    Página :303

    R. Kapoor, G. Nitin, M. Anil

    Esquema Esquema
  • ·UP-03.61 : Estimated GFR: modifying the standards for IVU administration in adult patients

    Página :303

    N. Hersey, J. Beatty

    Esquema Esquema
  • ·UP-03.62 : Indole-3-carbinol and 3,3’ diindolylmethane induce apoptosis in human prostate cancer cells

    Página :303-304

    A. Stein, B. Appel, M. Nachshon, A. Haj, F. Fares

    Esquema Esquema
  • ·UP-03.63 : Condylomata acuminata of the lower urinary tract: a case report

    Página :304

    D. Cicin-Sain, N. Kalauz, M. Dominis

    Esquema Esquema
  • ·UP-03.64 : Pelvic lipomatosis (PL) presenting as obstructive uropathy: a case report

    Página :304

    S. Bapat, P. Ketan, P. Satyajeet, Y. Pushkaraj, P. Abhijit

    Esquema Esquema
  • ·UP-03.65 : Laparoscopic treatment for renal hydatid cyst

    Página :304-305

    R. Rabii, H. Essaki, A. Joual, F. Meziane

    Esquema Esquema
  • ·UP-03.66 : Urogenital tuberculosis, a rare disease in Germany. Experiences of a department of urology from 1994 until 2006

    Página :305

    X. Krah, E. Klose, G. Atanassov, G. Eschholz

    Esquema Esquema
  • ·UP-03.67 : da Vinci^® prostatectomy: athermal nerve sparing technique and its effect on erectile recovery, negative margin rates and time efficiency

    Página :305

    R. Fagin

    Esquema Esquema
  • ·UP-03.68 : Ureteroscopic management of ureteral injury during gynecological surgery

    Página :305-306

    M. Nikoobakht, G. Pourmand, A. Mehrsai, A. Emamzadeh

    Esquema Esquema
  • ·UP-03.69 : Preoperative corporal biopsy can predict postoperative results in veno-occlusive erectile dysfunction

    Página :306

    M. Nikoobakht, A. Mehrsai, A. Saraji, A. Meysami, A. Emamzadeh

    Esquema Esquema
  • ·UP-03.70 : The relationship between lipid profile and erectile dysfunction

    Página :306

    M. Nikoobakht, A. Emamzadeh, H. Nasseh, G. Pourmand, A. Mehrsai

    Esquema Esquema
  • ·UP-03.71 : Assessment of sexual function (libido, potency, fertility) in patients before and after renal transplantation

    Página :306

    M. Mahboob Darabi, H. Ahmadnia, R. Taghavi

    Esquema Esquema
  • ·UP-03.72 : Incidence of prostate diseases and analysis of sexual function after prostatic biopsy

    Página :306-307

    S. Dutkiewicz

    Esquema Esquema
  • ·UP-03.73 : Slow releasing antibiotics membrane coated penile prosthesis in preventing prosthetic infections: an experimental rabbit model

    Página :307

    D. Tuglu, M. Basar, G. Bayramoglu, Y. Arica, D. Kilic, O. Bozdogan, E. Batislam

    Esquema Esquema
  • ·UP-03.74 : Sulcus nervi dorsalis penis/clitoridis: a previously unreported pubic structure and its clinical use

    Página :307

    L. Jarolim, J. Sedy, O. Nanka, J. Walro

    Esquema Esquema
  • ·UP-03.75 : Comparing sexual function between suprapubic prostatectomy and TURP in patient with BPH

    Página :307-308

    M. Razaghi, S. Hoseini, H. Kaeami, M. Barghi, S. Niknam

    Esquema Esquema
  • ·UP-03.76 : Evaluation of treatment of erectile dysfunction with phosphodiesterase type 5 inhibitors

    Página :308

    P. Chandrasekar, G. Krishnamoorthy, V. Sundarajan, B. Potluri

    Esquema Esquema
  • ·UP-03.77 : Farsi International Index of Erectile Function questionnaire as a screening tool before the performance of Doppler sonography in Iranian impotent men

    Página :308

    D. Mehraban, S. Shabani-Nia, G. Naderi, S. Kazemeyni, P. Araghi, M. Sedighi, A. Razi

    Esquema Esquema
  • ·UP-03.78 : A novel technique for insertion of semi rigid penile prosthesis in completely fibrosed corpora

    Página :308-309

    M. Omar, V. Mishra, O. Karim, H. Motiwala

    Esquema Esquema
  • ·UP-03.79 : Comparison of sexual activity in smokers and non-smoker men

    Página :309

    M. Hosseini, H. Yarmohammadi

    Esquema Esquema
  • ·UP-03.80 : Chronic pelvic pain in a male patient: joint view of a urologist and an anatomist

    Página :309

    M. Urban, V. Báca, R. Grill, V. Džupa, J. Herácek

    Esquema Esquema
  • ·UP-03.81 : Urodynamic analysis of men with normal prostate less than 20g combined with lower urinary tract symptoms

    Página :309

    Y. Kim, J. Huh, J. Lee

    Esquema Esquema
  • ·UP-03.82 : IVS: A successful technique in treatment of patients with stress urinary incontinence

    Página :309-310

    M. Darabi Mahboob, M. Keshvari, H. Ahmadnia

    Esquema Esquema
  • ·UP-03.83 : Abstract Withdrawn

    Página :310

    
  • ·UP-03.84 : Urinary urgency: using urodynamic parameters to differentiate detrusor overactivity with and without incontinence

    Página :310

    B. Stahl, N. Dwyer, K. Kreder

    Esquema Esquema
  • ·UP-03.85 : Comparative effects of duloxetine, besipirdine, and clomipramine on striated sphincter activity and bladder function in a rabbit model

    Página :310-311

    R. Vela Navarrete, F. Pérez Martı́nez, C. Castilla Reparaz, J. Ferté, H. Bienaymé, P. Attali

    Esquema Esquema
  • ·UP-03.86 : Credibility of abdominal leak point pressure in evaluation of stress urinary incontinence

    Página :311

    S. Yande

    Esquema Esquema
  • ·UP-03.87 : Systematic approach to diagnosis of genitourinary fistula in women

    Página :311

    M. Abdallah, N. Bissada, A. Feinkbeinar

    Esquema Esquema  
  • ·UP-03.88 : Bladder and urethral duplication: a case report

    Página :312

    S. Bapat, K. Pai, S. Purnapatre, P. Yadav, A. Padhye

    Esquema Esquema
  • ·UP-03.89 : Transobturator vaginal tape technique with the use of renal pedicle clamp in female stress urinary incontinence treatment

    Página :312

    S. Onol, F. Onol, H. Inal, S. Onur, O. Kose

    Esquema Esquema
  • ·UP-03.90 : Study of pelvic organ prolapse with dynamic MR imaging

    Página :312

    T. Realfonso, A. Manto, A. Cozzolino, U. Di Mauro, G. Napodano, R. Sanseverino

    Esquema Esquema
  • ·UP-03.91 : A new air-based technique in measurement of urethra pressure profile—T-doc system

    Página :312

    S. Laschke, S. Carl

    Esquema Esquema
  • ·UP-03.92 : Cyclooxigenase-2 expression in pTa/pT1 urothelial bladder carcinoma: the association between immunoreactivity location and tumour recurrence

    Página :312-313

    I. Mokos, J. Pasini, J. Jakic-Razumovic

    Esquema Esquema
  • ·UP-03.93 : 20q13 gain is associated with chromosomal instability in transitional cell carcinomas of the upper urinary tract

    Página :313

    J. Akao, H. Mastuyama, Y. Yamamoto, S. Sakano, K. Naito

    Esquema Esquema
  • ·UP-03.94 : Subdivision of Stage pT3 in urothelial carcinoma of the renal pelvis facilitates detection of patients at high risk for failure

    Página :313-314

    R. Zigeuner, G. Hutterer, T. Chromecki, P. Rehak, C. Langner

    Esquema Esquema
  • ·UP-03.95 : EGFR expression in urothelial carcinoma of the upper urinary tract correlates with disease progression and metaplastic morphology

    Página :314

    R. Zigeuner, G. Hutterer, T. Chromecki, S. Leibl, P. Rehak, C. Langner

    Esquema Esquema
  • ·UP-03.96 : Impact of tumor stage, tumor grade, and vascular invasion on metastasis-free survival of patients with urothelial carcinoma of the upper urinary tract

    Página :314

    G. Hutterer, R. Zigeuner, T. Chromecki, S. Leibl, P. Rehak, C. Langner

    Esquema Esquema
  • ·UP-03.97 : Biological significance of squamous and glandular differentiation in urothelial cell carcinoma of the upper urinary tract

    Página :314-315

    G. Hutterer, R. Zigeuner, T. Chromecki, P. Rehak, C. Langner

    Esquema Esquema
  • ·UP-03.98 : Radical cystectomy for invasive bladder cancer in patients eighty years or older: clinical parameters affecting morbidity

    Página :315

    M. Brausi, M. Gavioli, G. Verrini, G. Peracchia, G. de Luca, G. Simonini, M. Viola

    Esquema Esquema
  • ·UP-03.99 : Bladder tumor development after transitional cell carcinoma of the upper urinary tract is related to tumor location

    Página :315

    T. Chromecki, R. Zigeuner, G. Hutterer, P. Rehak, C. Langner

    Esquema Esquema
  • ·UP-03.100 : COX-2 expression in urothelial carcinomas of the upper urinary tract correlates with tumor progression

    Página :315-316

    T. Chromecki, R. Zigeuner, G. Hutterer, P. Rehak, C. Langner

    Esquema Esquema
  • ·UP-03.101 : Refining of the NMP22 in the diagnosis of bladder cancer

    Página :316

    C. Noh, J. Kim, S. Kim, R. Sung

    Esquema Esquema